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This thesis describes the development and application of solid phase microextraction (SPME) 
as a sample preparation technique for in vivo determination of pharmaceutical residues in fish 
tissue and wastewater. The occurrence, distribution and fate of pharmaceuticals in the 
environment are a subject of concern across the globe due to the impact they may have on 
human life and aquatic organisms. To address this challenge from an analytical perspective, a 
simplified and reliable analytical methodology is required to investigate and determine the 
concentration (bioconcentration factors) of trace pharmaceutical residue in fish tissue and 
environmental water samples (exposure). An improved SPME method, coupled with liquid 
chromatography with tandem mass spectrometry has been developed and applied to both 
controlled laboratory and field-caged fish exposed to wastewater effluent for quantitative 
determination of pharmaceutical residue in fish specific tissue. 
A new SPME configuration based on C18 thin film (blade) was developed and optimized to 
improve SPME sensitivity for in vivo determinations of trace pharmaceuticals in live fish. 
The C18 thin film extraction phase successfully quantified bioconcentrated fluoxetine, 
venlafaxine, sertraline, paroxetine, and carbamazapine in the dorsal-epaxial muscle of living 
fish at concentrations ranging from 1.7 to 259 ng/g. The reproducibility of the method in 
spiked fish muscle was 9-18% RSD with limits of detection and quantification ranging from 
0.08 - 0.21 ng/g and 0.09 - 0.64 ng/g (respectively) for the analytes examined. Fish were 
sampled by in vivo SPME for 30 min to detect pharmaceutical uptake and bioconcentration, 




In addition, a simplified analytical methodology based on SPME was developed and 
optimized for determination and bioconcentration factor of different classes of 
pharmaceuticals residues in fish bile. The reproducibility of the method in spiked fish 
Rainbow Trout  bile was 3-7% RSD with limits of detection (LOD) ranging from 0.3 – 1.4 
ng/mL for the analytes examined. The field application of SPME sampling was further 
demonstrated in Fathead Minnow (Pimephales promelas), a small-bodied fish caged 
upstream and downstream of a local wastewater treatment plant where fluoxetine, 
atorvastatin, and sertraline were detected in fish bile at the downstream location. Also, a 
simple automated analytical method using high throughput robotic system was developed for 
the simultaneous extraction of pharmaceutical compounds detected in surface waters. The 
proposed method successfully determined concentrations of carbamazepine, fluoxetine, 
sertraline, and paroxetine in treated effluent at concentrations ranging from 240 - 3820 ng/L 
with a method detection limit of 2-13 ng/L, and a relative standard deviation of less than 
16%. Application of the method was demonstrated using wastewater from pilot-scale 
municipal treatment plants and environmental water samples from wastewater-dominated 
reaches of the Grand River (Waterloo, ON).  
Finally, 4 and 8-d laboratory exposures were carried out with Rainbow Trout exposed to 
wastewater effluent collected from pilot scale at Burlington, ON. Additionally, wild fish, 
White Sucker (Catostomus commersonii) were collected and sampled from Waterloo and 
Kitchener downstreams containing local municipal effluent. Bioconcentration factors of the 
selected compounds were determined in both fish muscle and bile samples. The results show 
that anti-depressant drugs such fluoxetine, sertraline and paroxetine were uptake in the fish 
 
 v 
muscle and fish bile for both laboratory and field exposure. In summary, exposure of fish to 
micro-pollutants such as pharmaceuticals may be monitored through the analysis of bile, 
particularly at low concentration exposure of pharmaceuticals, where the sensitivity of 
analytical method may be challenged. SPME is a promising simple analytical tool which can 




I would like to take this opportunity to thank my supervisor Prof. Janusz Pawliszyn for 
offering me this challenging yet fascinating project in his group. His guidance, 
encouragement, and patience throughout these years have led to the completion of my thesis. 
Also, I would like to express my deep gratitude to Prof. Mark R. Servos (un-official co-
supervisor) for his guidance, instruction and continuous support for my research at 
University of Waterloo. 
For my committee members, Dr. Tadeusz Gorecki and Dr. Wojciech Gabryelski, I would like 
to thank them for their time and guidance. Special acknowledgement goes out to Dr. Ken 
Oakes for his help and support for the laboratory and field experiments conducted in the 
Biology department. I am grateful for the help of Leslie Bragg, Lisa Bowron and Rajiv 
Tanna for their help and support in setting up laboratory and field fish exposure. 
Finally, I thank all the group members for their help and friendship, especially Dr. Heather 
Lord, Erasmus Cudjoe.  I am also very thankful to all my other co-workers for their 




I dedicate this thesis to God the Father, Son and the Holy Spirit for his love, support and 
encouragement throughout my program. 
 
 viii 
Table of Contents 
AUTHOR'S DECLARATION ............................................................................................................... ii 
Abstract ................................................................................................................................................. iii 
Acknowledgements ............................................................................................................................... vi 
Dedication ............................................................................................................................................ vii 
Table of Contents ................................................................................................................................ viii 
List of Figures ..................................................................................................................................... xiii 
List of Tables ....................................................................................................................................... xv 
List of Abbreviations ......................................................................................................................... xvii 
Chapter 1 ................................................................................................................................................ 1 
Introduction ............................................................................................................................................ 1 
1.1 Emerging contaminants in environment ...................................................................................... 1 
1.2 Pharmaceuticals in aquatic environments .................................................................................... 2 
1.3 Occurrence of pharmaceuticals and their impacts on aquatic organisms ..................................... 2 
1.4 Analytical methodology for determination of pharmaceuticals ................................................... 4 
1.5 Solid phase microextraction: a sample preparation technique ................................................... 12 
1.6 In vivo sampling by SPME ......................................................................................................... 15 
1.7 Calibration methods in SPME .................................................................................................... 15 
1.8 Thesis objectives- analytical challenges of analyzing pharmaceuticals in fish and wastewater 17 
Chapter 2 .............................................................................................................................................. 20 
Study of kinetic desorption rate constants in fish muscle and agarose gel model using solid phase 
microextraction coupled with liquid chromatography with tandem mass spectrometry...................... 20 
2.1 Preamble .................................................................................................................................... 20 
2.2 Introduction ................................................................................................................................ 20 
2.3 Experimental .............................................................................................................................. 24 
2.3.1 Chemicals and materials ..................................................................................................... 24 
2.3.2 Preparation of fibre and SPME procedure .......................................................................... 25 
2.3.3 Desorption of compounds in gel model .............................................................................. 26 
2.3.4 In vivo desorption kinetic study in fish ............................................................................... 27 
2.3.5 Evaluation of PDMS and C18 extraction phase ................................................................... 28 
2.3.6 Instrumental analysis – LC/MS/MS .................................................................................... 29 
2.4 Results and discussion ............................................................................................................... 32 
 
 ix 
2.4.1 Characterization of SPME extraction phase ........................................................................ 32 
2.4.2 Absorption time profile in gel ............................................................................................. 33 
2.4.3 Absorption rate constant in gel ............................................................................................ 34 
2.4.4 Equilibrium partition constant in gel and PBS (pH = 7.4) .................................................. 37 
2.4.5 Desorption rate constant in gel models ................................................................................ 39 
2.4.6 In vivo SPME application in fish muscle ............................................................................. 42 
2.5 Conclusion .................................................................................................................................. 44 
Chapter 3 .............................................................................................................................................. 45 
Determination of Pharmaceutical Residues in Fish Bile by Solid-Phase Microextraction Coupled with 
Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS) ................................................... 45 
3.1 Preamble ..................................................................................................................................... 45 
3.2 Introduction ................................................................................................................................ 45 
3.3 Experimental section .................................................................................................................. 48 
3.3.1 Chemicals and supplies ....................................................................................................... 48 
3.3.2 Fish exposures ..................................................................................................................... 49 
3.3.3 Laboratory exposure to a mixture of pharmaceuticals ........................................................ 50 
3.3.4 Field exposure to municipal wastewater effluents............................................................... 50 
3.3.5 Enzymatic hydrolysis of bile samples ................................................................................. 54 
3.3.6 SPME method optimization ................................................................................................ 54 
3.3.7 Liquid (solvent) extraction .................................................................................................. 55 
3.3.8 Instrumental analysis ........................................................................................................... 56 
3.3.9 Statistical Analysis .............................................................................................................. 57 
3.3.10 Selection of target pharmaceuticals ................................................................................... 57 
3.4 Results and discussion ................................................................................................................ 58 
3.4.1 Method Performance ........................................................................................................... 58 
3.4.2 Single compound laboratory exposure of Rainbow Trout ................................................... 60 
3.4.3 Multi-component laboratory exposure of RBT ................................................................... 64 
3.4.4 Field exposure of fathead minnow ...................................................................................... 67 
3.4.5 Comparison of SPME and traditional methods ................................................................... 72 
3.5 Conclusion .................................................................................................................................. 73 
Chapter 4 .............................................................................................................................................. 74 
 
 x 
Determination of pharmaceutical residues in wastewater using automated thin film solid phase 
microextraction with liquid chromatography-tandem mass spectrometry ........................................... 74 
4.1 Preamble .................................................................................................................................... 74 
4.2 Introduction ................................................................................................................................ 74 
4.3 Experimental .............................................................................................................................. 77 
4.3.1 Chemical and material ........................................................................................................ 77 
4.3.2 Automation of sample preparation steps with PAS concept 96 auto sampler .................... 77 
4.3.3 Instrumental analysis (LC/MS/MS) .................................................................................... 78 
4.4 Thin film solid phase microextraction procedure ...................................................................... 79 
4.4.1 Extraction phase: Comparison of C18 fibre and thin film .................................................... 79 
4.4.2 Extraction and desorption time determination .................................................................... 80 
4.4.3 Effect of salt and pH on extraction efficiency .................................................................... 81 
4.4.4 Application to real samples ................................................................................................. 81 
4.4.5 Matrix effect study .............................................................................................................. 82 
4.5 Results and Discussion .............................................................................................................. 83 
4.5.1 Selection of extraction phase .............................................................................................. 83 
4.5.2 Effects of salt and pH on extraction efficiency ................................................................... 85 
4.5.3 Optimization of extraction and desorption conditions ........................................................ 86 
4.6 Method performance .................................................................................................................. 88 
4.6.1 Extraction efficiency (recovery) and sensitivity ................................................................. 88 
4.6.2 Linear range, detection and quantification limits ................................................................ 90 
4.6.3 Inter-day reproducibility in spiked wastewater ................................................................... 91 
4.6.4 Matrix effect ........................................................................................................................ 92 
4.6.5 Validation of SPME with traditional solid phase extraction (SPE) .................................... 95 
4.6.1 Application of the method to wastewater (effluent) from Burlington pilot plant and Grand 
River water samples ..................................................................................................................... 97 
4.7 Conclusion ............................................................................................................................... 103 
Chapter 5 ............................................................................................................................................ 104 
Optimization of solid phase microextraction for non-lethal in vivo determination of selected 
pharmaceuticals in fish muscle using liquid chromatography – mass spectrometry ......................... 104 
5.1 Preamble .................................................................................................................................. 104 
5.2 Introduction .............................................................................................................................. 104 
 
 xi 
5.3 Theoretical considerations ........................................................................................................ 105 
5.4 Experimental ............................................................................................................................ 107 
5.4.1 Chemicals and materials .................................................................................................... 107 
5.4.2 Fish exposure ..................................................................................................................... 108 
5.4.3 Thin film extraction phase preparation .............................................................................. 109 
5.4.4 Instrumental analysis – LC/MS/MS .................................................................................. 111 
5.4.5 In vitro evaluation of performance of thin film and fibre geometries in spiked fish tissue
 .................................................................................................................................................... 112 
5.4.6 Extraction kinetics of pharmaceuticals .............................................................................. 113 
5.4.7 Laboratory exposure of Rainbow Trout to wastewater effluent ........................................ 114 
5.4.8 Field caging of fathead minnow in municipal wastewater ................................................ 115 
5.4.9 Results and discussion ....................................................................................................... 116 
5.5 Conclusion ................................................................................................................................ 127 
Chapter 6 ............................................................................................................................................ 129 
Development and evaluation of new in vivo SPME device (sampler) for rapid sampling of 
pharmaceuticals in fish using LC/MS/MS ......................................................................................... 129 
6.1 Preamble ................................................................................................................................... 129 
6.2 Introduction .............................................................................................................................. 129 
6.3 Experimental ............................................................................................................................ 131 
6.3.1 Chemicals and material ..................................................................................................... 131 
6.3.2 New in vivo SPME device (sampler) ................................................................................. 131 
6.3.3 Evaluation of new in vivo device in spiked gel and fish muscle ....................................... 134 
6.3.4 In vivo sampling in Rainbow Trout exposed to municipal effluent in laboratory and field 
monitoring of wild fish ............................................................................................................... 135 
6.4 Result and discussion ............................................................................................................... 136 
6.4.1 Evaluation of extraction phase of in vivo SPME device .................................................... 136 
6.4.2 In vivo evaluation of new sampler in fish exposed to effluent in the laboratory and wild fish
 .................................................................................................................................................... 138 
6.5 Conclusion ................................................................................................................................ 139 
Chapter 7 ............................................................................................................................................ 141 
Laboratory and field study of bioconcentration of pharmaceutical residues in fish muscle and bile 
using solid phase microextraction coupled with liquid chromatography-tandem mass spectrometry 141 
 
 xii 
7.1 Preamble .................................................................................................................................. 141 
7.2 Introduction .............................................................................................................................. 141 
7.3 Experimental ............................................................................................................................ 143 
7.3.1 Chemicals and materials ................................................................................................... 143 
7.3.2 Laboratory exposure of Rainbow Trout to municipal effluent ......................................... 144 
7.3.3 In vivo and in vitro SPME sampling of pharmaceutical residues in fish bile and muscle 145 
7.3.4 Wild White Sucker sampling adjacent wastewater outfalls .............................................. 147 
7.3.5 Instrumental analysis – LC/MS/MS .................................................................................. 147 
7.4 Results and discussion ............................................................................................................. 148 
7.4.1 Laboratory verification of pharmaceutical uptake and bioconcentration .......................... 148 
7.4.2 Bioconcentration of pharmaceuticals in fish bile .............................................................. 152 
7.4.3 Bioaccumulation of pharmaceuticals in wild White Sucker ............................................. 157 
7.4.4 Bioconcentration of pharmaceuticals in wild White Sucker bile ...................................... 159 
7.5 Conclusion ............................................................................................................................... 161 
Chapter 8 ............................................................................................................................................ 163 
Summary and future directions of SPME technique .......................................................................... 163 
8.1 Summary of applications of SPME technique ......................................................................... 163 
8.1.1 Bioconcentration of pharmaceuticals in fish tissues: Analytical perspective ................... 163 
8.1.2 In vivo sampling and monitoring of pharmaceuticals in living organism ......................... 164 
8.1.3 High throughput analysis of pharmaceuticals in wastewater ............................................ 165 
8.2 Future direction of the SPME technique .................................................................................. 166 
8.2.1 In vivo sampling by SPME for environmental analysis .................................................... 166 
8.2.2 Rapid sampling of organic contaminants in fish with new in vivo sampler ...................... 167 




List of Figures 
Figure 1:1 Sources and distribution of pharmaceuticals in the environment15 ....................................... 4 
Figure 1:2 Schematic of equilibrium partitioning of analytes between the sample matrix and SPME 
extraction phase .................................................................................................................................... 14 
Figure 1:3 Structures of the selected pharmaceuticals utilized in the study ......................................... 18 
Figure 2:1 Extraction efficiency of PDMS and C18 fibres in phosphate buffer solution (PBS pH = 7.4)
 .............................................................................................................................................................. 29 
Figure 2:2 Extraction (absorption) time profiles of carbamazepine, diazepam, and nordiazepam in gel 
sample (0.9% w/v) at room temperature (25 oC). ................................................................................. 34 
Figure 2:3Absorption time profiles of carbamazepine (♦), diazepam (■), and nordizepam (▲) in gel; 
sample (0.9% w/v) at room temperature (25 oC). ................................................................................. 36 
Figure 2:4 Equilibrium recovery studies of carbamazepine, diazepam, and nordizepam in gel sample 
(0.9% w/v) and phosphate buffer solution (PBS). ................................................................................ 37 
Figure 2:5 Schematic diagram of experimental model for the study of mass transfer rate constant in 
agarose gel, dead and live fish muscle ................................................................................................. 41 
Figure 3:1 Description of field caging of Fathead Minnow (Pimephales promelas) along the Grand 
River at different locations for 2 weeks (Doon WWTP - Kitchener wastewater treatment plant) ....... 51 
Figure 3:2 Workflow of field exposure of fathead minnow in the Grand River near wastewater fall. 
This figure shows the experimental step by step approach for the caging and sampling of fathead 
minnow fish tissue by SPME technique. .............................................................................................. 53 
Figure 3:3 Comparison of extraction efficiency (recovery) of two extraction phases 
(Polydimethylsiloxane- PDMS and C18) ............................................................................................. 58 
Figure 3:4 Comparison of SPME and liquid-liquid extraction (LLE) method results for fluoxetine... 60 
Figure 3:5 Comparison of amount extracted before and after enzyme assisted hydrolysis for A) 
fluoxetine, B) carbamazepine, C) norfluoxitine (SPME-NE = solid phase microextraction without 
enzyme hydrolysis, SPME-E = solid phase microextraction with enzyme) ......................................... 62 
Figure 4:1 Extraction efficiency of C18 fibre and thin film coating for the target pharmaceuticals 
spiked phosphate buffer solution at pH = 7.4 ....................................................................................... 84 
Figure 4:2 Effect of pH on the extraction efficiency of the newly developed SPME thin film method
 .............................................................................................................................................................. 85 
Figure 4:3Effect of ionic strength on the extraction efficiency of the method ..................................... 86 
Figure 4:4 Extraction time profiles of the selected pharmaceuticals in spiked water .......................... 87 
 
 xiv 
Figure 4:5 Investigation of extraction efficiencies and reproducibility of the method in 10 discrete 
repeated analyses over 4 days in 2 ng/mL water spiked with target compounds ................................. 92 
Figure 4:6 Comparisons of slopes of calibration in spiked d5-diazepam (A) and d10-carbamazepine 
(B) in neat standard and waste sample extract ..................................................................................... 93 
Figure 4:7 Comparisons of concentrations of fluoxetine (A) and carbamazepine (B) between   SPME 
method and traditional method (SPE) .................................................................................................. 96 
Figure 4:8  Chromatogram of the sample extract from wastewater collected from Grand River at 
Kitchener downstream site ................................................................................................................. 101 
Figure 4:0:9 Concentration of selected pharmaceuticals detected and quantified in Grand River at 
Waterloo and Kitchener downstream sites ......................................................................................... 102 
Figure 5:1Schematic diagram of the C18 SPME extraction phase geometries used in this study. Both 
configurations utilize 45 µm coating thicknesses over a 1.5 cm coating length. A is a C18 cylindrical 
fibre (core of 200 µm diameter, length of 40 mm, extraction phase surface area of  8.1 mm2 (shown  in 
hypodermic needle);   B is C18 thin film extraction phase (core of 40 mm ×  2.1 mm × 0.07 mm and 
extraction phase surface area of  65.4 mm2. ....................................................................................... 110 
Figure 5:2 Extraction kinetics of fluoxetine (A) and carbamazepine (B) in spiked gel (1% w/v) using 
C18 thin film and fibre extraction phase geometries, extraction kinetics of ibuprofen (C) and 
gemfibrozil (D) in spiked gel (1% w/v) using C18 thin film and fibre extraction phase geometries .. 120 
Figure 6:1 Schematic diagram of in vivo tissue sampling device (above). In vivo SPME device with 
PDMS biocompatible coating (Top) Depressing the plunger exposes 1.5 cm SPME coating during the 
extraction. (Bottom) The device is shown retracted for storage. (University of Waterloo machine shop 
made this device for us) ..................................................................................................................... 133 
Figure 6:2  In vivo SPME device being used for sampling pharmaceuticals in live fish ................... 134 
 
 xv 
List of Tables 
Table 1:1 Advantages and limitations of commonly used sample preparation techniques for 
pharmaceutical analysis in aquatic organisms and environmental samples
31-38
 ..................................... 6 
Table 1:2 Analytical methodologies for determination of pharmaceuticals in fish tissues14, 39-51 .......... 9 
Table 2:1 a The retention time and MS parameters of the compound studied using Varian MS/MS. . 30 
Table 2:2 Limits of detection and quantification in gel and fish muscle .............................................. 32 
Table 2:3 Absorption rate constant in gel sample (0.9 % w/v) ............................................................ 35 
Table 2:4 Physico-chemical properties of the compounds 98, 99 ............................................................ 38 
Table 2:5 Desorption rate constant of selected drugs in different concentration of gel and 
unhomogenized fish tissue ................................................................................................................... 39 
Table 2:6 a   In vivo desorption time constant in Rainbow Trout muscle ............................................ 42 
Table 3:1 Extraction efficiency (%) and precision of SPME method in spiked bile at two different 
concentration levels using PDMS fibre ................................................................................................ 59 
Table 3:2 Bioconcentration factor of carbamazepine, fluoxetine in Rainbow Trout muscle and bile of 
single compound laboratory exposure .................................................................................................. 64 
Table 3:3 Physico-chemical properties of pharmaceuticals107, 129-130 and concentration of the 
compounds measured in exposure water, Rainbow Trout muscle and bile after 8-day laboratory 
exposure (3 ng/mL) .............................................................................................................................. 66 
Table 3:4a Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor 
of pharmaceuticals detected in fish bile of fathead minnow caged in the field near a municipal 
effluent outfall (n=6). ........................................................................................................................... 69 
Table 4:1Optimized extraction and desorption conditions for analysis of the selected pharmaceuticals 
in spiked water ...................................................................................................................................... 88 
Table 4:2  Method performance in wastewater effluent spiked with 0.5 and 2 ng/ml of analyte ........ 89 
Table 4:3Detection, quantification limit, correlation co-efficient (r2), and weighting ......................... 91 
Table 4:4 Comparison of the slope of linear regression of deteurated standard in spiked neat (pure) 
solvent and wastewater extract over dynamic range (0.039 -20 ng/ml) ( n = 3) .................................. 94 
Table 4:5 Concentration (ng/mL) of the target pharmaceutical compounds detected by thin film 
microextraction method (n = 3) ............................................................................................................ 98 
Table 5:1Condition of extraction and desorption of spiked compounds in fish tissue at room 
temperature (25 oC) ............................................................................................................................ 113 
 
 xvi 
Table 5:2 Relative extraction efficiencies of C18 thin film and cylindrical fibre configurations using 
fish tissue spiked with 100 ng/g analytes of interest .......................................................................... 117 
Table 5:3 The measured bioconcentrations factors of target pharmaceuticals in dorsal-epaxial muscle 
(ng/g n=5) of Rainbow Trout (Oncorhynchus mykiss) using thin film SPME. The concentration is 
expressed as min-max. Note that fish exposed to 50% CAS N (v/v)  and 50% CAS (v/v)  did not 
survive the 4 d exposure due to high concentrations of ammonia found in the effluent in these 
treatments. .......................................................................................................................................... 122 
Table 5:4 Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of 
pharmaceuticals detected in fish muscle of fathead minnow caged in the field near a municipal 
effluent outfall (n=6). Wastewater samples were extracted by solid phase extraction (SPE). Sites 1 
and 2 are 1.2 and 0.5 km upstream of the Doon outfall (respectively), while sites 3, 4, and 5 are 0.5, 
1.7, and 5.6 km downstream, respectively. ........................................................................................ 126 
Table 6:1 Extraction recovery of the target compounds in spiked gel sample at equilibrium ........... 137 
Table 6:2 Limit of detection in homogenized fish tissue and gel ...................................................... 137 
Table 6:3 The measured concentration and bioconcentrations factors of target pharmaceuticals in 
dorsal-epaxial muscle (ng/g , ±standard deviation)) of rainbow trout (Oncorhynchus mykiss) in 
laboratory 8-day exposure using new SPME device. Water concentration was determined by solid 
phase extraction. ................................................................................................................................ 138 
Table 7:1 The measured bioconcentrations factors of target pharmaceuticals in dorsal-epaxial muscle 
(ng/g , ±standard deviation)) of Rainbow Trout (Oncorhynchus mykiss) in laboratory exposure using 
thin film SPME. ................................................................................................................................. 149 
Table 7:2 Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of 
pharmaceuticals detected in fish bile of Rainbow Trout (Oncorhynchus mykiss) in a 4-day laboratory 
exposure using SPME method. .......................................................................................................... 153 
Table 7:3 Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of 
pharmaceuticals detected in fish bile of Rainbow Trout (Oncorhynchus mykiss) in a 8-day laboratory 
exposure using SPME method. .......................................................................................................... 155 
Table 7:4 Bioaccumulation factors of pharmaceutical residues in wild White Sucker muscle collected 
near a municipal effluent outfall in downstream Waterloo and Kitchener ........................................ 158 
Table 7:5 Measured bioaccumulation factor of pharmaceuticals in wild White Sucker bile near a 




                                      List of Abbreviations 
a- Time constant  
A- Surface area of a SPME fiber 
α- Effective volume fraction in a tissue 
BCF- Bioconcentration factor 
BAF- Bioaccumulation factor  
C0-   Initial analyte concentration  
CE- Collision energy  
CAS- conventional activated sludge  
CAS-N conventional activated sludge with nitrification  
CAS-BNR- conventional activated sludge with Biological Nitrifying Reactor  
CID- Collision induced dissociation  
CXP- Collision cell exit potential  
CBZ- Carbamazepine 
DP - Declusting potential  
d - Days 
Ds -Diffusion coefficient of analyte in the sample matrix  
EP- Entrance potential  
ESI- Electrospray ionization  
ISTD- Internal standard  
Fibre- extraction phase 
GC -Gas chromatography 
 
 xviii 
HPLC- High performance liquid chromatography 
J- Mass flux  
K- Equilibrium constant of the analyte between the solid fiber surface and the sample matrix   
    -Distribution coefficient of the analyte between the liquid fiber and the sample matrix  
LC- Liquid chromatography  
LOD- Limit of detection 
Log Kow- log of octanol/water partition coefficient 
LOQ- Limit of quantitation 
LLE- Liquid-liquid extraction 
MRM- Multiple reaction monitoring mode 
MDL- Method detection limit 
MS- Mass spectrometer/spectrometry 
MW- Molecular weight  
n- Amount of analyte extracted by SPME fibre at a specific time 
ne -Amount of analyte extracted by SPME fibre at equilibrium  
NA- Not available  
ND- Not detected 
PPCPs- Pharmaceuticals and Personal Care Products 
PBS- Phosphate buffered saline, pH 7.4 
PDMS- Polydimethylsiloxane 
q0- Amount of calibrant preloaded on fibre  
Q- Amount of calibrant remaining on the fibre after extraction 
 
 xix 
QC -Quality control 
Rpm- Revolutions per minute  
RSD- Relative standard deviation  
SPE- Solid phase extraction  
SRM- Selected reaction monitoring mode  
SPME- Solid-phase microextraction 
Z- Diffusion path length 
t- Sampling time  
Vf- Volume of fibre coating  
Vs -Sample volume 














1.1 Emerging contaminants in environment  
The near ubiquitous detection of emerging contaminants is a global issue raising concern among 
scientists, government agencies, and the general public, due to the potential impact of such 
contaminants on human life and aquatic organisms
1-8
. According to the United States 
Environmental Protection Agency (USEPA), “emerging contaminants” can be broadly defined as 
synthetic or naturally occurring chemicals or microorganisms that are not commonly monitored 
in the environment, but have the potential to enter the environment and cause known or 
suspected adverse ecological or human health effects
8
. These contaminants are predominantly 
unregulated despite their potential threat to environmental and human health. Many of these 
contaminants were unrecognized as persisting in environmental comportments until new, 
sensitive analytical methods were developed, hence use of the term “emerging”. Classes of 
environmentally significant emerging contaminants include pharmaceutical and personal care 
products, persistent organic pollutants, perfluorinated and brominated compounds, and 
nanomaterials, among many others. One of the most prominent classes of emerging contaminants 
receiving widespread media and scientific attention are pharmaceutical and personal care 
products, which include chemicals that are used for health or cosmetic purposes
9
. The main 
sources of pharmaceuticals and their metabolites in the environment are either through 
discharges via sewage treatment plant effluents, or by run-off leaching over or through the soil 







1.2 Pharmaceuticals in aquatic environments 
Pharmaceuticals are classified as a large and diverse group of medicinal compounds used for the 
diagnosis, cure, treatment or prevention of disease in humans and animals
9
. The persistence of 
pharmaceuticals and their active metabolites in the aquatic environment, as well as the possible 
effects they may cause on living organisms have recently raised concern, since these compounds 
are not completely removed during sewage treatment processes. Factors that may affect the 
bioavailability of pharmaceuticals and their respective metabolites include their 
physical/chemical properties as well as the conditions of the surrounding ecosystem. As well, the 
environmental distributions of pharmaceutical/metabolites are greatly influenced by their 
properties governing partitioning between different environmental phases.  A number of studies 
have shown that the presence of sediments or particulates phases can dramatically affect 




1.3 Occurrence of pharmaceuticals and their impacts on aquatic organisms 
 The primary source of pharmaceuticals and their metabolites in our environment is municipal 
wastewater continually infused with receiving environments due to the inefficient removal of 
these compounds by municipal treatment plants. Studies indicate that these emerging 
contaminants also enter the environment via disposal of unused or expired pharmaceutical 
products, although this is likely a minor pathway 
12, 15, 16
. In some cases, a significant portion of 
pharmaceuticals are excreted in unmetabolized form as the parent compound, or, if metabolized, 
often retaining biological activity as active metabolites
17
. Some of these compounds may escape 
the wastewater treatment plant with little discernible degradation, with the pharmaceutical 




influent. Upon entering the environment, pharmaceutical pollutants are subject to a number of 
processes such as hydrolysis and photolysis which may, depending on the nature of each 
compound, elicit a chemical transformation of the pharmaceutical. Biodegradation and 
biotransformation are the most common mechanisms depleting drug residues, with seasonal 
variations in temperature and light intensity considered to be significant factors determining the fate of 
pharmaceuticals in surface waters 18, 19, 20.  Figure 1.1 illustrates the major pathways of 
pharmaceutical residues entering and distributing in aquatic environments. The specific 
distribution of pharmaceutical pollutants is dependent on human use, the physicochemical properties of 
the compounds (such as solubility, octanol-water partition coefficient), and compound-specific 
pharmacokinetic/metabolic transformation. In addition, the type of wastewater treatment process (es) 
employed for the removal of pharmaceuticals at a particular site can affect its distribution in surface 
waters. Upon entrance to surface water sources, the pharmaceutical is now available to interact with 
biological receptors, potentially impacting the health of human and aquatic organisms. Recently, it 
was reported environmental pharmaceutical exposure, particularly in drinking water, may result 
in abnormal physiological processes and increase potential for reproductive impairment in 
children, pregnant women
21, 22
. From an environmental perspective, the effects of synthetic 
estrogens used in birth-control pills have been well documented on fish, particularly with respect 








         
Figure 1:1 Sources and distribution of pharmaceuticals in the environment
15
 




1.4 Analytical methodology for determination of pharmaceuticals 
Appropriate analytical methodologies and instrumentation (selectivity and sensitivity) are 
important tools for obtaining reliable data when determining pharmaceutical concentrations in 
environmental water and complex biological samples (e.g. fish tissues). Analytical procedures 
comprise the following steps: sampling, sample preparation, separation, detection, and data 
analysis.  In general, each step is important to ensure accurate results, but sampling and sample 
preparation steps are critical steps affecting the success of the analysis, accounting for over 70-
80% of the analysis time 
26, 27
. The goal of sampling and sample preparation is to isolate and pre-
concentrate analytes of interest from a complex matrix before instrumental analysis for 
quantification. Conversion of analytes in real matrix to suitable isolated states amenable for 
analysis requires an understanding of the interactions of analytes with their matrix based on their 




of analytes can affect the applicability of sample preparation technique in terms of accuracy and 
precision
27
. Consequently, the choice of sample preparation technique for specific analytes in a 
given matrix is critical to ensure reliable analytical results. Table 1.1 summarizes the principle 
and application of sample preparation techniques which are commonly employed for 
pharmaceutical analysis in aquatic matrices. 
Recent advances in analytical instrument capability in combination with sample preparation 
techniques and clean-up procedures have made it possible for more accurate quantification of 
pharmaceuticals and their metabolites in complex matrices. Moreover, chromatographic 
resolution as well as detection sensitivity and specificity have increased considerably in recent 
years. Gas and liquid chromatographic techniques, in combination with mass spectrometry 
detectors, are two commonly used analytical methodologies for analysis of pharmaceuticals in 
environmental and biological samples
28, 29
. In the case of gas chromatography–mass 
spectrometry (GC–MS or GC-MS
2
) methods, derivatizations of acidic compounds (polar 
compounds) are often required before analysis because pharmaceuticals have high polarity and 
ionizability. However, liquid chromatography–mass spectrometry (LC–MS) and LC–tandem MS 
do not require a derivatization step, thereby making the technique suitable for analysis of polar 
pharmaceuticals and their metabolites in aqueous environmental samples
30
. Table 1.2 
summarizes the different sample preparation techniques and analytical methodologies used for 









Table 0:1 Advantages and limitations of commonly used sample preparation techniques for 






Principles of extraction Advantages Limitations 
Liquid-liquid 
extraction (LLE) 
Partitioning of analytes 
between two immiscible 
liquid (equilibrium 
partition) based on 
solubility and log Kow 
of the analytes. 
Applicable for aqueous 
samples. 
-Exhaustive extraction 
of analytes through 
repeated extraction. 
-Cheap solvent for 
extraction of semi-
volatile compounds. 
-Labor intensive and 
time consuming, 
low/variable recovery. 
-Large usage of 
solvent and sample, 
disposal of solvent. 
Clean up step required. 
-Poor selectivity and 





partitioning of analytes 
to extraction phase 
based on affinity of 
analytes. Applicable for 
aqueous samples. 
-Exhaustive extraction 
technique with good 
recovery. 
-Requires less solvent 
compared to LLE. 
-Automation possible 
for high throughput. 
- Multiple steps can 
introduce larger 
uncertainty in results. 
-Labor intensive and 
time consuming. 
-Requires selection of 








Partitioning of analyte 
from solid matrix to 





minimal use of solvent. 
-Fully automated for 
high throughput. 
- Initial equipment 
cost is high. 
-Large amount of 





(ASE) solubility increases and 
mass transfer is faster. 
Applicable for solid 
samples. 
-Exhaustive extraction 
technique with good 
recovery. 
- Multiple steps are 
involved including a 
clean-up step. 
-Poor selectivity and 





Partition, adsorption and 
interaction of analytes in 
solid matrix with solid 
support bonded-phase, 
eluting solvent using 
mechanical blending to 
produce complete 
sample disruption. 
Applicable for solid 
samples. 
 
- Rapid and 
inexpensive technique, 
it uses a smaller size of 
sample combined with 
lower solvent 
consumption. 
- Exhaustive extraction 
technique with good 
recovery. 
-Labor intensive and 
time consuming. 
- Multiple steps can 
introduce larger 
uncertainty in results. 
- Clean up steps may 
be required. 

















Analyte partition into 
the extraction phase 
(triolein) by diffusion 
across a membrane. It is 
based on solubility of 
analytes in triolein 
(extraction phase) and 
diffusion co-efficient of 
analytes of interest. 
Applicable for aqueous 
samples. 
 




analytes in water 
sample. 
-It is relatively less 
expensive. 





-Labor intensive and 
time consuming.  
-Multiple steps can 
introduce larger 
uncertainty in results. 












Analyte partition into 
the extraction phase 
(sorbent) by diffusion 
across the membrane. It 
is based on affinity of 
analytes to the sorbent 
used. 
Applicable for aqueous 
samples. 




analytes in water 
samples. 
-It is relatively less 
expensive 
- Good for passive 
sampling of polar 
compounds 
-Labor intensive and 
time consuming,  
-Multiple steps can 
introduce larger 
uncertainty in results. 









absorption of analytes to 
the extraction phase 
(sorbent) based on the 








sample volume and 
least solvent compared 
to other approaches. 
-Automation possible 
for high throughput 
- Applicable for in vivo 
sampling in living 
organism 
-Susceptible to low 
recovery of analytes in 
biological samples. 
 
-Possibility of fibre 
fouling and 
competition effect. 
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Most of the target 
compounds were 
detected in fish 
muscle and liver 
44 
Diclofenac Fish bile SPE HPLC-ESI-
MS/MS and 
QTOF 
Diclofenac and its 
metabolites were 










sertraline, and their 
degradation 
products were 
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and its metabolite 
desmethylsertraline 
were observed in 
all tissues in 
decreasing 
abundance: liver > 














plasma was low, 








Fish bile SPE HPLC-ESI-
MS/MS 
naproxen and its 
metabolites were 



















1.5  Solid phase microextraction: a sample preparation technique 
 
Solid phase microextraction (SPME) was introduced in the early 1990s as a solvent-free sample 
preparation technique for analysis of volatile compounds using gas chromatography
52-54
. A 
convenient and simple technique, its applications have been demonstrated in the sample 
preparation of semi-volatile compounds and non-volatile compounds such as pharmaceutical 




being used with liquid chromatography for determination of pharmaceutical compounds in 
complex biological and environmental samples
55-57
. The principle of SPME is based on the 
equilibrium partitioning of analytes between a sample matrix and the extraction phase (coating 
on a fibre). Figure 1.2 illustrates equilibrium partitioning of analytes between the SPME fibre 
coating and the sample matrix. According to SPME fundamental principles
52
, the amount of 
analyte extracted by SPME is proportional to the volume of the extraction phase as shown in 
equation 1.1. The larger the partition coefficient of an analyte between the coating and the 
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where n is the amount of analyte extracted at equilibrium, Kfs is the partition coefficient between 
the extraction phase and the sample matrix, Vf is the volume of extraction phase, Vs is the volume 
of sample, and C0 is the original concentration of the analyte. For large sample volumes, KfsVf  
<< Vs, equation 1.1  can be simplified to equation 1.2 
 
 


















                                               
                                                                                                   
Figure 1:2 Schematic of equilibrium partitioning of analytes between the sample matrix and 
SPME extraction phase 
 
The mechanism of analyte extraction from sample matrices is either by absorption or adsorption 
depending on the type of sorbent (extraction phase) used. Since different types of coatings 
provide different extraction mechanisms for different kinds of analytes, a careful selection of 
appropriate solvents is necessary during method development. Generally speaking, liquid 
coatings extract analytes from sample matrix via absorption mechanisms, while solid coatings 
extract via adsorption. Consequently, the extraction process for absorption- and adsorption-type 
SPME coatings is different
52, 58
, highlighting the importance of SPME coating selection as a 
critical step to the success of such determinations. SPME methods have three main steps for 
determination of analytes using liquid chromatography. The first is to extract analytes from a 
sample matrix; the second is to desorb those analytes directly into solvent in a vial, while the 





1.6 In vivo sampling by SPME 
An emerging and important application of SPME technique is its ability to sample analytes from 
living animals without the requisite destruction of the living system. Indeed, SPME technique 
can be considered a non-lethal sampling technique option, which, together with the development 
of biocompatible extraction phases has made possible in vivo sampling without major side-
effects or toxic consequences to the living system. In fact, SPME engenders minimal 
disturbances to the investigated system, as no biological fluids and only small fractions of 
analytes are removed (by non-exhaustive extraction) from the investigated system
59-61
.  This 
unique feature of SPME allows monitoring of chemical changes and partition equilibrium in a 
living system with minimal disturbance to the system. As a non-lethal sampling technique, 
SPME has been demonstrated as a viable option in the determination and monitoring of volatile 
emissions and non-volatile compounds (including pharmaceutical compounds) from plants and 
animals
62-64
. SPME is increasingly gaining favour for use in in vivo sampling due to its unique 
format and convenience of design. The miniaturization of the technique is a great advantage for 
in vivo sampling because of the ability to deploy and sample analytes in small animals with 
minimal or no invasiveness, including determinations of pharmaceutical bioconcentration 
factors
62
. SPME is an environmentally friendly sample preparation technique ideal for in vivo 
sampling technique due to its portability, as well as the integration of sampling and sample 




1.7 Calibration methods in SPME  
Calibration of SPME for quantitative analysis of compounds in biological and environmental 




extraction and only a small portion of the target analytes are extracted from the sample matrix 
66-
68
. For in vitro studies, traditional calibration methods and equilibrium extraction are the methods 
most frequently used for quantification analysis. Traditional calibration may utilize external, 
internal and standard addition methods. Equilibrium calibration is based on equation 1.1, where 
the amount extracted by the extraction phase is directly related to the initial concentration of 
analytes in the sample matrix under equilibrium extraction conditions. From equation 1.1, the 
amount of analyte extracted onto the coating (n) is linearly proportional to the analyte 
concentration in the sample (C0), which is the analytical basis for quantification using SPME. In 
order to accurately determine analyte concentrations by equilibrium calibration, the partition 
coefficient of each analyte must first be determined experimentally in the appropriate sample 
matrix where the analyte is found. 
For in vivo sampling of analytes in living systems by SPME, the traditional calibration method is 
not relevant as there is no direct spiking of standard to the animal or plant tissues. Further, 
equilibrium sampling may not be feasible in a living system, particularly for compounds that 
have longer equilibration times. Therefore, a new kinetic calibration method was developed in 
order to accurately determine target analytes under pre-equilibrium conditions. Kinetic 
calibration methods are used under pre-equilibrium conditions to determine concentrations of 
target compounds in living systems. This calibration method is based on isotropic diffusion-
controlled mass-transfer between absorption and desorption process during extraction in a 
sample matrix
69-72
. The procedure uses desorption of standards preloaded in the extraction phase 
to calibrate the extraction of analytes from the living system. The initial concentrations of target 
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where n is the amount of analytes extracted pre-equilibrium time, Q is the amount of preloaded 
standard remaining in the extraction phase (fibre) after sampling, q0 is the initial amount of 
deuteurated standard preloaded on the extraction phase before extraction, Ve is the volume of the 
extraction phase and Kes is the distribution coefficient of the analyte between the extraction phase 
and the sample matrix. Utilizing this kinetic calibration approach, accurate and precise 
quantification of analytes in living organisms can be achieved with SPME technique. 
 
1.8 Thesis objectives- analytical challenges of analyzing pharmaceuticals in fish 
and wastewater 
The challenge of accurately quantitating active pharmaceutical ingredients (APIs) in the 
environment is a subject of great interest worldwide.  As a result, improvements in analytical 
methodology (and capabilities), particularly with respect to sample preparation techniques, are 
important in order to reliably determine these pollutants in environmental and biological 
samples. Since these contaminants are frequently detected in water and fish samples, 
development of a simple and suitable analytical methodology to monitor pharmaceuticals in fish 
tissue and wastewater is paramount.  
The main objective of this thesis is to develop improved analytical methods based on solid phase 
microextraction as the sample preparation method for in vivo determination of pharmaceuticals 
of diverse physicochemical properties in living fish and water. Figure 1.3 showsthe structures of 




of this thesis were utilized to investigate uptake and bioconcentration of pharmaceuticals in 
different fish tissues. In addition, the environmental relevance of this analytical methodology 




Figure 1:3 Structures of the selected pharmaceuticals utilized in the study 
 
The thesis can be divided into five main parts: First, in vitro evaluations of the SPME method 
developed in fish tissue and gel (mimicking matrix) were carried out. Analytical performance 
and characterization of the method were also evaluated (Chapter 2). Secondly, the development 
and application of SPME with liquid chromatography-tandem mass spectrometry (LC-MS/MS) 




determination of pharmaceuticals in live fish by SPME with liquid chromatography-tandem mass 
spectrometry is described in Chapter 4.  Fourthly, the development and optimization of 
automated SPME (based on blade geometry) with liquid chromatography-tandem mass 
spectrometry method for high throughput analysis of pharmaceuticals in wastewater was 
investigated and developed (Chapter 5). Fifth, development and evaluation of new in vivo SPME 
device for rapid determination of pharmaceuticals in fish is described in Chapter 6. Finally, the 
use of in vivo SPME method for determination of pharmaceuticals in fish exposed to municipal 
effluent and wild fish (White Sucker) collected adjacent to a municipal treatment plant outfall is 
described in Chapter 7. Conclusions of the research are summarized in Chapter 8, in addition to 

















Study of kinetic desorption rate constants in fish muscle and agarose 
gel model using solid phase microextraction coupled with liquid 
chromatography with tandem mass spectrometry 
 
2.1 Preamble 
This chapter has been modified and published as a paper: O.P. Togunde, K. D. Oakes, M. R 
Servos, and J. Pawliszyn " Study of kinetic desorption rate constant in fish muscle and agarose 
gel model using solid phase microextraction coupled with liquid chromatography with tandem 
mass spectrometry", Oluranti Paul Togunde, Ken Oakes, Mark Servos, and Janusz Pawliszyn. 
Anal. Chem. Acta (2012), doi:10.1016/j.aca.2011.12.034.  The figures and tables are reprinted 
from this manuscript with the permission of Elsevier (Copyright Elsevier 2012). 
  
2.2 Introduction 
Solid phase microextraction (SPME) is increasingly used for measuring freely dissolved 
concentration of compounds in biological and environmental samples due to its simplicity as a 




Understanding the underlying mechanism of 
transport (diffusion) of pharmaceuticals from aquatic environments (such as water) into fish 
muscle and subsequent distribution in fish tissue is very important so as to know the fate and 
bioavailability of drugs in fish muscle.  Some studies have shown that pharmaceuticals in water 
can diffuse into fish muscle leading to bioaccumulation 
14, 40.
 
In addition, movement (transport) of drugs from water to fish tissue is based on the diffusion 
pathway, such as partitioning processes between fish tissue and water. Hence, diffusion 
parameters such as mass-transfer coefficient (diffusion coefficient), absorption and desorption 




gel is being used to study partition process of the drugs because the diffusion of analytes in the 
agarose gel follows Fick’s law of diffusion, in which free movement of drugs is allowed without 
significant obstruction of the diffusion of drugs in the gel 
76-82
. As a result, an agarose gel of 
different viscosity was used to investigate the kinetic studies of selected drugs in order to find 
mass-transfer phenomena in both SPME polymer coating and semi-solid matrices such as gel 
and fish tissue. Previous studies have also shown that the unionised form of most drugs diffuse 
across the cell membrane readily 
77, 83
. As a result, Fick’s law of diffusion can be applied to study 




Accumulation of drugs in in vivo fish 
muscle is a dynamic and complex process because it involves simultaneous drug uptake, 
metabolism, transport and excretion until equilibrium is reached between the tissue compartment 
and interstitial body fluid. Therefore, drug distribution rate can be affected by the rate of blood 
flow, tissue mass, and partition characteristics of the drugs between blood and tissue 
compartment 
85
.   In addition, the porosity of fish tissue and tortuosity (tissue hindrance to 
diffusion) play a significant role on the rate of diffusion in the tissue sample, thereby affecting 
distribution of drugs in the fish tissue. In the present study, agarose gel is considered as an 
alternative for in vitro approach of mass transfer phenomenon study. 
The aim of this study is to investigate desorption rate constants of selected drugs in tissue 
samples (fish muscle) and agarose gel using solid phase microextraction as an investigative tool. 
In this study, kinetic of desorption of the target drugs was studied under specific conditions using 
different sample matrices. Also, desorption rate constants in gel and fish matrices were compared 
with the aim to determine the gel concentration which could be used to mimic the diffusion of 
drugs in fish muscle matrix. Based on free diffusion of drugs, estimation of the mass transfer 




distribution and partitioning of the drugs in a specific matrix.  Hence, determination of 
desorption rate constants of the selected drugs in gel and in fish muscle (in vitro,  in vivo) are 
compared with a view of gaining insight into the mass transfer phenomenon in gel matrix and 
fish muscle. 
SPME is a sampling and sample preparation technique which has demonstrated its usefulness for 
pharmacokinetic studies in biological samples and in vivo systems 
43, 86
.   SPME technique is an 
equilibrium extraction method in which analytes partition between the extraction phase and 
sample matrix until equilibrium is reached. Therefore, the amount of analytes extracted at 
equilibrium (ne) is governed by distribution constant and volume of extraction phase as shown in 
equation (1.1) 
38, 87 
The diffusion of analytes between fibre coating and sample matrix (fish muscle) follows Fick’s 
law of diffusion, though the diffusion path length in the tissue matrix is greater due the porosity 
of the matrix (tortuosity). As a result, the kinetic of diffusion of analytes in fish muscle is a slow 
process which has been described elsewhere 
88, 89
 as shown in equation (2.1). 
 
                                         
                                                                 2.1   
  
where   J is the mass flux of the analytes from fibre coating to the sample matrix, A is the surface 
area of the fibre, δn is the amount of analyte absorbed on the fibre surface at a specific time δt, 
Df is the diffusion coefficient of analyte in the fibre coating, Ds is the diffusion coefficient of the 
analyte in the tissue. α is the effective volume fraction (V0/V) which is usually lower that 1 for 
soft tissue. Vo is the interstitial space volume and V is the total volume. Cf and Cs are the 




From equation 2.3, the extraction kinetic (absorption process) to the extraction phase is governed 
by equation (2.2) 
71, 72, 90
 
                                                                                                                              2.2                                  
Also, the desorption process (desorption kinetic of preloaded standard) is mathematically 
expressed in equation (2.3) 
90-92
  
                                                                                            2.3 
where n is the amount of analytes in the extraction phase for a particular sampling time t, qo is 
the amount of standard preloaded in the extraction phase and Q is the amount of standard 
remaining in the extraction phase after the extraction phase is exposed to the sample matrix for a 
particular sampling time t, a is a time constant that is used to describe how quickly equilibrium is 
reached. Based on the symmetry of absorption and desorption of compounds on the extraction 
phase, the time constant can be related to the diffusion coefficient in the sample matrix. The 
concept is based on diffusion controlled mass transfer between the extraction phase and the 
sample matrix, hence a is described as a parameter that depends on fibre parameters like fibre-
sample distribution coefficient and diffusion coefficient of the analytes in the sample matrix 
72  
as 
described  in equation (2.4) 
                                                                                         2.4 
where δs is the thickness of boundary layer which is affected by agitation condition, A is the 
surface area of the fibre coating. All other parameters have been previously defined. 
When fibre coating is preloaded {direct extraction from spiked water or Phosphate Buffer Salt 













matrix (gel, fish muscle), the mass transfer of the analytes from the extraction phase to the 
sample matrix is based on free diffusion of analytes due to concentration gradient between the 
two phases 
81, 93-94
. Therefore, the kinetic of desorption of the analytes from the extraction phase 
to the sample matrix can be described by Fick’s laws of diffusion for free diffusion of 
compounds. As a result, kinetic of desorption, which is described in equation (2.3), can be used 
to compare desorption rate of analytes in fish tissue and agarose matrix based on free diffusion of 
analytes. Hence, comparison of the desorption time constant of fish muscle and different gel 
concentrations would provide valuable information on the mass transfer phenomenon of analytes 
under in vitro condition, thereby yielding information on the gel concentration, which could be 
used to mimic the rate of desorption in fish muscle. In addition, desorption rate of the 
compounds can be investigated in in vitro and in vivo fish muscle, thereby providing information 
on in vivo diffusion of compounds in fish muscle. 
 
2.3 Experimental 
2.3.1 Chemicals and materials 
All chemicals used for the study were purchased from Sigma-Aldrich (Oakville, ON, Canada) 
unless otherwise stated. Fluoxetine, diazepam, nordiazepam, diazepam d5 were purchased as 
certified standards from Cerilliant Corp.  (Round Rock TX, USA) and carbamazepine was 
obtained from Sigma-Aldrich (Oakville ON Canada) while paroxetine and sertraline were 
purchased from Toronto Research Chemical (Toronto, ON, Canada). Diazepam, nordiazepam 
and lorazepam were purchased from Cerilliant (Round Rock, TX USA) as 1 mg/mL methanolic 
solution. Lorazepam was used as internal standard. Also, HPLC grade acetonitrile, methanol 




the preparation of phosphate buffered saline (PBS, pH = 7.4) were purchased from Sigma 
Aldrich. PBS was prepared by dissolving 8.0 g of sodium chloride, 0.2 g of potassium chloride, 
0.20 g of potassium phosphate and 1.44 g of sodium phosphate in one litre of purified water and 
adjusting the pH to 7.4 as necessary. Also, distilled water used in this study was purified and 
deionised to 18.3 MΩ with a Barnstead Nanopure Diamond UV water purification system. For 
the preparation of biocompatible PDMS fibres (silicone tubing), the fibres were purchased from 
Helix medical silicone tubing (Carpenteria CA) with internal diameter of 0.31 mm and outer 
diameter of  0.64mm. This silicon tubing was used as extraction phase as described in section 
3.2. Medical grade stainless steel wire (0.483 mm o.d.) was purchased from Small Parts Inc. 
(Miami Lakes FL., USA). The experimental procedures for in vitro and in vivo study were 
approved by local Care Committee at the University of Waterloo (AUP #’s 04-24, 08-08). 
Rainbow Trout (Oncorhynchus mykiss) were purchased from Silver creek Aquaculture (Erin, 
ON, Canada). 
 
2.3.2 Preparation of fibre and SPME procedure 
PDMS fibres were made in-house by inserting the silicon tubing (made of PDMS) onto a 4 cm 
stainless steel wire and conditioning in methanol/water (1:1 v/v) for a minimum of 30 min as 
described previously 
72,85,88
. Following, the preconditioned fibres were loaded directly from a 
spiked PBS solution at two different concentrations (0.1 and 1 ug/mL) for 3 hours. Organic 
content (methanol) of all spiked PBS and standards which were used in this study were kept at 
1% (v/v) in order to reduce partition of the drugs to organic phase. The rationale for the use of 
spiked PBS solution for loading the target compounds to the extraction phase is based on the fact 






2.3.3  Desorption of compounds in gel model 
Agarose was used as a matrix-free mimicking system (diffusion medium) for the kinetic studies 
of the modelled drug because it allows free diffusion of drugs in a semi-solid matrix. Hence, 
useful information such as rate of diffusion and diffusion coefficient can be estimated from 
mass-transfer kinetics of the drugs in the gel 
71, 90, 91
 
Kinetic desorption of model drugs were performed at different concentrations (viscosity) of gel 
matrix prepared in PBS (pH = 7.4).The concentration (viscosity) used ranged from 2.0 % (w/v) 
to 0.8 % (w/v). For example, 2.0 % (w/v) gel matrix was prepared by adding 2 g agarose gel 
(Agarose 15, BDH Chemical Ltd, Poole England) with 100 ml of PBS. Subsequently, the 
mixture heated for about 30 min at temperature 90
o
C until the agarose completely dissolved in 
PBS and a clear solution is observed. The solution of the agarose is stirred intermittently to 
ensure that the solution is homogeneous and the temperature is held at 70
o
C when dispensing the 
solution to vials. Having prepared the gel solution, 3 ml of the gel solution is dispensed to a 4 ml 
vial where the solution is allowed to cool to ambient temperature. Consequently, a semi-solid gel 
is obtained when the sample is allowed to stay at ambient temperature for about 3 h of 
stabilization. 
Moreover, the amount of the drug “preloaded” (direct extraction from PBS, pH = 7.4) on the 
fibre can be determined by direct extraction of the compounds in a known spiked PBS solution 
(0.1 mg/L used previously). The fibre is introduced to a spiked PBS solution in a 2ml vial while 
the extraction is carried out at a predetermined time or until equilibrium is reached between the 
fibre and the sample matrix. The extraction is carried out under agitated condition at 1000 rpm 
on an oscillating shaker. Subsequently, the fibre was desorbed in a mixture of acetonitrile: water 
{ACN/H20 (1:1 v/v)} under an agitated condition similar to the extraction process. Therefore, the 




extract.  The amount of compound remaining on fibre (Q) at different times of kinetic desorption 
was determined by preloading the fibre from a spiked PBS solution. After kinetic desorption in 
gel matrix, the fibre is desorbed in desorption solvent {ACN (acetonitrile) /Water 1:1)} in order 
to determine the amount of analytes remaining on the fibre. However, subsequent desorption of 
the preloaded fibre was done in a known gel sample for a specific time (10 -1600 min). 
Therefore, the amount of compounds remaining on the fibre for a specific time was determined 
by desorbing the fibre again in ACN/ water (1:1) immediately as the fibre was removed from the 
gel sample.  
In the case of fish muscle (in vitro study), the muscle was collected from Rainbow Trout held in 
clean reference water. The fish muscle was immediately stored at -80
o
C until it was used for this 
study. The muscle was cut and weighed into centrifuge tube, then preloaded fibres (loaded with 
the target compounds) were desorbed in fish muscle (unhomogenized) in the centrifuge tube for 
specific time ranging from 10 – 300 min. This is similar to desorption kinetic study performed in 
gel matrix. The amount of the analyte remaining on the fibre after each timepoint was 
determined by desorbing the fibre in the desorption solution (ACN: Water, 1:1) after the 
preloaded fibre was removed from each centrifuge tube. After desorption for 90 min, 20 uL of 
the sample extract was injected to the LC/MS/MS for instrumental quantification. 
 
2.3.4  In vivo desorption kinetic study in fish 
In this case, Rainbow Trout were kept in a 34L aquarium tank where the fish were allowed to 
acclimatize to the laboratory conditions of the well water for 1 day. Subsequently, the preloaded 
compounds on the PDMS fibres were desorbed in the live fish for different times (0.5 – 50 hrs), 




the fish was anesthetized, a 12- gauge needle was used to pierce the fish muscle, and then the 
fibres were inserted in the muscle. After the insertion of the fibre (n = 3), the fish were returned 
to the tank, and, within 1 min, the fish were able to regain their consciousness. After a specified 
period of time, the fibres were removed from the fish muscle. Consequentely, the fibres were 
desorbed in a mixture of water/acetonitrile (1:1) containing internal standards and the amount of 
the target drugs remaining on the fibre at each time point was determined.  
2.3.5  Evaluation of PDMS and C18 extraction phase 
The performance of biocompatible coatings (C18 and PDMS) was evaluated and compared at 
equilibrium. Extraction of the selected compounds was carried out in spiked buffer at pH 7.4. 
PBS buffer solution was spiked with selected compounds at a concentration 50 ng/mL and 
subsequently, extraction was performed with the fibres for 3 h with agitation speed of 1000 rpm. 
After extraction, the analytes were desorbed from the fibre to the desorption solvent under the 
same agitation conditions for 90 min. The results obtained for the comparison of the two fibres 



































Figure 2:1 Extraction efficiency of PDMS and C18 fibres in phosphate buffer solution (PBS pH = 
7.4)   
 
2.3.6  Instrumental analysis – LC/MS/MS 
Analysis of gel and fish samples was carried out using LC/MS/MS system that is made up of the 
following: Varian 500 LC-ion trap-MS, Prostar model 430 autosampler and Varian 212-LC 
pump (Walnut creek, CA USA). The mobile phase used was A: acetonitrile: water: acetic acid 
(100:90:0.1 v/v) while B contains acetonitrile: water: acetic acid (90:10:0.1 v/v). The total 
solvent A and B were gradually programmed as: 100% held for 0.5 min, subsequently, there was 
linear increase to 90% B in 2.5 min, held for 2 min. Then the column is re-equilibrated for 1 
mins at 100% A. Therefore, the total chromatographic run for the separation of target compounds 
is 6 min. All the compounds were optimized on the MS by direct infusion of 1 µg/mL standards 
of each of the compound using electrospray ionization in positive ion mode; the dry gas 
temperature was set at 400
o
C. For the chromatographic separation of the compounds, a Supelco 
3.5 µm C18, analytical column was used, having dimensions of 50 mm by 2 mm. The flow rate 
used was 0.3mL/min while 20µL of the sample was injected to the MS in duplicate. After all 
data acquisition was obtained, the processing was done on Varian MS workstation version 6.6.  









Table 2:1 a The retention time and MS parameters of the compound studied using Varian 
MS/MS. 























Carbamazepine 2.8 237 194 3920 67 70 1.00 
Diazepam 3.4 285 257 3920 85 79 1.31 
Nordiazepam 3.2 271 140 3920 85 77 1.06 
Lorazepam (IS) 3.0 321 275 3920 62 88 2.02 
                
        RF- Radio frequency  
 
Table 2.1b The MS parameters of the compounds studied using Sciex QTrap MS/MS 
      
 
        











Carbamazepine 237.1 193.3 55 4.9 14 51 3 
Fluoxetine 310.3 44.3 48 2.9 12 44 7 
Diazepam 285.5 154.2 71 4.0 37 4 10 
Nordiazepam 271.1 140.2 176 7.0 39 4 20 
Paroxetine 330.1 70.1 51 5.5 45 4 14 
Sertraline 306.0 159.0 26 3.5 35 4 14 
        d10-
carbamazapine 247.2 204.4 61 4.3 17 28 3 
d5-fluoxetine 315.2 44.2 50 4.0 19 38 3 
d5-diazepam 290.0 198.3 66 2.0 12 39 3 
d4-paroxetine 334.0 74.0 106 7.0 14 51 12 
d3-sertraline 309.0 275.0 36 3.0 14 15 8 
DP- Declustering potential, EP- Entrance potential, CEP- Collison entrance potential, CE- 
Collision energy, CXP- Collison exit potential. 
 
The MS response in terms of sensitivity and linearity was monitored for each set of samples 




after each set of samples. Also, the quality of the data obtained from the MS was monitored 
during each run of the sample by injecting a quality control sample of 50µg/L for every 12 
injections. Good precision was obtained with an external calibration curve (RSD < 7%), and 
linearity (R
2
 > 0.99) was good as well. In vivo study of the selected compounds was carried out 
using ABS-Sciex 3200 QTrap Mass Spectrometry equipped with a Turbo Ion Spray source 
(Applied Biosystems Sciex, Foster City, CA, USA). Liquid chromatography (LC) was performed 
on a HP1100 HPLC system (Agilent Technologies) equipped with a degasser, a binary pump, an 
autosampler and a column oven. Chromatographic separation was performed on a Zorbax 
Eclipse XDB C18 (150 mm × 21 mm, 3.5µm) column which was preceded by a C18 guard column 
at a flow rate of 0.8 mL/min with a mobile phase A (95% water, 5% methanol, 0.1 % acetic acid) 
and B (95% MeOH, 5 % water and 0.1% acetic acid). The compounds of interest were separated 
with a gradient elution program and the injection volume was set at 20 uL. The gradient elution 
was programmed as follows: mobile phase B was increased from 10% to 50% in 0.5 min and 
50% to 100% in 7.5 min, held at 100% for 2 min and then reduced to 10% in 1 min, thereby 
bringing it back to initial chromatographic conditions within 5 min. Detection and quantification 
was done with a 3200 Qtrap triple quadrupole-linear ion trap mass spectrometer. The limit of 
detection (LOD) and Limit of Quantitation (LOQ) were determined using a statistical approach 
in which the standard deviation of the background signal of the blank sample were calculated 
and divided by the slope of calibration  (LOD = 3*SD blank/slope and LOQ = 10*SD blank/slope) 




2.4  Results and discussion   
2.4.1  Characterization of SPME extraction phase 
The performance of two biocompatible coatings, namely PDMS and Supelco C18 fibres, were 
evaluated in PBS (pH =7.4) under the same condition in order to compare the amount of analytes 
extracted at equilibrium for the selected drugs. In general, the C18 fibres have higher amounts of 
extracted analytes compared to PDMS fibres. As expected theoretically, the results demonstrate 
that the C18 fibre has a higher amount of extracted analytes in a simple or clean matrix such as 
PBS solution since the fibre behaves as a porous extraction phase (coating) 
58
. In addition, 
hydrophobicity of each of the compounds will affect the extraction efficiency of the fibre. Since 
detection (sensitivity) of the selected drugs is good, any of the two fibres can be used for this 
study. In this study, PDMS fibre is used since it behaves as a biocompatible liquid polymer 
coating, which has been used for study of pharmaceuticals in fish and it is not prone to 




 The detection and quantitation limit of SPME method 
determined in gel and fish matrices are shown in Table 2.2.The detection limit in gel ranged 
between 0.01 – 0.07 ng/ml, while in  fish muscle it is between 0.07 - 0.34 ng/g.   
 
Table 2:2 Limits of detection and quantification in gel and fish muscle 
             Gel                     Fish    
Compounds 
LOD  




(ng/g)     
LOQ  
(ng/g)  
          
Carbamazepine 0.01 0.10 0.07 0.48 
Diazepam 0.02 0.19 0.30 0.97 





2.4.2  Absorption time profile in gel 
The kinetics of absorption of the selected pharmaceuticals was investigated in the gel model (1 
% w/v) and PBS solution in order to determine the equilibration time between fibre coating and 
gel matrix (or PBS solution). Also, useful information such as absorption rate can be 
extrapolated from the study. Therefore, the diffusion rate and partition processes of the selected 
drugs can be determined in a simple sample matrix such as gel. It can be deduced from observing 
the extraction time profile that the results obtained for static extraction in gel matrix clearly 
demonstrate that equilibrium is reached at 40 hours for all compounds, except for diazepam 
(Figure 2.2). As a result, a longer extraction time is required for diazepam to reach equilibrium 
because of its high distribution constant.  The diffusion of the selected pharmaceuticals in gel 
matrix is generally slow due to the nature of the sample matrix.  Essentially, gel samples are 
more viscous than water or PBS, and as a result, the diffusion of the drugs is slower; 
consequently the diffusion coefficient would be small due to slow mass transfer rate. In addition, 
the molecular weight and partition constant of each drug may also affect the partition and 






Figure 2:2 Extraction (absorption) time profiles of carbamazepine, diazepam, and nordiazepam in 




2.4.3 Absorption rate constant in gel   
The extraction time profiles of the selected drugs under study was obtained by analyzing freshly 
spiked gel samples that were extracted under static condition (without agitation) between 0.5 to 
70 h at a constant room temperature (25 
o
C). The kinetics of extraction and partition of organic 
compounds to SPME fibre has been described in the literature in detail 
95-97
. In this study, the 
extraction time profile of selected drugs in gel samples (0.9% w/v) under static conditions is 
shown in Figure 2.2. A consistent pattern of diffusion was observed for the extraction time 
profile in the gel sample without agitation, although the extraction rate is much slower compared 
to the aqueous sample. Therefore, the results suggest that the extraction process in gel samples is 
governed by Fick’s law of diffusion. However, the diffusion coefficient in the gel sample is 




































In addition, the absorption time (rate) constant is determined from the extraction profile data by 
using a linear regression for the plot of natural logarithm of (1-nt/ne) against the extraction time, 
where nt is the amount of analyte extracted at a specific time. The slopes of the regression are 
extrapolated as the absorption rate constant, as can be seen in Table 2.3. 
 
 Table 2:3 Absorption rate constant in gel sample (0.9 % w/v) 
   
Compounds 
   Rate constant 
  R
2
    (a, min
-1
) ± SE  
Carbamazepine 17.4 x 10
-4
 ± 7 x 10
-4
 0.9813 
Diazepam 11.9 x 10
-4
 ±  5 x 10
-4
 0.9883 
Nordiazepam 18.7 x 10
-4
 ±  5 x 10
-4
 0.989 
      
SE – Standard error 
 
 The absorption rate of carbamazepine and nordiazepam has a similar rate of diffusion in the gel, 







Figure 2:3Absorption time profiles of carbamazepine (♦), diazepam (■), and nordizepam 




The time constant rate of each compound being investigated reflects how fast the equilibrium is 
reached between SPME and sample matrix, since time constant is concentration independent 
89
. 
The rate of diffusion of each drug can be determined by its corresponding time constant. As a 
result, the diffusion rate (time) constant provides insight and useful information (diffusion 
coefficient) on the diffusion rate of the compounds in different sample matrices
72
. This study 
demonstrates one of the applications of SPME as a simple investigative tool to study the 
diffusion and partitioning process of compounds in a semi-solid sample matrix such as gel. The 
mass transfer kinetic of absorption (extraction) and desorption of drugs on SPME fibre are 
similar, since both are diffusion-controlled mass transfer processes based on Fick’s first law of 
diffusion 
72, 87
. Also, the diffusion of drugs in and out of the extraction phase (fibre) is controlled 
by a number of factors, such as concentration gradient, distribution coefficient of the analytes 
and boundary layer in the sample matrix. In the case of absorption, there is an upward mass 
CBZ- y = -0.0017x + 0.0095
R² = 0.9813
DIA- y = -0.0012x - 0.0022
R² = 0.9883


























transfer of analytes from the sample matrix to the fibre due to the concentration gradient and 
partition process until equilibrium is established between the two phases. However, the 
desorption process involves mass transfer of analytes from the pre-loaded fibre to the sample 
matrix such as fish muscle, where a partition process is established, as previously discussed. 
Hence, the concept of standard on the extraction phase is a very useful technique for in vivo 




2.4.4  Equilibrium partition constant in gel and PBS (pH = 7.4) 
The equilibrium partitioning process was studied in gel model (0.9 % w/v) and compared to a 
matrix-free sample (PBS) in order to investigate if there is potential binding in the gel samples 
with respect to the compounds being studied. As shown in Figure 2.4, the amount extracted at 
equilibrium in PBS and gel samples were the same.  
 
Figure 2:4 Equilibrium recovery studies of carbamazepine, diazepam, and nordizepam in 



































The results show that there is no significant difference in terms of the equilibrium partition 
constant between the gel and PBS for the selected pharmaceuticals. In addition, it was observed 
that the drugs under investigation reached equilibrium faster in PBS than in gel. One possible 
explanation for this observation is that PBS is an aqueous sample while the gel is a semi-solid, 
whose diffusive mass transfer rate is slower because of the high viscosity of the gel sample 
compared to simple aqueous PBS. As a result, faster distribution of drug and equilibration might 
have happened in the PBS sample. Hence, the diffusion and partitioning processes in PBS and 
gel are presumed to be largely controlled by the diffusion coefficients of the drugs in the sample 
matrix, although the thickness of the boundary layer may play a significant role as well during 
diffusion of the drugs in sample. In addition, as shown in Table 2.4, physico-chemical properties 
of the drugs such as their particular molecular weight, solubility and partition coefficient can also 
affect the diffusion coefficient of the drugs in sample matrix 
78, 80, 94 
 
Table 2:4 Physico-chemical properties of the compounds 
98, 99 
 
        
  
Estimated 
 Analytes pKa Log Kow Molecular weight 
Carbamazepine 7 2.45 236.3 
Diazepam 3.4 2.82 284.8 
Nordiazepam N.A 2.93 270.7 
    
 




2.4.5  Desorption rate constant in gel models 
Desorption rate constant of the selected drugs was studied in different concentrations (viscosity) 
of gel sample ranging from high concentration (highly viscous) of gel to very low concentration 
(less viscous), as shown in Table 2.5.  
Table 2:5 Desorption rate constant of selected drugs in different concentration of gel and 
unhomogenized fish tissue 
 
  Fish tissue   
Compounds 
Time 
constant Standard Estimated 




) Error RSD (%) 
Carbamazepine 0.00076 8 E-05 11 0.9742 
Diazepam 0.00051 2 E-05 4 0.9781 
Nordiazepam 0.00077 4 E-05 5 0.9792 










) Error RSD (%) 
Carbamazepine 0.00083 1 E-04 12 0.9002 
Diazepam 0.00055 1 E-04 14 0.9004 
Nordiazepam 0.00076 1 E-04 9 0.9698 
    
  
1.0 % ( w/v) gel matrix 
  
Time 
constant Standard Estimated 






) Error RSD (%) 
 
Carbamazepine 0.00057 5 E-05 9 0.9185 
Diazepam 0.0004 8 E-05 15 0.7482 
Nordiazepam 0.00066 8 E-05 14 0.8721 
             
 
  
1.5 % (w/v) gel 
matrix     
  
Time 
constant Standard Estimated 




) Error RSD (%) 
Carbamazepine 0.00022 3 E-05 15 0.8480 
Diazepam 0.00012 1 E-05 12 0.8990 







2.0 % ( w/v) gel matrix 
  
Time 
constant Standard Estimated 










1 E-05 7 0.9617 
Diazepam 0.000167 
 
4 E-05 15 0.9000 
Nordiazepam 0.000163   1 E-05 8 0.9491 
 
The results suggest that as the concentration of gel increases from a less viscous to a high 
viscous gel matrix, desorption rate constant of the drug decreases. This observation can be 
explained in line with the viscosity of the gel. As the viscosity of the gel reduces, the diffusion of 
the drugs in the gel becomes faster. However, as the viscosity of the gel increases, the diffusion 
of the drugs becomes slow. Consequently, the mass transfer coefficient would be small, leading 
to a reduction in desorption rate constant in the gel. In addition, an increase in gel concentration 





2.5 shows the schematic experimental model for the study of mass transfer rate constant in 
agarose gel and in vitro fish samples. Also, desorption rate constant in unhomogenized fish 
muscle (Rainbow Trout) studied using the same SPME procedure is summarized in Table 2.5. 
Hence, a comparison of desorption rate constant in fish muscle under investigation suggests that 
the rates of desorption kinetics of the model drugs in the unhomogenized fish muscle and 0.8% 
(w/v) are similar, based on the similar values obtained for desorption rate constants for both 





Figure 2:5 Schematic diagram of experimental model for the study of mass transfer rate 
constant in agarose gel, dead and live fish muscle 
A- Preloading of standard to the fibre from spiked PBS ( pH = 7.4) 
B- In vitro desorption of preloaded fibre in dead fish muscle  at different time 
C- Desorption of fibre in acetonitrile: water (1:1) for 90 min with agitation speed of 1000 
rpm 
D- Instrumental analysis and quantification 
E- In vitro desorption of preloaded fibre in the agarose gel at different time 
F- Same as C 
G- In vivo desorption of preloaded fibre in live fish muscle at different time 







2.4.6 In vivo SPME application in fish muscle  
Desorption rate constants of the selected drugs was determined in live fish (Figure 2.5). As 
shown in Table 2.6a, carbamazepine displays faster diffusion in both gel and fish samples when 
compared to diazepam and nordiazepam, based on their desorption rate constants. In addition, 
faster diffusion and equilibration was observed for in vivo desorption kinetics of the drugs 
compared to the in vitro desorption study in fish muscle, as shown in  Table 2.6a and b, although 
carbamazepine, nordiazepam  and sertraline showed  a different pattern. For example, there was 
no significant difference in terms of the desorption rate of carbamazepine for in vitro and in vivo 
fish muscle.  
 


















    
 
Compounds 





 Standard  
   error 
Estimated  
RSD (%)    R
2
 
Carbamazepine 0.00150 1.6E-04 11 0.9654 
Diazepam 0.00015 1.9E-05 13 0.9238 
Nordiazepam 0.00032 3.1E-05 10 0.9627 
Fluoxetine 0.00039 3.3E-05 9 0.9710 
Sertraline 0.00041 6.1E-05 15 0.9176 
Paroxetine 0.00036 2.0E-05 6 0.9880 
          





Table 2.6b: In vitro desorption time constant in Rainbow Trout muscle 
 
Compounds 






  error 
Estimated  
 RSD (%)    R
2
 
Carbamazepine 0.00142 6.9E-05 5 0.9908 
Diazepam 0.00003 5.9E-06 17 0.9196 
Nordiazepam 0.00039 2.7E-05 7 0.9756 
Fluoxetine 0.00012 6.0E-06 5 0.9907 
Sertraline 0.00062 5.1E-05 8 0.9863 
Paroxetine 0.00016 1.7E-05 10 0.9686 
          
     
     RSD- Relative standard deviation  
 
In the case of sertraline and nordiazepam, the in vitro desorption rate constant is greater than the 
desorption rate constant determined in the in vivo fish muscle. One possible explanation for the 
observed difference between the two systems ( in vivo and in vitro ) under study is that the 
diffusion of compounds and its subsequent desorption in a complex and dynamic system such as 
live fish would be aided by potential agitation, coupled with the flow of the blood and biological 
fluids. As a result, there is facilitated diffusion/ transport of drugs in a dynamic system whose 
time constant would be affected compared to non-dynamic systems (dead fish muscle), where 
potential agitation does not occur. Therefore, the kinetics of diffusion of drugs in dead fish is 
likely to be different live fish, considering that the latter is a dynamic system. In conclusion, 
there is a need for careful extrapolation of rate constant or diffusion constant when comparing 







The study demonstrates that desorption rate constant in 0.8 % w/v gel matrix and 
unhomogenized fish tissue are similar based on the free diffusion of drugs in the matrices. 
Therefore, this gel composition can be used as a template to study the kinetic of diffusion as well 
as its partition processes, in order to understand diffusion of drugs in fish tissue. In addition, it 
can be deduced that desorption rate constant of selected pharmaceuticals in a dynamic system 
(such as live fish) is different from a static system (such as dead fish). Also, SPME method has 
been demonstrated as a simple investigative tool to study the diffusion rate constant of organic 
compounds (pharmaceuticals) in stable model systems such as gels as well as a dynamic systems 
(live fish tissue). Hence, the SPME method is a promising analytical tool which can be used for 
the study of diffusive mass transfer in an in vivo or dynamic system such as fish. Also, the 
bioavailability of target compounds in fish tissue may be investigated through the use of SPME 
technique. Lastly, these studies demonstrate that the diffusion and equilibrium partitioning 


















Determination of Pharmaceutical Residues in Fish Bile by Solid-Phase 




This chapter has been modified and published as a paper: Oluranti P. Togunde, Ken. D. Oakes, 
Mark. R Servos, and Janusz Pawliszyn. 2012. "Determination of Pharmaceutical Residues in 
Fish Bile by Solid-Phase Microextraction Couple with Liquid Chromatography-Tandem Mass 
Spectrometry (LC/MS/MS)”.  Environmental Science and Technology 46 (10):5302-5309. The 
figures and tables are reprinted from this manuscript with the permission of American Chemical 
Society (ACS 2012).  
 
3.2 Introduction 
 The frequent detection of pharmaceuticals in aquatic environments has elicited concern in both 
public and scientific arenas due to the potential endocrine modulating impacts of these 
compounds on exposed aquatic organisms
100-102
.The presence of pharmaceuticals in surface 
waters has been largely attributed to low removal efficiencies for many of these compounds in 
municipal wastewater treatment plants, which were not designed to remove these trace 
contaminants from their effluents
103-105.  
Consequently, human pharmaceutical residues have been 
recognized as “emerging” environmental pollutants due to their near ubiquitous detection 
adjacent urban areas at trace or ultra-trace levels; a phenomenon accelerated by rapid urban 
growth and aging population demographics
43, 106-107.  
Continuous release of these compounds and 
their bioactive metabolites and degradation products within municipal wastewater discharges 








Consequently, the presence, uptake and bioconcentration of these pollutants 
by aquatic organisms should be monitored to characterize the environmental persistence and 
potential impact on exposed organisms. 
Fish bile can be useful in assessing the exposure and uptake of xenobiotic compounds from 
water as biliary excretion is an important removal mechanism for many environmental 
contaminants, and considerable bioaccumulation of analytes may occur in this complex 
matrix.
111-113
 Water insoluble contaminants are eliminated from organisms by either 
hydroxylating or metabolizing to more water-soluble forms, often with further conjugation to 
larger water soluble molecules to facilitate excretion. Glucuronidation is often the main 
conjugation process leading to the formation of concentrated environmental contaminants in the 
bile. Enzyme-assisted hydrolysis can cleave conjugated compounds and facilitate the detection of 




Consequently, the detection of unmodified parent 
compounds or their metabolites in bile can be used as biomarkers of pharmaceutical uptake by 
fish exposed to these emerging contaminants in aquatic receiving environments.  
Recently, polydimethylsiloxane (PDMS) as SPME liquid fibre coating (extraction phase), was 
evaluated in several complex matrices, where it demonstrated its suitability for extraction of 
pharmaceuticals in fish tissue without significant biofouling and with sorptive properties 
unaffected by the matrix composition.
47,117-118
 SPME is advantageous as an analytical tool within 
complex matrices such as biological tissues because it incorporates extraction and clean-up into a 
single step and often has no significantly matrix effects, particularly when internal standard is 
used.
119
  The aim of this study is to develop and validate an analytical method based on SPME to 
investigate uptake and  bioconcentration of pharmaceuticals in fish bile. Recently  C18 extraction 




compounds, and may extract a greater range of analytes than are extractable by PDMS fibre 
coatings, particularly polar compounds.
120
 In the case of hydrophobic compounds such as  
atorvastatin, the PDMS extraction phase will provide higher recovery. PDMS and C18 fibres 
were used as the extraction phases for SPME method to determine concentration of target 
pharmaceuticals using small volumes of fish bile samples, collected from fish exposed to 
selected pharmaceuticals in the laboratory and caged fish in the field near a municipal 
wastewater treatment plant effluent outfall. The development of SPME protocol for assessing 
exposure and uptake of environmental pharmaceutical residues would be of significant 
advantage for both fundamental research and biomonitoring purposes. One of the major 
advantages of SPME is that it is a simple, solvent-free, environmentally friendly extraction 
technique that integrates sampling and sample preparation into a single step. 
Based on the basic fundamentals of the method, the amount of analyte extracted by SPME at 
equilibrium is governed by the distribution constant between the extraction phase and samples 
matrix as shown in equation (1.1). When equilibrium partition of analytes between the extraction 
phase and the sample matrix is achieved, the concentration of analyte in the sample can be 
determined, since the amount of target compound on the extraction phase is directly proportional 
to the concentration of the analyte in the sample using equilibrium calibration approach. During 
the method development, important parameters such as partition constant (Kfs) are determined in 
the real samples (bile).  The ability of SPME technique to determine free or total concentration 
of analytes from a single biofluid sample is dependent on using appropriate calibration strategies. 
In order to determine the total concentration of analytes in bile samples, matrix-matched 
calibration is used by performing the calibration using standards prepared in blank bile samples 




plotted against the total analyte concentration (analyte concentration spiked in the biological 
fluid). Based on this equilibrium calibration approach, the total concentration of analytes can be 
determined in the real samples. In addition, measurement of free concentration of compounds in 
biological samples by SPME can provide important information about the bioavailability of a 




3.3 Experimental section 
3.3.1  Chemicals and supplies  
All chemicals used in this study were obtained at the highest available purity and used without 
further refinement. Fluoxetine, diazepam, nordiazepam, and diazepam-d5 were purchased as 
certified standards from Cerilliant Corp (Round Rock, TX, USA). Gemfibrozil, atorvastatin, 
ibuprofen, atrazine, carbamazepine, diclofenac, naproxen, and bisphenol-A (BPA) were obtained 
from Sigma-Aldrich (Oakville, ON, Canada) while paroxetine and sertraline were purchased 
from Toronto Research Chemical (ON, Canada). Isotopically-labeled atorvastatin-d5, atrazine-d5, 
BPA-d16, carbamazepine-d10, diclofenac-d4, fluoxetine-d5, gemfibrozil-d6, ibuprofen-d3 and 
13
C-
naproxen-d3 were purchased from CND Isotope Inc (Point-Claire, QC, Canada) while sertraline-
d3 and paroxetine-d4 were purchased from Toronto Research Chemical. Chemical stock solutions 
were prepared in methanol and stored at -20
o
C while working solutions were diluted aliquots of 
these stock solutions. Dilution water was obtained from a Barnstead Nanopure diamond UV 
water purification system deionized to 18 Ω. Deconjugating enzymes (β-glucosidase, β-
glucoronidase and sulfatase) as well as methanol (HPLC grade) were obtained from Sigma-
Aldrich. All animal experimental procedures were approved by the local Animal Care 




(Oncorhynchus mykiss) were purchased from Silver creek Aquaculture (Erin, ON, Canada) while 
Fathead Minnow were obtained from Silhanek Baitfish (Bobcaygeon, Ontario). 
3.3.2  Fish exposures 
 Laboratory exposure to carbamazapine and fluoxetine. The juvenile Rainbow Trout 
(Oncorhynchus mykiss) used in the carbamazepine (CBZ) exposure (14.4±0.34 cm; 25.4±1.46 g, 
mean ±SE, n=22) and the fluoxetine (FLX) exposure (15.4±0.26 cm; 29.3±1.18, n=30) were 
purchased from Silver Creek Aquaculture (Erin, ON Canada). Fish were acclimatized to 
laboratory conditions in continuously flowing non-chlorinated well water and fed every other 
day with 2.0 Pt floating commercial trout ration (Martin’s Feed Mill, Ontario) until 4 d prior to 
the onset of the experiment. Fish were not fed during the exposure to prevent the release of bile 
from the gallbladder to the duodenum, a response stimulated by feeding. These static exposures 
were conducted in 34 L glass aquaria with three fish per tank,  renewed every  48 h with an array 
of concentrations (0, 3.2, 32 and 320 μg/L) of fluoxetine or carbamazepine to accumulate a range 
of each analyte in fish bile. The actual concentration of these compounds was determined using 
traditional solid phase extraction (SPE) method. Exposure water quality was checked daily and 
maintained at conditions considered optimal for trout (12.5 ± 0.05 
o
C; pH 8.17 ± 0.06; ammonia 
23.5 ± 1.5 μg/L). At the conclusion of the 7-day exposure, fish were anaesthetized with 0.1% 
ethyl 3-amino benzoate methanesulfonate and killed by spinal severance according to Animal 
Care Protocols (#04-24; 08-08)  approved by the University of Waterloo Animal Care 
Committee. Bile was collected from the gallbladder, immediately frozen in liquid nitrogen and 
stored at -80
o





3.3.3 Laboratory exposure to a mixture of pharmaceuticals 
In a second study, juvenile Rainbow Trout were also used, with length and weight of 23.1 ± 1.1 
cm and 108.1 ± 15.9g respectively, and  n = 20. Fish were again acclimatized for 3 days in 34 L 
exposure aquaria containing municipal dechloraminated water prior to the onset of an 8 d 
exposure to a 3 µg/L mixture of pharmaceuticals (fluoxetine, gemfibrozil, atorvastatin, 
ibuprofen, carbamazepine, atrazine, diclofenac, naproxen, and bisphenol-A) spiked to the 
dechloraminated reference water in 100 μL of ethanol as the carrier solvent and renewed daily. 
Water quality remained optimal (12.4 ± 0.05 
o
C; pH 7.79 ± 0.04; ammonia 54.9 ± 3.6 μg/L, n = 
20) for this species throughout the exposure. At the conclusion of the exposure, fish were 
sampled as described previously. 
 
3.3.4 Field exposure to municipal wastewater effluents  
Fathead Minnow (Pimephales promelas), a small bodied fish (5.58±0.03 cm; 1.43±0.02 g; n 
=300) were caged in the Grand River watershed (southern Ontario, Canada) adjacent the Doon 




25’ 12.04”W) at 2 upstream and 3 downstream 
sites (Figure 3.1) for 14 d in October 2010. The most upstream of the two reference sites is 
located 1.2 km upstream of the Doon municipal effluent outfall, but 19.45 riverine km 
downstream of the municipal wastewater discharge from the City of Waterloo. The second 
reference was 0.5 km upstream of the Doon outfall. The three downstream stations were 0.5, 1.7, 
and 5.6 km below the Doon wastewater effluent release. At each site, two cages (Rubbermaid™ 
containers) were deployed, each containing two commercial baitfish buckets (FlowTroll®, 




perforated on all surfaces with 2 cm holes and contained a 60 x 60 cm concrete patio stone 
beneath the bait buckets for weighting. 
 
 
Figure 3:1 Description of field caging of Fathead Minnow (Pimephales promelas) along the 










The cages were anchored to the substrate with t-posts fastened to ¼” cable running through a 
homemade pipe frame. This caging design exposed fish to minimal current, thereby reducing 
exposure stress from constantly swimming, yet allowed water to pass freely through the 
enclosure. After 2 weeks of exposure, fish were anesthetized and sampled as described for the 
laboratory-based Rainbow Trout exposures. As the amount of bile collected from each fish was 
less than 10 µL, a variable number of fish bile samples were pooled to obtain 50 µL, which was 
the experimental unit extracted by SPME for the investigation. The workflow procedure of 


















Figure 3:2 Workflow of field exposure of fathead minnow in the Grand River near 
wastewater fall. This figure shows the experimental step by step approach for the caging 






3.3.5   Enzymatic hydrolysis of bile samples 
Deconjugation of bile samples was performed to determine the total concentration of the target 
analytes using the following hydrolytic enzymes: β-glucoronidase (1000 units/mL) sulfatase (2 
units /mL) and β-glucosidase (20 units /mL). Deconjugation by these hydrolytic enzymes has 
been shown to be specific (with no cross reactivity among the three enzymes) when employed 
according to standardized procedures as described elsewhere.
115, 123   
Briefly,
 
200 µL of each 
deconjugating enzyme was added to 100 µL of bile sample, followed by 750 µL of phosphate 
buffer solution (PBS, pH 6.0) and 400 µL of ultrapure water prior to a 16 h incubation at 37
o
C.  
The same identical procedure, but lacking enzyme hydrolysis, was used to determine the free 
(un-conjugated) fraction of pharmaceuticals in the bile samples. Extraction in bile samples, with 
and without enzyme hydrolysis, using both SPME extraction phases and solvent, enabled the 
determination of both relative method sensitivities, as well as free and total conjugated drug 
concentrations in bile samples. In order to confirm the presence or absence of the parent drug in 
fish bile, target metabolites such as norfluoxetine and carbamazepine10, 11-epoxide were 
investigated in the bile sample extract. When the sample was injected to the LC/MS/MS system, 
the target ion mass of the metabolites were monitored along with the parent compounds as well. 
 
3.3.6 SPME method optimization 
Polydimethylsiloxane (PDMS) fibre coating, supported internally by a 4 cm long stainless steel 
wire (0.483 mm diameter from medical grade; Small Parts Inc., Miami Lakes, FL), was one of 
the SPME extraction phases used in this study.  Custom made PDMS hollow fibre membrane 
tubing (Helixmark, Carpinteria, CA) was cut into 1.5-cm portions. Each PDMS portion (165 µm 




coating (1.5 cm coating length, 45 µm thickness supplied by Supelco Bellefonte, PA, USA) was 
used to monitor the metabolites (norfluoxetine and carbamazepine-10, 11-epoxide) of selected 
compounds while PDMS was used to determine the parent compounds. All SPME fibre coatings 
were pre-conditioned for at least 30 min in a mixture of water/ methanol (1:1) prior to use. At the 
onset of method development, extraction and desorption time was optimized for each extraction 
phase in a spiked PBS buffer (pH = 6.0). Subsequently, optimal conditions were further 
evaluated in spiked reference (clean) bile samples at different concentration levels (2.5, 5.0, 20 
ng/mL) to evaluate the precision and accuracy of the SPME method. Method repeatability was 
checked by analyzing replicate aliquots of bile samples at different times and concentration 
ranges, and is expressed as a relative standard deviation (RSD). The method detection limit and 
limit of quantification were determined from 200 µl reference Rainbow Trout bile samples 
spiked at different concentrations and incubated for 30 min at 4
o
C prior to dilution with PBS (pH 
= 6) and ultrapure water as described previously. A 1.95 mL aliquot of the spiked bile sample 
was transferred to a 2 mL HPLC vial for extraction. PDMS fibres were inserted into the vial for 
equilibrium extraction at under 1200 rpm continual vortex agitation (model DVX-2500, VWR 
International, Mississauga ON, Canada) followed by a 1.5 h, 1200 rpm desorption of extracted 
analytes into 0.2 mL methanol/water (1:1) containing 20 ng/ml deuterated  analogue of the target 
compounds as internal standards. 
 
3.3.7  Liquid (solvent) extraction  
Liquid extraction was used to determine the un-conjugated fraction of selected pharmaceuticals 
in bile. In addition, the total (free and bound) analytes were utilized to validate SPME-derived 




fluoxetine and carbamazepine in bile, 430 µL of MeOH was added to 100 µL of bile, followed 
by 20 µL of 500 ng/mL deuterated analogues (d5-fluoxetine or d10-carbamazepine). Following 
the addition of the internal standard, the resulting mixture was homogenized and agitated for 3 h 
using a digital vortex at 1000 rpm. After agitation, the sample was centrifuged at 3000 rpm for 5 
min at 4
o
C. Then, the supernatant was syringe-filtered (0.2 µm Acrodisc 13 mm, Pall 
Corporation USA) into a glass vial. Subsequently, 20 µL of the sample extract was injected to 
the LC/MS/MS system for quantification analysis.  
 
3.3.8   Instrumental analysis  
Liquid chromatography (LC) was performed on a HP1100 HPLC system (Agilent Technologies) 
equipped with a degasser, a binary pump, an autosampler and a column oven. Chromatographic 
separation was performed on a Zorbax Eclipse XDB C18 (150 mm × 21 mm, 3.5µm) column 
preceded by a C18 guard column at a flow rate of 0.8 mL/min with a mobile phase A (95% water, 
5% methanol, 0.1 % acetic acid) and B (95% MeOH, 5% water and 0.1% acetic acid). The 
injection volume was 20 µl and the gradient elution program was as follows: mobile phase B was 
ramped  from 10% to 50% over 0.5 min, from 50% to 100% over 7.5 min, held at 100% for 2 
min, then reduced to 10% over 1 min, thereby bringing back the initial chromatographic 
condition within 15 min. Detection was done with a 3200 QTrap triple quadrupole-linear ion trap 
mass spectrometer equipped with a Turbo Ion Spray source (Applied Biosystems Sciex, Foster 
City, CA, USA). The target compounds in the bile samples were analyzed in positive and 
negative modes. Optimized MS/MS parameters were determined by manual infusion of a 
standards solution using syringe-pump with the automatic optimization function within the MS 




spiked at 2.5 ng/mL, the average recovery and standard deviation of the seven replicates were 
calculated. Hence, MDL was calculated as three times standard deviation at 95% confidence 
interval (MDL = (standard deviation) times (student t-value), t = 3 for seven replicates). The 
LOQ was determined as 10 times the standard deviation obtained from the seven replicate runs.  
Also, the linearity of the target compounds was studied by injecting different concentrations of 
standard solution in the range of 0.9 - 500 ng/mL. In addition, the precision of the method was 
examined at different concentration levels which were run at different days. 
3.3.9    Statistical Analysis  
A comparison of SPME and liquid (solvent) extraction analytical methods was performed using 
a linear regression on the log-transformed data. The relationship between the exposure 
concentration and amount of drugs detected in the fish bile was described using a linear 
regression at the 95% confidence level. Assessments of the effects of enzyme hydrolysis on bile 
analytes were performed by comparing slope and correlation coefficients from the linear 
regression. 
 
3.3.10 Selection of target pharmaceuticals  
The pharmaceuticals selected for investigation in this study (carbamazepine, fluoxetine, 
ibuprofen, gemfibrozil, paroxetine, sertraline, and diazepam) are frequently detected in both 
wastewater treatment effluents and surface waters adjacent urban areas at trace (ng/L –µg/L) 
concentrations.
14,23,124
 All the drugs except ibuprofen and gemfibrozil (non-steroidal anti-
inflammatory and hypolipidemic therapeutics, respectively), are prescription anti-depressives 
that are increasingly detected in wastewater effluent and environmental matrices.
100
 The 




as one of the pharmaceuticals requiring heightened environmental monitoring for its fate in 




3.4 Results and discussion 
3.4.1  Method Performance  
The relative extraction efficiencies of both PDMS and C18 extraction phases were evaluated in 
phosphate buffer saline - PBS, (pH 7.4), and generally, more analyte was extracted by C18 than 
PDMS, although both fibres have shown affinity towards the pharmaceuticals of interest (Figure 
3.3).  
 
          
 
Figure 3:3 Comparison of extraction efficiency (recovery) of two extraction phases 

























Both extraction phases had good extraction efficiency for the selected pharmaceuticals in this 
study.  Method sensitivity was evaluated by determining the method detection limit (MDL) and 
Limit of Quantitation (LOQ) as reported in Table 3.1.  
 
Table 3:1 Extraction efficiency (%) and precision of SPME method in spiked bile at two 
different concentration levels using PDMS fibre 
  QC Low   QC Medium   
Compounds 




n = 7 




n = 8 
Carbamazepine 9.0 7 8.4 6 
Fluoxetine 35.2 5 30.9 3 
Diazepam 64.6 3 72.8 4 
Nordiazepam 36.0 8 36.4 6 
Sertraline 66.6 5 37.0 8 
Paroxetine 19.0 7 16.2 4 
    
   








A good linearity was observed over the specified concentration range with correlation coefficient 
R
2
 > 0.995. Precision was expressed as relative standard deviation and summarized in supporting 
information Table 3.1 with RSDs within acceptable range (RSD < 9 %). Extraction recovery of 
the selected compounds in spiked bile samples ranged from 8 – 72 % depending on the affinity 
of each of the compounds for the extraction phase. Recovery in this study was calculated as the 
mean percentage extraction of the SPME at equilibrium in spiked bile samples. The comparison 
of SPME and Liquid (solvent) methods for bile samples collected from laboratory exposed fish 
using fluoxetine showed good agreement, with correlation co-efficient of R
2 
> 0.99 (Figure 3.4)  
 
     
 Figure 3:4 Comparison of SPME and liquid-liquid extraction (LLE) method results for 
fluoxetine. 
 
3.4.2 Single compound laboratory exposure of Rainbow Trout 
Fluoxetine (FLX) accumulation in fish bile during the single-compound exposure was correlated 
with the aqueous exposure concentration (R
2
= 0.86 - 0.98) and both fluoxetine and its primary 
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metabolite norfluoxetine were detected in fish bile, indicating some biotransformation activity.  
When treated with deconjugating enzymes, the amount of fluoxetine detected in the trout bile 






                    
        
Figure 3:5 Comparison of amount extracted before and after enzyme assisted hydrolysis for 
A) fluoxetine, B) carbamazepine, C) norfluoxitine (SPME-NE = solid phase 






Fluoxetine strongly bioconcentrated in bile (bioconcentration factors, BCFs of 83 – 481) while 
BCFs of carbamazepine in bile were less than 1 (Table 3.2). The bioconcentration factor was 
calculated as the ratio of concentration of the compound in fish tissue and measured water 
concentration. Actual water concentration was used for the calculation for BCF since it was 
different from nominal exposure concentration. In addition, the bioconcentration of FLX in fish 
muscle ranged from 3-63, indicating tissue distribution in fish tissue. The observed difference 
between the measured and nominal water concentration may be due to degradation of the 
compound or possibly due to adhesion to the aquarium tank. Low concentration of   fluoxetine 
was detected in control fish, possibly from trace contamination of water.  Background 
concentrations were determined and subtracted prior to the calculation of BCF. The low CBZ 
BCF in fish muscle and bile may be due to a higher biotransformation capacity of carbamazepine 
in fish, as confirmed in the literature.
126-128
. Also taken into consideration is the fact that 














Table 3:2 Bioconcentration factor of carbamazepine, fluoxetine in Rainbow Trout muscle 
and bile of single compound laboratory exposure 
 





Measured  water 
conc. 
Conc. 
in bile RSD BCF  
Conc. in 
muscle BCF  
 
(ng/mL) (ng/mL) n = 8 (ng/mL) (%) n = 3 (bile) (ng/g) (muscle) 
 
Fluoxetine 
       Control 0 0 - NA 0 NA 
 3.2 0.3 ± 0.1  132.9 10 416 0.92 3 
 32 6.7 ± 0.7 3171.3 3 481 428.8 63 
 320 102.7 ± 7.9 8519.4 29 83 ND* ND* 
 
Carbamazepine 
       Control 0 0 - NA 0 NA 
 3.2 2.9 ± 0.1  0.7 4 0.26 0.28 0.10 
 32 24.7 ± 0.4 2.2 13 0.09 1.68 0.07 
 320 175.3 ± 10.9  10.3 14 0.06 28.3 0.16 
 
        ND* - The muscle concentration was not determined because fish were not healthy 
NA - not applicable 
 
 
       
3.4.3 Multi-component laboratory exposure of RBT 
In a similar manner to single fluoxetine or carbamazepine exposure, the mixture of 
pharmaceuticals displayed varying BCFs determined for pharmaceuticals in fish bile exposed in 
the laboratory to 3 μg/L for a range of chemicals. The varying BCF value for these 
pharmaceuticals may be due to their physicochemical properties which modify uptake (Table 
3.3). The concentration of pharmaceuticals in fish muscle, which was determined by Zhang et 
al.
119
, was compared to the corresponding pharmaceuticals in bile extracted from the same set of 
fish and the result is shown in Table 3.3. In addition, the BCF value for most of the 
pharmaceuticals were greater in bile compared to fish muscle except for carbamazepine. 




contaminants, particularly where the trace concentration of organic contaminants may be 




Table 3:3 Physico-chemical properties of pharmaceuticals
107, 129-130
 and concentration of the compounds measured in exposure 
water, Rainbow Trout muscle and bile after 8-day laboratory exposure (3 ng/mL) 







 (mg/L) at 






(ng/mL) BCF bile 
Conc. in 
muscle22 
(ng/mL) BCF muscle 
Carbamazepine 0.6 17.7 2.45 13.9 2.91 ± 0.15 ND NA 1.0-1.6 0.3 - 0.6 
Fluoxetine 0.4 38.6 4.05 8.7 2.76 ± 0.13 56.2 -289.2  20 -104 106 -189 38 -68 
Norfluoxetine 0.3 126.9 2.30 9.1 NA 2.9-35.5 NA NA NA 
Ibuprofen 0.7 21 3.97 4.9 2.79 ± 0.16 2.3 -3.5 1 3.1-4.4 1.1 - 6.6 
Bisphenol A 5.0 300 3.64 9.6 2.65± 0.16 234.6 -697 89-263 ND NA 
Naproxen 3.9 15.9 3.18 4.2 2.88 ± 0.9 ND NA ND NA 




1014 0.5 -1.5 0.2 - 0.6 
Diclofenac 1.4 2.4 4.51 4.2 2.86 ± 0.17 < LOQ NA ND NA 
          NA – Not applicable, ND – Not detected, n = 3.   







In the case of exposures done with multiple pharmaceuticals, the BCF of fluoxetine in bile was 
20-104, while the concentration of its metabolite norfluoxetine was found to be 2.9 – 35.5 ng/mL 
(Table 3.3). The detection of this metabolite (norfluoxetine) showed that the parent compound 
may have been biotransformed during phase I and II metabolism. In the case of bisphenol A and 
gemfibrozil, the BCF was found to be 89- 263 and 141-1014 respectively. This shows that a 
greater concentration of bisphenol A and gemfibrozil were bioconcentrated in the Rainbow Trout 
bile. Although diclofenac was also detected in the fish bile, its concentration was below the limit 
of quantitation. Naproxen and carabamazepine were not detected in Rainbow Trout bile. It is 
very likely the physicochemical properties of the compounds not detected in bile exhibit limited 
bioconcentration due to their rapid excretion. Also, efficient biotranformation of diclofenac, 
naproxen and ibuprofen to their respective metabolites may have occurred since these 




3.4.4 Field exposure of fathead minnow 
The antidepressant sertraline was detected in bile of fish at all sites with mean concentrations at 
the two upstream sites of 1.14 ± 0.3 and 0.72 ± 0.1 ng/mL, while the three downstream sites 
where sertraline was detected had concentrations of 0.85± 0.2, 0.68 ± 0.1, 0.22 ± 0.04 ng/mL at 
sites 3, 4 and 5 respectively (Table 3.4a). Conversely, atorvastatin was detected only in the bile 
of fish caged at one upstream site (site 1) with a concentration of 2.1± 2.5 ng/mL while 
downstream locations were surprisingly below detection limits, potentially due to up-regulated 
excretion mechanisms at the more polluted downstream stations. In addition, antidepressant 
paroxetine was detected in fish bile in the upstream sites 1 and 2 with concentrations of 2.84 




was 1.0 ±0.2 ng/ml. Although target pharmaceuticals were detected in the bile, the 
concentrations were lower when compared to the concentrations found during static laboratory 
exposure in which different fish species were used. In the case of field exposure of caged fish in 
the Grand River, it is likely that the fish were feeding on algae/biofilms; thereby reducing the 
volume of the bile collected from each fish (volume of bile in each fish was less than 20 µL). As 
a result, the gallbladder, in which bile is stored, may have been periodically emptied to the 
intestine to aid digestion due to feeding. Therefore, the concentration of the pharmaceuticals in 
the bile would be reduced and this factor may explain the low concentration of the 
pharmaceuticals in the fish bile. Another possible explanation is based on the bioavailability of 
the drugs in the river. The concentration of the pharmaceuticals in river water is likely to 
fluctuate, thereby affecting direct uptake by fish. In addition, the lipid content in this fish species 
may have been lower, thereby affecting the bioconcentration of the drugs in fish tissue. Overall, 
the BCF of most of the compounds in the bile of the compounds were larger at site 3 and 4 when 




Table 3:4a Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of pharmaceuticals 
















Carbamazepine ND NA ND NA ND NA ND NA ND NA 
Fluoxetine < LOQ NA ND NA < LOQ NA < LOQ NA < LOQ NA 
Atorvastatine 2.1 ± 2.5 150 0.50±0.04 70 0.41±0.05 9 ND NA < LOQ NA 
Venlafaxin 0.44 ± 0.05 16 0.35 ± 0.01 15 0.33 ± 0.01 1 0.30 ±  0.01 1 0.30 ± 0.02 3 
Norfluoxetine 0.46 ± 0.10 153 0.20 ± 0.01 115 0.26 ± 0.03 130 0.27 ± 0.05 135 < LOQ NA 
Sertraline 1.14  ± 0.30 163 0.70  ± 0.10 144 0.85 ±  0.20 65 0.68 ± 0.05 68 0.22 ± 0.04    28 
Paroxetine 2.8 ± 2.0 710 1.10 ± 0.30 29 1.07 ± 0.20 214 ND NA 0.57 ± 0.30 1 
                      
  









Table 3.4b: Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of pharmaceuticals 





















Carbamazepine ND NA ND NA ND NA ND NA ND NA 
Fluoxetine 4.0 ± 2.0 800 1.7 ± 1.0 425 < LOQ NA < LOQ NA 3.0 ± 1.7 753 
Atorvastatine ND NA ND NA ND NA ND NA ND NA 
Venlafaxin 17 ± 13 607 7.27 ± 4.0 303 < LOQ NA < LOQ NA 2.3 ± 1.2 22 
Norfluoxetine ND NA ND NA ND NA ND NA ND NA 
Sertraline 1.3 ± 1.0 186 2.1 ± 1.0 418 < LOQ NA < LOQ NA 0.43±0.1 54 
Paroxetine 0.3 ± 0.2 82.5 0.4 ± 0.3 10 0.14 ± 0.20 28 < LOQ NA 0.40±0.30 133 
                      
            








Table 3.4c: Summary of the concentration (ng/mL) of field wastewater samples determined by solid phase extraction (SPE) 
method near a municipal effluent outfall 
                      
Analytes Site 1  
RSD  








n=3 PAT 4 
RSD  
( %) 




Carbamazepine 0.022 9 0.024 10 0.117 3 0.109 5 0.049 5 
Fluoxetine 0.005 9 0.004 11 0.005 10 0.004 14 0.004 5 
Atorvastatine 0.014 10 0.007 11 0.047 16 0.043 14 0.018 7 
Venlafaxin 0.028 6 0.024 5 0.264 3 0.245 5 0.106 2 
Norfluoxetine 0.003 12 0.002 14 0.002 11 0.002 3 ND 
 Sertraline 0.007 9 0.005 10 0.013 11 0.010 9 0.008 10 
Paroxetine 0.004 5 0.037 7 0.005 3 0.004 6 0.003 8 
Ibuprofen 0.025 9 0.028 2 0.730 14 0.660 5 0.170 8 
Gemfibrozil 0.009 12 0.009 3 0.017 13 0.016 10 0.010 9 
                      
           
 




   Of those compounds detected at higher concentrations at upstream sites, it is possible the 
additional nutrients at the wastewater-exposed downstream stations would have resulted in 
additional feeding opportunities for the caged fathead minnow. If they were feeding regularly, 
the periodic release of bile to the duodenum would have routinely flushed the bile, while periods 
of fasting have been known to further concentrate bile analytes
131
. Finally, some of the 
pharmaceuticals may partition to organic carbon or suspended particulates in the wastewater, 
making them less bioavailable. Consequently, these various factors may reduce the amount of 
selected pharmaceuticals bioconcentrated in fish, resulting in low levels being detected (or below 
detection limits) in the tissue and bile.  
 
3.4.5 Comparison of SPME and traditional methods  
The SPME method was validated against traditional solvent extraction (liquid-liquid), with good 
agreement (R
2
= 0.99, slope = 0.88, Figure 3.3). Consequently, SPME is a viable alternative for 
determining the concentration of pharmaceuticals in fish tissue, with the benefit of simplicity, as 
it integrates sampling and sample preparation into a single step. In contrast, the traditional liquid 
extraction method is relatively laborious, involving multiple steps which can affect the precision 
of the analytical method. While SPME is environmentally friendly in that it uses little or no 
solvent during the sample preparation, traditional approaches rely on substantial use of solvents, 
creating potential health and environmental concerns. SPME provides a rapid and inexpensive 
technique for biopharmaceutical analysis, where analyte loss during sample preparation is 
reduced due to the integration of multiple steps into a single step while sampling complex 






3.5   Conclusion 
 In this study, SPME provides a simple and rapid method for monitoring the bioconcentration 
and excretion of target pharmaceuticals in fish bile. For many analytes, detection is only feasible 
in the bile as normal physiological functions naturally bioconcentrate contaminants in the bile 
prior to excretion. However, as a complex matrix, bile is difficult to analyze. SPME can be a 
useful sampling technique which limits analytical interference on compounds of interest from a 
co-extracted matrix. This SPME approach successfully analyzed target pharmaceuticals and 
target metabolites of fluoxetine and carbamazepine in fish bile following laboratory exposures 
and exposure to complex mixtures in fish caged near wastewater outfalls. Uptake and 
bioconcentration of pharmaceuticals in tissues and bile will vary based on their properties, 





















Determination of pharmaceutical residues in wastewater using 
automated thin film solid phase microextraction with liquid 
chromatography-tandem mass spectrometry 
 
4.1 Preamble 
This chapter has been submitted for publication in the Journal of Chromatography A which is 
under peer-review. This chapter will be published as a paper: Oluranti P. Togunde, Erasmus 
Cudjoe, Ken D. Oakes, Fatemah S. Mirnaghi, Mark R. Servos, and Janusz Pawliszyn 
“Determination of pharmaceutical residues in wastewater using automated thin film solid phase 
microextraction with liquid chromatography-tandem mass spectrometry”. The figures and tables 




The frequent detection of pharmaceutical residuals of human and veterinary origin in surface and 
wastewater at trace to ultra-trace concentrations (ng/L to µg/L) 
3, 23, 30,133-137
 has engendered both 
public and scientific concern. Such apprehension surrounding the now near ubiquitous reports of 
pharmaceuticals detected in surface water adjacent to urban areas or areas of intensive 
agriculture is focused on the anticipated subtle effects such unregulated exposure might produce 
in aquatic organisms and humans
12,138-139
. One source of these “emerging contaminants” has 
been attributed to incomplete removal, and hence near continuous environmental infusion, of 
pharmaceutical residues from municipal wastewater treatment plants 
4,140-141
. Agricultural 




however, such introductions to surface water are more seasonal than continuous, often 
corresponding to the application of manure to fields in the spring and fall. Leachate from solid 
waste landfills and the application of biosolid as an inexpensive nutrient amendment to 
agricultural fields have also been identified as sources of pharmaceutical entry to aquatic 
environments.  
Since pharmaceuticals are usually detected in surface water and wastewater at trace or ultra-trace 
concentrations, sensitive analytical methods are required for determination of these compounds 
in environmental samples. The use of high performance liquid chromatography (HPLC) coupled 
with tandem mass spectrometry (LC/MS/MS) has been the technique of choice due to the high 
selectivity and sensitivity achieved by this method. In general, pharmaceuticals are designed to 
be polar and relatively non-volatile, thus, they can be readily measured using HPLC without the 
additional step of derivatization as required by gas chromatography 
4,142-143
. Off-line solid phase 
extraction (SPE) is commonly used as a sample preparation technique to extract and pre-
concentrate pharmaceuticals from environmental samples 
144-149
. One of the major drawbacks 
associated with manual (offline) SPE is that it is a laborious and time consuming multi-step 
sample preparation method. Although the use of automated online SPE method is increasing 
150-
152
, relatively expensive instrumentation is required to perform the extraction. In addition, SPE is 
subject to clogging during extraction, particularly when handling very dirty environmental water 
samples without prior filtration. Hence, sample pre-treatment processes such as filtration are 
therefore required prior to SPE extraction, but loss of matrix-bound analytes during the filtration 
process is a valid concern. 
Recently, solid phase microextraction coupled with liquid chromatography-tandem mass 




concentrations in water samples, although the desired sensitivity could be a challenge due to the 
limited volume and type of extraction phase used 
140,153.
 To address the drawbacks associated 
with traditional solid phase microextraction (SPME) methods, a new SPME configuration based 
on thin film configuration (using C18 extraction phase) is proposed, which can improve the 
method sensitivity and provide faster analysis of pharmaceuticals in water. The new 
configuration provides large surface area-to-volume-ratio, in which C18 particles are immobilized 
on a flat thin stainless steel. Since the geometry of the extraction phase is different from 
traditional SPME fibre, the new configuration used for this study is called thin film solid phase 
microextraction for the purpose of clarity. This new TF-SPME can be used in a 96-well plate 
format, thereby improving current high throughput analysis of pharmaceuticals in environmental 
water samples. The aim of this study is to develop a simple, fast, and sensitive analytical method 
based on automated SPME (SPME/LC/MS/MS) for determining concentrations of selected 
pharmaceuticals in wastewater in a high throughput 96-well plate format. To this end, the SPME 
configuration was modified and coupled with a very sensitive mass spectrometer to improve 
method sensitivity while maintaining the major advantages of SPME as a solvent free, 
environmentally friendly extraction technique that integrates sampling and sample preparation 
into a single step. The amount of analyte extracted by SPME at equilibrium is governed by the 
distribution constant between the extraction phase and sample matrix as shown in equation (1.1) 
38
. When equilibrium between the extraction phase and the sample matrix is achieved, the initial 
concentration of analyte in the sample can be determined, since the amount on the extraction 





4.3 Experimental  
4.3.1  Chemical and material 
All chemicals and reagents utilized in this study were obtained at the highest available purity and 
were used without further refinement. Fluoxetine, diazepam, and diazepam-d5 were purchased as 
certified standards from Cerilliant Corp (Round Rock, TX, USA). Carbamazepine was obtained 
from Sigma-Aldrich (Oakville, ON, Canada), while paroxetine, paroxetine-d4, sertraline, and 
sertraline-d3 were purchased from Toronto Research Chemical (Toronto, ON, Canada). 
Isotopically-labeled standards carbamazepine-d10 and fluoxetine-d5 were purchased from CDN 
Isotope Inc (Point-Claire, QC, Canada). Chemical stock solutions were prepared in methanol 
with working solutions diluted as aliquots of this stock. Dilution water was obtained from a 
Barnstead Nanopure water purification system deionized to 18 Ω. HPLC-grade methanol 
(MEOH), HPLC-grade acetonitrile (ACN) and acetic acid were purchased from Fischer 
Scientific (Ottawa, ON, Canada). Individual 1mg/mL stocks for each pharmaceutical (except for 
diazepam which was purchased as 1 mg/mL in methanol) were prepared in methanol and stored 
at -20
o
C. A 10 mg/L mixture of all selected pharmaceuticals was prepared by diluting individual 
stocks with methanol. The C18 thin film extraction phase used in this study was obtained from 
Supelco (Bellefonte, PA, USA), and polypropylene 96-well deep plates were purchased from 
VWR International (Mississauga, ON, Canada). 
4.3.2  Automation of sample preparation steps with PAS concept 96 auto sampler 
 All SPME steps including conditioning of the extraction phase, extraction, and desorption were 
automated by the Professional Analytical System (PAS) Concept 96 auto sampler (PAS 
Technology, Magdala, Germany). In this study, TF-SPME performed parallel sample 




provides a high throughput analysis of pharmaceuticals in wastewater without user intervention, 
with the exception of placement of samples into the multi-well plate. All experiments were 




4.3.3  Instrumental analysis (LC/MS/MS) 
Analysis was carried out using an Accela
TM
 instrument from Thermo Scientific equipped with a 
binary pump, vacuum degasser, and an auto sampler coupled with a MS/MS system. System 
control and data analysis were performed by X-Calibur
® 
software version 2.0.7 provided by 
Thermo Scientific. Chromatographic separation was performed using a Waters
®
 reversed phase 
C18 column of 100 mm × 2.1 mm i.d, 3 µm particles. The mobile phase consisted of a mixture of 
eluent A (90% water, 10% ACN and 0.1% acetic acid) and B (90% ACN, 10% water and 0.1% 
acetic acid) at room temperature with a flow rate of 0.5 mL/min. Optimal pharmaceutical 
separation was achieved using the following solvent gradient elution: mobile phase B was 
increased from 0% to 95% over 2 min, held for 1 min, and ramped back to 0% over 2 min. 
Analysis run time was 5 min including re-equilibration of the analytical column. The sample 
injection volume was 10 µL and samples were kept in the auto sampler at 5 
o
C. Identification 
and quantification of the analytes were carried out using a sensitive TSQ Vantage
TM
 (triple stage 
quadrupole) mass spectrometer equipped with ESI sources. Heated nitrogen gas (N2) was used as 
both nebulizer and desolvation gas in the ESI sources, while argon was used as a collision gas for 
collision induced dissociation. Full scan and MS/MS spectra of the individual standard were 
optimized by direct infusion of 1 mg/L of individual standard solution at a flow rate of 10 
µL/mL. All analytes formed protonated molecular species (MH+) and were detected using 




4.4 Thin film solid phase microextraction procedure 
4.4.1 Extraction phase: Comparison of C18 fibre and thin film  
Development of any SPME procedure requires the selection of an appropriate extraction phase 
with affinity for the target compound(s). In the present study, during the preliminary stage of 
extraction phase selection, in-house polydimethysiloxane (PDMS) and polymeric C18 extraction 
fibre (Supelco, Bellefonte PA, USA) were compared using pure water spiked with 
pharmaceuticals to determine the relative affinity of the target compounds. Preparation details 
for the in-house PDMS extraction phase have been described elsewhere 
88
. Relative extraction 
efficiencies and repeatability for the PDMS and C18 extraction phases were evaluated and 
compared using 2 ng/mL spiked water for equilibrium extraction (n = 12). Based on SPME 
fundamental principles, the amount of analyte extracted is a function of the physico-chemical 
properties of the extraction phase. As the coating length or volume increases, so increases the 
amount of extracted analyte from the sample, thereby resulting in enhanced method sensitivity. 
In this study, method sensitivity was improved by changing the geometry of the SPME 
extraction phase to a thin film in order to increase the amount of target analyte extracted from the 
sample. In other words, the method sensitivity is enhanced due to the increase in the coating 
surface area and volume. This new configuration based on thin film C18 extraction phase was 
used in a 96-well plate to achieve high throughput analysis of the pharmaceuticals in water 
samples. The extraction efficiency and reproducibility of the method were also evaluated in 





4.4.2 Extraction and desorption time determination 
Extraction and desorption time are important parameters affecting SPME performance, with the 
highest possible sensitivity afforded by extended sampling time allowing for equilibrium 
extraction. Consequently, equilibrium extraction time was optimized and determined for each of 
the selected pharmaceuticals by extracting the target analyte from spiked water over time frames 
of 20-180 min under agitation. Prior to extraction, the extraction phase was conditioned in a 1:1 
mixture of methanol and water under agitation (1000 rpm) for 30 min to activate the sorbent. 
Subsequently, a 1.8 mL aliquot of spiked water (2.0 ng/mL, n = 3) was dispensed into a 2.0 mL 
96-well plate prior to the introduction of the extraction phase, with extraction carried out in the 
well under agitation (1000 rpm) to accelerate extraction by reducing the boundary layer 
thickness. After extraction, the extraction phase was removed from each well in the 96-well plate 
and desorbed in the desorption solution for 1 h with agitation at 1500 rpm. Optimization of 
desorption solvents was carried out using differing ratios of methanol/water, with a 60:40 
mixture maximizing the removal of the target analytes from the extraction phase with an 
observed carryover of less than 1%. Different desorption times were also evaluated, ranging 
from 30 to 120 min to ensure timely but thorough desorption of analyte. Preconditioning, 
extraction, and desorption steps were automated with PAS concept software, with the samples 
extracted at each time point analyzed by a sensitive TSQ Vantage
TM
 (triple stage quadrupole) 
mass spectrometer. Following optimization, subsequent desorptions utilized 0.6 mL of 
desorption solvent (60% methanol aqueous) to ensure that the entire extraction phase was 
immersed in the desorption solution. In order to minimize the variability from the instrument and 
method procedure, isotopic labeled internal standards were used to correct injection variability 





4.4.3  Effect of salt and pH on extraction efficiency 
The effect of salt on extraction efficiency was evaluated by preparing spiked water samples (2 
ng/mL, n = 12) with different concentrations of sodium chloride (0-20 % w/v) added. The sample 
was homogenized for 5 min before extraction and desorption; analysis of analyte at each salt 
concentration was performed, as previously described. In addition, the effect of pH on extraction 
efficiency and method sensitivity was evaluated using pH values ranging from 3 to 8. Nanopure 
water was adjusted with 0.1M solutions of HCl and NaOH using a Thermo Fisher Scientific 
ORION 3-Star pH meter to achieve the desired pH value, and then the sample was spiked to a 
final concentration of 3 ng/mL of analytes. After thorough homogenization (2 min), extraction of 
the spiked water with different pH values was carried out at equilibrium time under 1000 rpm 
agitation. After extraction, a 1 h desorption of analytes from the extraction phase under agitation 
at 1500 rpm was immediately conducted under the desorption conditions already described.  
 
4.4.4  Application to real samples  
The application of an automated TF-SPME for analysis of selected pharmaceuticals in 
wastewater was evaluated by analyzing Burlington, ON municipal wastewater treated under a 
variety of pilot-scale conditions from July to September 2011. Wastewater samples were treated 
by either conventional activated sludge (CAS), conventional activated sludge with nitrification 
(CAS-N), or conventional activated sludge with Biological Nitrifying Reactor (CAS-BNR). All 
samples were analyzed and quantified by the new method with liquid chromatography-tandem 
mass spectrometry as described previously. The feasibility of the newly developed automated 
method for monitoring pharmaceuticals in the environment was evaluated using wastewater 




Waterloo wastewater treatment plants. Samples were collected in glass amber bottles (1000 mL) 
and transported to the laboratory on ice. Following transportation, the samples were subsequently 
preserved using 0.2 g/L sodium azide and 0.05 g/L ascorbic acid (to inhibit microbial 
degradation of analyte) and stored at 4
o
C until extraction.  
 
4.4.5 Matrix effect study 
The effect of matrix on the method was evaluated by comparing the MSMS response of a known 
amount of deuterated standard of the target compounds spiked in neat solvent and matrix extract 
from wastewater (post extraction spiked method at one concentration level). The matrix effect 
(i.e signal suppression or enhancement) was assessed using the method described by 
Matuszewski et al. 
156
, which involved relating the peak area of standard obtained from a neat 
solvent to the peak area of the corresponding analytes in a matrix extract sample. In this case, the 
wastewater sample and pure water were extracted with the TF-SPME method and the extract was 
spiked with deteurated standard of the target analytes at one concentration level (5 ng/mL). Next, 
the extract was injected to the LC/MS/MS system for the quantification of the analytes. This 
experiment was performed in triplicate (n = 3). In addition, the effect of matrix was assessed at 
multiple concentration levels based on the post extraction spike method in order to generate the 
regression line. The assessment of the matrix effect was based on determining the slopes of 
regression lines in neat solvent (S1) and wastewater extract (S2). The pure solvent used in this 
case was the desorption solution (60% methanol, 40% water) which was spiked at different 
concentration levels (0.039 – 20 ng/ml). Also, the wastewater sample was extracted by the TF-
SPME method, after which the extract was spiked at the same concentration level as the pure 




The slopes of regression line in pure solvent and matrix extract were compared. The matrix 
effect calculation is shown below: 
ME (%) = S2/S1*100 
S1 = slope of regression line in solvent 
S2 = slope of regression line in wastewater 
 
4.5  Results and Discussion 
4.5.1  Selection of extraction phase  
One of the parameters affecting the extraction efficiency and sensitivity of the method is the 
selection of appropriate type of extraction phase (coating). In this study, the extraction efficiency 
of the method using different extraction phases and configurations was evaluated in spiked pure 
water, in-house polydimethysiloxane (PDMS) tubing (165 µm thickness), C18 fibres (45µm 
thickness), and C18 thin film (45 µm thickness). The coating length for all extraction phases was 
1.5 cm. At an earlier stage of method development, extraction efficiencies of in-house  PDMS 
and commercially-available C18 fibres (45 µm thickness) extraction phases were evaluated in 
spiked water (buffered at pH 7.4) at equilibrium extraction times. Although both extraction 
phases have affinity for the compounds of interest, non-polar PDMS fibres have less affinity for 
hydrophilic compounds such as carbamazepine,  and C18 fibres have shorter extraction times 
(equilibration times) than PDMS coatings due to coating  thickness. Since the coating thickness 
in PDMS is three times greater than C18 fibre, this will result in longer extraction time. Previous 
evaluations have demonstrated that equilibrium extraction of pharmaceuticals with PDMS can 
take up to 3 or 4 hours, while C18 fibres can equilibrate in as short as 60 min, again due to the 




configured in its thin film geometry was evaluated in spiked water. The greater extraction phase 
volume (8 times higher) and surface area (1 order of magnitude greater) of the C18 thin film 
configuration relative to the C18 fibre configuration resulted in higher extraction efficiencies for 
all the analytes examined (Figure 4.1) when compared to the traditional approach using  C18  
fibre.  
 
       Figure 4:1 Extraction efficiency of C18 fibre and thin film coating for the target 
pharmaceuticals spiked phosphate buffer solution at pH = 7.4 
 
This result shows a good agreement with the results that were reported elsewhere based on the 
use of thin film configuration 
155
. Consequently, the C18 thin film geometry was selected for this 
study, due both to its enhanced extraction abilities and its ease of automation in a 96-well plate 
format, improving high throughput analysis of pharmaceuticals in wastewater samples. As a 
result of the larger volume of the extraction phase in the thin film geometry, the amount of target 
























extraction sensitivity, or the amount of analyte extracted at equilibrium, is improved with C18 thin 
film geometry, and the higher extraction rate is distinctly advantageous in this study. 
 
4.5.2  Effects of salt and pH on extraction efficiency 
Extraction efficiency of an analytical method can be greatly influenced by sample pH due to 
ionization of analyte 
157-158
. As the pH changes, the extractable form of the analyte is affected; 
consequently, the extraction efficiency of the C18 thin film geometry was studied over a pH range 
of 3-8, since receiving environment chemistry can change over time. Thus, if increases in acidity 
were realized, these would decrease the extraction efficiencies for the anti-depressant drugs of 
sertraline, fluoxetine, and paroxetine, due to protonation of these basic compounds in acidic 
medium (Figure 4.2), which was also reported elsewhere in the literature 
158
  
       
































 In this study, however, carbamazepine and diazepam, being neutral compounds, did not vary 
significantly in their extraction efficiencies as the pH varied between 3 and 8. The effect of ionic 
strength on SPME extraction efficiency as modified by the addition of sodium chloride (NaCl, 0 
– 20% (w/v) proportionally increased extraction efficiency up to 10% (w/v) salt, which was 
consistent with previous reports 
153, 159
. However, as Figure 4.3 illustrates, increasing salinity 
from 10 to 20% (w/v) produced a gradual decrease in extraction efficiency, perhaps due  to 
interactions between analyte and salt molecules 
153, 159, 160
. It can be deduced from the results that 
the increase in the extraction efficiency was not significant compared to the sample without the 
addition of salt.  
 
Figure 4:3Effect of ionic strength on the extraction efficiency of the method 
 
4.5.3 Optimization of extraction and desorption conditions 
Extraction time and desorption conditions are important factors affecting SPME performance; in 
the present study, method optimization was performed by sequentially varying one parameter at 

































shortest extraction time achieving equilibrium, which required approximately 70 min for the 
selected pharmaceutical analytes (Figure 4.4).  
                   
Figure 4:4 Extraction time profiles of the selected pharmaceuticals in spiked water  
 
Since the amount of analyte extracted at equilibrium yielded the highest sensitivity, these 
extraction times were used for all subsequent experiments.  Desorption solvents of varying 
concentrations of aqueous methanol were also evaluated in preliminary experiments; 1:1 ratios of 
methanol: water resulted in incomplete desorption of compounds such as diazepam and sertraline 
from the extraction phase, resulting in higher carryover (3-6%). Conversely, as the percentage of 
the organic (methanol) phase increased to 70%, analyte peak shapes in the chromatogram were 
broadened. As a result, a 60:40 ratio of methanol: water was used as the desorption solvent, 
resulting in efficient desorption of analytes from the extraction phase with negligible carryover 
(≤ 1%).  In order to ensure that there was no cross contamination between each extraction step, 
the extraction phase was always pre-conditioned in conditioning solution (MeOH: water, 1:1). 


























Table 4:1Optimized extraction and desorption conditions for analysis of the selected 
pharmaceuticals in spiked water 
 
            
Parameters optimized on automated SPME robotic system 
Extraction volume                                     1.8 mL 
 Extraction time                                          70 min 
 Extraction agitation speed                         1000 rpm 
 Desorption solvent composition                MeOH/Water (60:40) 
Desorption time                                         60 min 
 Desorption volume                                    600 µL 
 Desorption agitation speed                        1500 rpm  
       
4.6 Method performance 
4.6.1 Extraction efficiency (recovery) and sensitivity 
Method extraction efficiency was evaluated in spiked wastewater samples (n = 8)  at 0.5 ng/mL 
and 2 ng/mL from surface water from the Grand River upstream of wastewater releases, as 
downstream samples are strongly influenced by the wastewater discharges. For each spiked 
concentration, extraction efficiency was determined by comparing the amount of analyte 
extracted from the spiked samples. Some of the target compounds were detected in the blank 
(non-spiked) water sample; although it was collected upstream of the Kitchener wastewater 
discharge, it was influenced by the wastewater released 20 km upstream at Waterloo. Therefore, 
the amount of the target compound detected in the blank water sample was subtracted from each 




spiked at the two concentrations ranged from 71-87.5%, with acceptable repeatability (relative 
standard deviation, RSD, n = 8) of 9-15% (Table 4.2).  
 
Table 4:2  Method performance in wastewater effluent spiked with 0.5 and 2 ng/ml of 
analyte 
 
  0.5 ng/ml   
 











RSD (%)  
n = 8 
Paroxetine 78.3 11 Paroxetine 74.1 12 
Fluoxetine 73.4 13 Fluoxetine 71.2 9 
Sertraline 77.9 11 Sertraline 74.3 14 
CBZ 83.7 14 CBZ 80.0 15 
Diazepam 85.7 11 Diazepam 87.5 15 
            
       
 
All test analytes were satisfactorily determined in spiked samples at both 0.5 and 2 ng/mL 
concentrations with acceptable reproducibility over different days. As method sensitivity is 
directly proportional to the amount of analyte extracted, the larger surface area of the C18 thin 
film geometry conferred 2 to 3 times more sensitivity than traditional C18 fibre SPME methods, 





4.6.2  Linear range, detection and quantification limits  
The method linearity for each compound was evaluated between 0.01 – 10 ng/mL (n = 3) in 
spiked wastewater samples, with all compounds being linear within the spiked concentration 
range (correlation coefficient > 0.99). Generally, the linear response of the compounds covered 
2-3 orders of magnitude and the calibration curves were generated using linear regression 
analysis. The quantitative performance of the method was satisfactory since most of the 
compounds could be quantified within the linear range. The detection limit was determined as 
the minimum detectable amount of an analyte in the spiked wastewater extract based on S/N 
ratio of 3. Three replicate wastewater samples were spiked to obtain a final concentration of 500 
ng/L and taken through the entire analytical method procedure. Limit of detection (LOD) was 
determined based on the signal-to-noise ratio (S/N) method as 3× S/N in wastewater. The limit of 
quantitation (LOQ) for the extraction of the target compounds calculated was based on 10× S/N. 
All LODs were in the range of 2-13 ng/L while the limit of quantification ranged from 10-50 
ng/L, with acceptable reproducibility (Table 4.3). The precision of the chromatographic method 
was determined by the repeated injection of quality control standard on different days at a 











Table 4:3Detection, quantification limit, correlation co-efficient (r
2
), and weighting  
 
        
Analytes 
  LOD   LOQ 




  index (ng/mL) (ng/mL) 
Sertraline 0.006  0.02 0.9993 1/x 
Fluoxetine 0.009  0.03 0.9960 1/x 
Paroxetine 0.013  0.05 0.9952 1/x 
Carbamazepine 0.002  0.01 0.9991 1/x 
Diazepam 0.005  0.02 0.9998 1/x 
          
      
4.6.3 Inter-day reproducibility in spiked wastewater 
The inter-day reproducibility was determined in wastewater spiked using 2 ng/mL of the analytes 
of interest over 4 days and 10 repeated analyses (n = 8/time-point). These assessments were 
performed using the high-throughput automated 96-plate format, which yielded good inter-day 
reproducibility with an RSD of 4-15% (Figure 4.5). Using this approach, the average extraction 
efficiency of paroxetine was 80%, with an inter-day RSD of 6-12%. Average extraction 
efficiencies of fluoxetine, sertraline, carbarmazepine, and diazepam were 77-94 % with inter-day 
reproducibility (RSDs) of 4-12% (Figure 4.5), which was deemed acceptable. Instrument 
performance (reproducibility and sensitivity) was always checked at the beginning and end of 






Figure 4:5 Investigation of extraction efficiencies and reproducibility of the method in 10 
discrete repeated analyses over 4 days in 2 ng/mL water spiked with target compounds 
 
 
4.6.4 Matrix effect 
The slope of the spiked extract calibration curve was related to the slope of the corresponding 
spiked neat standards. There was no significant difference between the slopes of the linear 
regression of the target compounds investigated in both matrices, suggesting that matrix 
influences on the quantitation of these compounds were negligible (Figure 4.6). In this study, 
there was no significant matrix effect when using the developed method to quantify the target 




































Figure 4:6 Comparisons of slopes of calibration in spiked d5-diazepam (A) and d10-
carbamazepine (B) in neat standard and waste sample extract  
 
 
Also, it is worth mentioning that matrix interference was not observed with the method even 
when internal standard was not used, when comparing the slope of linear regression in pure neat 
y = 23003x - 2313
R² = 0.997























y = 76728x - 17294
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standard and wastewater extract (Figure 4.6). As shown in Table 4.4, the results indicate that the 
effect of matrix co-extraction was not observed for these compounds being investigated.  
 
Table 4:4 Comparison of the slope of linear regression of deteurated standard in spiked neat 





Compounds Slope (S1) R
2
 correlation Slope (S2) R
2
 correlation     ME (%) 
d4-Paroxetine 437 0.9852 460 0.9924 105 
d5-Fluoxetine 2956 0.9985 2805 0.9978 95 
d3-Sertraline 33534 0.9982 34059 0.9929 102 
d10-
Carbamazepine 79440 0.9954 76728 0.9940 97 
d5-diazepam 22494 0.9989 23003 0.9970 102 
            
       
 This shows that SPME extract was relatively clean, and may not be causing ionization 
suppression or enhancement. The present results demonstrate that wastewater matrix components 
that can interfere with the method performance were not co-extracted in the SPME extraction. In 
addition, the instrument response was linear ( r
2
 > 0.99)  in the dynamic range (0.039 – 20 ng/ml) 
except for d4-paroxetine, whose correlation co-efficient was greater than 0.98. The use of isotope 
dilution was also employed to compensate for any matrix effects, particularly when dealing with 
complex samples such as wastewater 
161-168
. The use of SPME as a sample preparation technique 
is also an effective way to deal with matrix effect, particularly when the internal standard 







4.6.5 Validation of SPME with traditional solid phase extraction (SPE)  
The optimized SPME method was validated with the well-established SPE method during the 
analysis of the Burlington pilot-scale wastewater effluent samples using isotopically-labelled 
standards in both approaches. With both methods, the concentrations of carbamazepine and 
fluoxetine were comparable with acceptable precision in all treatment types, with no significant 
differences in the concentrations determined by the two methods (Figure 4.7).  
 
                    



























                                               
Figure 4:7 Comparisons of concentrations of fluoxetine (A) and carbamazepine (B) between   
SPME method and traditional method (SPE) 
 
 
However, the use of automated SPME proved to be more rapid and simpler when compared to 
the traditional SPE approach. It is notable that the developed method required no sample pre-
treatment or vacuum pump and was not subject to matrix clogging of the extraction phase as 
occurs with SPE, thereby potentially limiting extraction efficiency. For SPE extraction, the 
samples have to be filtered to avoid clogging. However, while the reproducibility of both 
methods is comparable, the detection limit of SPE was lower than SPME, reflecting the 
exhaustive extraction of analytes by SPE leading to higher pre-concentration factors because of 
the larger volume of sample used. Notwithstanding, the newly developed SPME method can be 
useful for high-throughput analysis of pharmaceuticals in wastewater samples with a sensitive 
instrument being used in tandem with the thin film geometry extraction phase. In addition, the 
TF-SPME system used in this study is relatively less expensive as it does not require a pump to 



























4.6.1 Application of the method to wastewater (effluent) from Burlington pilot plant and 
Grand River water samples 
To demonstrate the application of the automated SPME method in urban wastewater samples, the 
approach was applied to undiluted Burlington, ON wastewater effluent treated by three processes 
(CAS, CAS-N, and CAS-BNR) at pilot-scale treatment plants. The samples, which visibly varied 
in clarity and matrix between treatment types (CAS most opaque, CAS-BNR clearest), also 
varied in detected analyte concentrations over the intervals collected, perhaps reflecting 




Table 4:5 Concentration (ng/mL) of the target pharmaceutical compounds detected by thin film microextraction method (n = 
3) 
    24-Aug     28-Aug     30-Aug   





  BNR CAS CAS-N BNR CAS CAS-N BNR CAS CAS-N 


























Sertraline 1.41 ± 0.27 1.93 ± 0.18 
 1.91 ± 
0.34 
1.38 ± 






















Diazepam ND ND ND < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ 
 
      
 





   
  
 








    16-Sep     18-Sep     20-Sep   





Compounds BNR CAS CAS-N BNR CAS CAS-N BNR CAS CAS-N 













Fluoxetine 2.29 ± 0.41  3.82 ± 0.32 
 3.01 ± 
0.46 
1.12 ± 
0.08 1.74 ± 0.25 
1.44 ± 
0.22 ND ND ND 




0.30 1.88 ± 0.32 
1.81 ± 
0.27 ND ND ND 




0.07 0.45 ± 0.06 
0.41 ± 
0.06 < LOQ < LOQ < LOQ 
Diazepam < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ 
                    
      




Most target compounds, with the exception of diazepam, were detected and quantified in all 
treatments, with antidepressants such as fluoxetine, sertraline, and to a lesser extent, paroxetine, 
being detected at relatively higher concentrations. However, there was an instance when 
sertraline and fluoxetine were detected but not quantified in two wastewater samples, since the 
compounds were below the limit of quantitation of the method.  In addition, anti-convulsant 
carbamazepine was detected in the treated effluent at lower concentrations of 390-640 ng/L. 
Although diazepam was detected in some of the effluents analyzed, the concentrations were 
below the limit of quantification, either due to relatively low rates of use in the populace or 
efficient removal by the pilot-scale treatment plants. Another possible reason could relate to 
microbial activity, which may degrade the organic contaminants including pharmaceuticals, 
particularly when conventional activated sludge treatment is used for the removal of 
contaminants. The feasibility of the newly developed method was demonstrated in wastewater 
samples collected from Grand River at Kitchener and Waterloo downstream sites. Figure 4.8 
indicates the chromatogram of some of the ubiquitous compounds detected in the wastewater 






Figure 4:8  Chromatogram of the sample extract from wastewater collected from 
Grand River at Kitchener downstream site 
 
 
Figure 4.8 demonstrates that this method is capable of detecting the selected pharmaceuticals in 
wastewater collected along the Grand River in Waterloo and Kitchener downstream sites. As 
shown in Figure 4.9, the concentration of these compounds ranged from 200 – 650 ng/L with 





Figure 4:9 Concentration of selected pharmaceuticals detected and quantified in Grand 
River at Waterloo and Kitchener downstream sites 
 
Again, diazepam was detected but was not quantified because it was lower than the limit of 
quantitation of the method. The present results demonstrate a simplified methodology for the 
determination of emerging contaminants such as pharmaceutical residue in the environment. 
Based on the proposed method, a large number of wastewater samples were processed within a 
short time frame due to the automation of the extraction and desorption steps, in addition to the 
use of 96-well plate format for high throughput analysis. In addition, the author’s laboratory is 
currently developing more polar and mixed coatings to advance the future of the TF-SPME 































This study demonstrates the efficacy of the automated TF-SPME approach in detecting 
pharmaceuticals in water samples with varying degrees of matrix and good reproducibility.  
Based on the thin film configuration of the extraction phase, the sensitivity of the method is 
improved when compared to the traditional SPME method. The sensitivity of the method is 
contingent on the enhanced extraction efficiencies afforded by the surface area of the thin film 
extraction phase and the sensitivity of the analyzing mass spectrometer. In addition, the 
automated TF-SPME provides high throughput analysis of pharmaceuticals in water samples. 
This method is simple, reproducible, and consistent with analyte determinations quantitated by 
traditional solid phase extraction. The study demonstrates that automated TF-SPME (based on 
SPME principle) is a promising method of pharmaceutical analysis in wastewater effluents and 
effluent-influenced surface waters with acceptable detection limits capable of identifying the 
selected pharmaceuticals in environmental water. In addition, no matrix effect was observed with 








Optimization of solid phase microextraction for non-lethal in vivo 
determination of selected pharmaceuticals in fish muscle using liquid 
chromatography – mass spectrometry 
5.1 Preamble 
This chapter has been modified and published as a paper: O.P. Togunde, K. D. Oakes, M. R 
Servos, and J. Pawliszyn. 2012. “Optimization of solid phase microextraction for non-lethal in 
vivo determination of selected pharmaceuticals in fish muscle using liquid chromatography – 
mass spectrometry” Journal of ChromatographyA. 2012, 1261, 99-106. The figures and tables 
are reprinted from this manuscript with the permission of Elsevier (Copyright Elsevier 2012). 
 
5.2 Introduction 
Recently, there has been sustained global scientific interest surrounding the detection and 
potential impact of pharmaceuticals released into the environment on exposed organisms 
12,169-
171
. The detection of pharmaceutical residues in surface waters influenced by municipal 
wastewater effluents (MWWEs) and agricultural runoff has raised concerns from regulatory 
agencies around the globe 
23,172-173
. As a consequence of the continuous release of human 
pharmaceuticals in MWWEs, fish inhabiting these receiving environments can bioconcentrate 
considerable amounts of these bioactive compounds in their tissues, despite their relatively water 
soluble properties 
40,174
. Various analytical methods have been proposed and utilized to 
determine the concentrations of environmental pharmaceuticals in fish 
14, 31, 39,174-177
. Traditional 
methods include solid phase extraction (SPE) 
40
, liquid extraction (LE) 
31






. However, none of these approaches can be applied in vivo to determine 
concentrations of organic contaminants in fish. Traditional analytical methods require lethal 
sampling of a large number of fish to obtain sufficient tissue and variance estimates to accurately 
determine bioconcentration rates. From the perspective of animal care, such sampling procedures 
are undesirable, and in some jurisdictions, unacceptable. Recently, SPME has proven itself a 
simple alternative analytical method that is particularly relevant for the non-lethal in vivo 
sampling of pharmaceutical residues in fish muscle 
43, 61,127,178-179
. However, the small extraction 
surface area and volume of PDMS fibres limited sensitivity and presented challenges for 
detecting fairly polar pharmaceuticals (i.e. carbamazepine) or those with low bioconcentration 
factors under pre-equilibrium sampling conditions. To overcome these limitations, a new SPME 
configuration based on C18 thin film geometry (a modification of SPME) was proposed, with 
potential to improve the sensitivity of the method. Furthermore, the proposed SPME 
configuration has the potential to improve extraction kinetics under pre-equilibrium sampling 
conditions relative to traditional PDMS or C18 fibre configurations. The objective of this study is 
to investigate and optimize the new octadecyl (C18) thin film geometry to improve SPME 
sensitivity and in vivo extraction kinetics when quantifying pharmaceuticals in fish.   
   
5.3 Theoretical considerations  
The volume and type of the extraction phase is a critical parameter modifying the distribution 
constant between the extraction phase and sample matrix, as well as the amount of analyte 
extracted. SPME extraction kinetics and sensitivity (recovery) can be improved by changing the 




extraction is directly proportional to the surface area of the extraction phase 
180
 as described in 
equation (1):  
 
                     ………………………………………… 5.1 
 
where dn/dt is the rate of extraction, Ds is the diffusion coefficient of the analyte in the sample 
matrix, A is the surface area of the extraction phase, δ is the thickness of the boundary layer 
surrounding the extraction phase and Cs is the concentration of analyte. Based on this equation, 
extraction kinetics can be improved (particularly during pre-equilibrium extraction) when the 
traditional cylindrical fibre geometry is changed to a thin film configuration, which will provide 
a faster extraction rate for the analytes of interest. SPME sensitivity is a function of extraction 
phase type and volume
89, 181
 as the amount of analyte extracted from a sample matrix at 
equilibrium is proportional to the volume of the extraction phase as shown in equation (1.1). 
Equation 1.1 can be further simplified to equation 1.2 when sampling large volumes, such that 
KfsVf  << Vs 
Based on equation 1.2, the amount of analyte extracted in fish can be related to the volume of the 
extraction phase and partition co-efficient between the extraction phase and fish sample matrix. 
Therefore, the use of C18 thin film geometry will theoretically improve pre-equilibrium SPME 
extraction kinetics relative to traditional C18 coated fibre geometries for in vivo detection of 










5.4.1  Chemicals and materials  
All reagents and pharmaceuticals standards were of the highest purity grade available. 
Fluoxetine, diazepam, nordiazepam, and diazepam-d5 were purchased as certified standards from 
Cerilliant Corp (Round Rock, TX, USA). Gemfibrozil, atorvastatin, ibuprofen, carbamazepine, 
diclofenac, naproxen, and bisphenol-A (BPA) were obtained from Sigma-Aldrich (Oakville, ON, 
Canada), while paroxetine and sertraline were purchased from Toronto Research Chemical (ON, 
Canada). Isotopically-labeled atorvastatin-d5, atrazine-d5, BPA-d16, carbamazepine-d10, 
diazepam-d5, diclofenac-d4, fluoxetine-d5, gemfibrozil-d6, ibuprofen-d3, and 
13
C-naproxen-d3 
were purchased from CND Isotope Inc (Point-Claire, QC, Canada) while sertraline-d3 and 
paroxetine-d4 were purchased from Toronto Research Chemical. Chemical stock solutions were 
prepared in methanol and stored at -20
o
C while working solutions were diluted aliquots of these 
stocks. Dilution water was obtained from a Barnstead Nanopure diamond UV water purification 
system deionized to 18 Ω. Acetonitrile (HPLC grade), methanol (HPLC grade), and glacial 
acetic acid were purchased from Fisher Scientific (Ottawa, ON, Canada). Phosphate-buffered 
saline (PBS) solution, pH 7.4 was prepared by dissolving 8.0 g of sodium chloride, 0.2 g of 
potassium chloride, 0.2 g of potassium phosphate, and 1.44 g of sodium phosphate in 1 L of 
purified water and by adjusting the pH to 7.4 using 1M sodium hydroxide (NaOH).  The C18 thin 
film extraction phase (45 µm, 1.5cm coating length) and traditional C18 fibres (45µm, 1.5 cm 
coating length) were obtained from Supelco (Bellefonte, PA USA). A 10 mg/L mixed solution 





5.4.2  Fish exposure 
Immature Rainbow Trout (Oncorhynchus mykiss) were purchased from Silvercreek Aquaculture 
(Erin, ON, Canada) and fathead minnow (Pimephales promelas) were purchased from Silhanek 
Baitfish (Bobcaygeon, ON, Canada). All animal experimental procedures were approved by the 
local Animal Care Committee at the University of Waterloo (AUP #’s 04-24, 08-08). For the 
laboratory exposure, Rainbow Trout were acclimatized to laboratory conditions in de-
chloraminated municipal water and fed every other day with 2.0 Pt floating commercial trout 
ration (Martin’s Feed Mill, Ontario) until 4 d prior to the onset of the experiment. Subsequently, 
the fish were exposed to municipal effluent diluted with dechloraminated municipal water. In the 
field caging experiment, fathead minnow (Pimephales promelas), a small-bodied fish, were 





25’ 12.04”W) at 2 upstream and 3 downstream sites for 14 
d in October 2010. Following the exposure, pharmaceuticals extracted from the fish tissues were 
desorbed in the desorption solution (methanol: water, 3:2) and analyzed by liquid 
chromatography–tandem mass spectrometry. The quantification of target pharmaceuticals 
extracted from free-moving Rainbow Trout was performed using a well-established kinetic 
calibration approach 
71,182
.  Kinetic calibration is a pre-equilibrium calibration approach utilizing 
known amounts of preloaded deuterated analyte desorbing from the extraction phase, to calibrate 
the rate of adsorption of the target analytes from the fish tissue to the extraction phase (based on 
the symmetric relationship between extractions and desorption kinetics). The concentration of 
analytes in fish tissue can be determined by equation 1.3 
 






5.4.3 Thin film extraction phase preparation 
Traditional C18 SPME fibres were obtained from Supelco (Bellefonte PA, USA) and consisted of 
a flexible stainless steel core with a 1.5 cm coating immobilized on the bottom portion (Figure 
5.1a). In contrast, for the thin film extraction phase configuration, a slurry of biocompatible 
binder polyacrilonitrile (PAN) containing 5 μm C18-coated porous silica particles were 
















                               
Figure 5:1Schematic diagram of the C18 SPME extraction phase geometries used in this 
study. Both configurations utilize 45 µm coating thicknesses over a 1.5 cm coating length. A 
is a C18 cylindrical fibre (core of 200 µm diameter, length of 40 mm, extraction phase 




 in hypodermic needle);   B is C18 thin film extraction phase 








The flattened metal support for the thin film configuration was obtained from Professional 
Analytical System Technology (PAS, Magdala, Germany), the surface upon which the C18 
particles were immobilized as described in detail elsewhere 
183
. Briefly, the blade metal is etched 
with concentration HCl for 1 hprior to rinsing with water for 30 min. The metal blade is then 
dried in an oven at 150 
o
C for 30 min. The slurry of C18 particles (5 μm discovery silica-based-
C18 particles, Supelco, PA) is made with a mixture of proprietary biocompatible binder PAN (10 
w/w) and N, N-dimethylformamide (DMF) purchased from Caledon Laboratories (ON, Canada). 
Coatings (mass of 0.28±0.05 g) were immobilized on the metal fibre core using a flask type 
sprayer connected to a nitrogen gas line (250 mL Erlenmeyer flask with a sprayer head). After 
spraying, the coated blade was dried at 180 
o
C for  2 min, with the spraying and drying processes 
repeated at least three more times until a desired coating thickness was achieved. C18 fibre is 
cylindrical with a metal fibre core of 200 µm in diameter, while C18 thin film is rectangular with 
surface area of 0.625 cm
2
. Figure 5.1 illustrates the relative physical dimensions of both C18 
configurations. 
 
5.4.4 Instrumental analysis – LC/MS/MS 
Analyses were performed on an AB-Sciex 3200 QTrap Mass Spectrometer equipped with a 
Turbo Ion Spray source (Applied Biosystems Sciex, Foster City, CA, USA). Liquid 
chromatography (LC) was performed on an HP1100 HPLC system (Agilent Technologies) 
equipped with a degasser, binary pump, an autosampler, and a column oven. Chromatographic 
separation was performed on a Zorbax Eclipse XDB C18 (150 mm × 21 mm, 3.5µm) column 
which was preceded by a C18 guard column at a flow rate of 0.8 mL/min with mobile phase A 




injection volume for analysis of all the samples was 20 µL. The elution gradient was 
programmed as follows: mobile phase B was increased from 10% to 50% over 0.5 min and 50% 
to 100% over 7.5 min, held at 100% for 2 min, and then reduced to 10% over 1 min. Analyst® 
version 1.4.2 software was used for the data analysis. Quality control samples (10 ng/mL of 
target compounds) were utilized at the beginning and end of each run to ensure instrumental 
stability. All analytes were analyzed using selective reaction monitoring (SRM) of the transitions 
with electrospray ionization (ESI). Optimal MS/MS transitions for the target analytes were 
determined with either positive or negative ionization mode.  
 
5.4.5  In vitro evaluation of performance of thin film and fibre geometries in spiked fish 
tissue  
Extraction efficiency of the two SPME configurations (C18 fibre and C18 thin film) was evaluated 
in spiked fish tissue under pre-equilibrium sampling conditions. Evaluation of recovery by the 
extraction phases was carried out using homogenized (Teflon™ homogenizer at 1100 rpm for 20 
min) Rainbow Trout dorsal-epaxial muscle (4.0 ± 0.2 g) spiked with 200 µL of 2 mg/L solutions 
of target compounds. Subsequently, the 100 ng/g spiked muscle sample was vortexed for another 
20 min to ensure complete analyte mixture within the tissue prior to 2 h incubation at 4
o
C. After 
incubation, extraction was performed for 24 h in the spiked fish muscle sample using C18 fibre 
and thin film extraction phases. After the 24 h extraction, both C18 extraction phase 
configurations were washed with distilled water for 5 sec, and gently wiped with a Kimwipe® 
tissue. The C18 fibres were immediately desorbed in 100 µL of desorption solvent (3:2 methanol: 
water) for 90 min at 1000 rpm using a multi-tube vortex (model DVX-2500, VWR International, 




analytes from the extraction phase. The extraction and desorption conditions are summarized in 
Table 5.1 
 




                
Extraction conditions   Desorption conditions   
Extraction time             24 h 
 
Desorption time          90 min 
 Extraction sample         spiked  fish 
 
Desorption solvent      MeOH/H2O (3:2) 
Spiked concentration    100 ng/g 
 
Desorption volume     100 and 300 µL 
Extraction mass            4 g 
 
Agitation speed          1000 rpm 
 Agitation condition       static         
         
5.4.6 Extraction kinetics of pharmaceuticals 
Extraction kinetics of both extraction phase configurations for drugs utilized in this study were 
determined in spiked 1% w/v agarose gel samples due to limited availability of fish muscle and 
previous use of 1% w/v agarose gel in other studies determining in vitro mass transfer 
phenomenon 
181
. Agarose gel was used for in vitro study as both the gel and fish muscle are 
semi-solids of comparable porosity and tortuosity, allowing free diffusion of drugs along their 
concentration gradient with mass transfer governed by Fick’s law in both sample matrices 
38,96
 
The detailed gel preparation procedure has been discussed elsewhere 
43
. In brief, agarose was 
weighed and dissolved in hot phosphate buffer (pH = 7.4) and allowed to solidify at room 
temperature for 3 h. Just prior to solidification, a known volume of agarose gel was spiked (100 
ng/mL n = 3 ) with a mixture of the selected drugs and vortexed for 10 min in a 4 mL vial to 




time profiles were determined (20, 30, 40, 50, and  60 min) using C18 fibres and C18 thin film 
extraction phases, which simultaneously performed extractions from different vials for each time 
point. After each interval, both extraction phases were removed from their respective spiked gels, 
rinsed gently with distilled water, and patted dry with a Kimwipe®. Immediately thereafter, the 
fibres and thin film extraction phases were desorbed in desorption solvent (60:40 methanol-
water) for 90 min as previously described. Extracts from both C18 configurations at each 
extraction interval were quantified by LC/MS/MS. 
 
5.4.7 Laboratory exposure of Rainbow Trout to wastewater effluent  
The juvenile Rainbow Trout used in this study (14.4±0.34 cm; 25.4±1.46 g, mean ±SE, n = 40) 
were acclimated to laboratory conditions in 1400 L holding tanks continuously receiving  de-
chlorinated clean water, and fed every other day with floating commercial trout ration (Martin’s 
Feed Mill, Elmira, ON). Acclimation within the 34 L exposure aquaria (containing previously 
acclimated clean water) began 4 d prior to the onset of the experiment. The experiment began 
when fish were exposed to wastewater collected from three pilot treatment plants receiving raw 
effluent generated from the City of Burlington (Burlington, ON). Wastewater samples were 
treated by Conventional Activated Sludge (CAS), Conventional Activated Sludge with 
Nitrification (CAS-N), or Conventional Activated Sludge with Biological Nitrifying Reactor 
(CAS-BNR). A detailed description of the properties and process operation of each type of 
wastewater treatment has been provided elsewhere 
184
. The exposure involved two controls and 
six different treatments: CAS-20%, CAS-50%, CAS-N-20%, CAS-N-50%, CAS-BNR-20%, and 
CAS-BNR-50%. Each 34 L aquaria housed 5 fish in each tank and the exposure duration was 4 d 




diluents. Exposure water quality was checked daily and maintained at conditions considered 
optimal for trout (12.5 ± 0.05
o
C; pH 8.17 ± 0.06; ammonia 23.5 ± 1.5 μg/L) under a 12 h:12 h 
light:dark cycle.  
The thin film extraction phase was preloaded with deteurated standard (50 ng/mL in spiked 
phosphate buffer solution) by direct extraction under agitation (500 rpm) for 3 h on a shaker 
platform. At the conclusion of the 4 d exposure period, in vivo sampling by thin film 
microextraction (TFME) was performed in dorsal-epaxial muscle of anaesthetized (0.1% ethyl 3-
amino benzoate methanesulfonate) fish for 30 min (under pre-equilibrium conditions). After 30 
min, the extraction phases were removed from fish muscle and rinsed with distilled water prior to 
immersion in desorption solvent (60:40 methanol-water) for 90 min; an aliquot of desorption 
solution was injected for LC/MS/MS instrumental analysis. After removal of the extraction 
phase from their muscle tissue, fish were killed by spinal severance in accordance with protocols 
approved by our local Animal Care Committee (AUPP 10-17).  
 
5.4.8  Field caging of fathead minnow in municipal wastewater  
Fathead Minnow (Pimephales promelas), a small bodied fish (5.58±0.03 cm; 1.43±0.02 g, n 
=300) were caged in the Grand River watershed (southern Ontario, Canada) adjacent the Doon 




25’ 12.04”W) at 2 upstream and 3 downstream 
sites for 14 d in October 2010. The most upstream of the two reference sites is located 1.2 km 
upstream of the Doon municipal effluent outfall, but 19.45 riverine km downstream of the 
municipal wastewater discharge from the City of Waterloo. The Waterloo WWTP serves a 
population of more than 120,055 and the Kitchener MWWTP serves more than 190,000 




second reference was 0.5 km upstream of the Doon outfall. The three downstream stations were 
0.5, 1.7, and 5.6 km below the Doon wastewater effluent release, respectively. At each site, two 
cages (Rubbermaid™ containers) were deployed, each containing two commercial baitfish 
buckets (FlowTroll®, Frabill Inc, Jackson, WI) holding 15 fish each (30 fish/cage). The 
Rubbermaid containers were perforated on all surfaces with 2 cm holes and contained a 60 x 60 
cm concrete patio stone beneath the bait buckets for weighting. The cages were anchored to the 
substrate with t-posts fastened to cable running through a homemade pipe frame. This caging 
design exposed fish to minimal current, thereby reducing exposure stress from constant 
swimming, yet allowing water to pass freely through the enclosure. After 2 weeks of exposure, 
fish were anesthetized and sampled as described for the laboratory-based Rainbow Trout 
exposures. 
5.4.9 Results and discussion 
5.4.9.1 Extraction efficiency of the method  
The influence of C18 fibre and thin film extraction phase geometry on method extraction 
efficiency was determined by the amount of analyte extracted by each configuration under 
identical conditions. As the extraction phase/sample matrix partition coefficients should be the 
same for both C18 configurations, the influence of the extraction phase volume on extraction 
efficiency can be directly compared in spiked fish tissue. As shown in Table 1, the amount of 
pharmaceuticals extracted by the thin film extraction phase was significantly higher than that of 
the fibre geometry, attributable to its greater volume. According to SPME fundamental 
principles, as the volume of the extraction phase increases, the amount of extracted target analyte 
will increase proportionally for equilibrium extraction. The C18 thin film geometry can extract 




surface area of the thin film, particularly under pre-equilibrium sampling. The use of C18 thin 
film for in vitro sampling of selected pharmaceuticals in spiked fish dorsal-epaxial muscle 
demonstrates that both extraction efficiency and method sensitivity in terms of recovery can be 
enhanced when compared to traditional C18 fibre configurations. In both extraction phases, 
acceptable reproducibility (4-22% RSD) was achieved for the suite of pharmaceuticals examined 
(Table 5.2). 
 
Table 5:2 Relative extraction efficiencies of C18 thin film and cylindrical fibre configurations 
using fish tissue spiked with 100 ng/g analytes of interest  
 















Carbamazepine 0.55 4 4.62 13 8 
Fluoxetine 0.02 5 0.17 14 9 
Diazepam 0.24 16 2.72 17 11 
Norfluoxetine 0.03 22 0.19 11 6 
Velanfaxin 0.03 11 0.33 16 11 
Ibuprofen 0.31 5 2.38 9 8 
Gemfibrozil 0.03 4 0.36 18 12 
 
MTFME is the amount of analytes extracted by thin film extraction phase and mSPME is the amount 
of analytes extracted by solid phase fibre 
 
 
5.4.9.2 Pre-equilibrium extraction kinetics  
Based on equation 5.1, the extraction rate is expected to be proportional to the surface area of the 




spiked gel with the aim to improve in vivo extraction rates under pre-equilibrium conditions such 
as detecting pharmaceuticals in fish. The surface area of the rectangular thin film C18 extraction 
phase (0.21 cm x 1.5 cm) is approximately 0.625 cm
2
 while the surface area of a C18 cylindrical 
fibre is approximately 0.08 cm
2
; therefore, the surface area of the thin film extraction phase is 
approximately eight times greater than that of the fibre. Based upon the pre-equilibrium 
extraction of selected drugs from the 100 ng/mL spiked gel ( n = 3) for 30 min under static 
conditions, it is evident that the extraction rates of carbamazepine, ibuprofen, gemfibrozil and 
fluoxetine were higher when using the C18 thin film configuration relative to the comparable 














Figure 5:2 Extraction kinetics of fluoxetine (A) and carbamazepine (B) in spiked gel (1% 
w/v) using C18 thin film and fibre extraction phase geometries, extraction kinetics of 
ibuprofen (C) and gemfibrozil (D) in spiked gel (1% w/v) using C18 thin film and fibre 






The use of C18 thin film extraction geometries would improve extraction kinetics of 
pharmaceuticals, particularly under pre-equilibrium sampling conditions, due to increased 
surface area leading to faster extraction rates.  In addition, the amount of analyte extracted under 
pre-equilibrium conditions (30 min) by the thin film extraction phase is higher than the fibre 
configuration due to the larger surface area in contact with the sampled matrix.  
 
5.4.9.3 In vivo determination of pharmaceuticals in fish  
In this study, the concentration of pharmaceuticals from fish muscle exposed for 4 d to 
wastewater effluent was successfully determined using thin film microextraction under pre-
equilibrium conditions. The physico-chemical properties of the pharmaceuticals, the inter-fish 
variability in the uptake, as well as inducible depuration enzymes affect the bioconcentration of 
the drugs in fish tissue and contribute to the high fish-to-fish variability observed in this study 
(RSD 15-90 % n = 5). Consequently, the concentration of the pharmaceuticals in fish muscle is 







Table 5:3 The measured bioconcentrations factors of target pharmaceuticals in dorsal-epaxial muscle (ng/g n=5) of Rainbow 
Trout (Oncorhynchus mykiss) using thin film SPME. The concentration is expressed as min-max. Note that fish exposed to 
50% CAS N (v/v)  and 50% CAS (v/v)  did not survive the 4 d exposure due to high concentrations of ammonia found in the 
effluent in these treatments. 


































n=3 ±S.D BCF 








65.2 0.83±0.01 37-79 1.7-119.9 1.00±0.01 2-133 
Velanfaxin <0.09 0.23±0.01 NA <0.09 0.30±0.01 NA <0.09 0.30±0.01 NA <0.09 0.60±0.01 NA 
Sertraline 7.5-160.8 0.36±0.01 
19-




39.5 0.37±0.01 34-99 11.2-75.8 0.12±0.01 
112-
758 
Paroxetine 5.3-13.4 <0.06 NA 3.4-16.7 <0.06 NA 2.5-5.73 <0.06 NA 2.3-18.8 <0.06 NA 
CBZ 0.6-1.7 0.75±0.03 1.0-2 0.4-0.5 0.80±0.01 1 0.5-4.9 0.86±0.01 5.0-49 0.2-2.4 0.23±0.01 1.0-12 
Ibuprofen <0.84 1.30±0.05 NA <0.84 0.13±0.02 NA <0.84 0.10±0.01 NA <0.84 0.20±0.02 NA 
Gemfibrozil <0.40 0.30±0.03 NA <0.40 0.23±0.01 NA <0.40 0.23±0.01 NA <0.40 0.70±0.01 NA 
              
CBZ: Carbamazepine, BCFm: Bioconcentration factor in muscle 




Fish exposed to 100% effluent experienced high mortality within a few hours of exposure due to 
high ammonia concentrations. Again, in response to ammonia toxicity, fish exposed to 50% CAS 
N (v/v) and 50% CAS (v/v) also did not survive the 4 d exposure. Bioconcentration factors 
(BCFs) were calculated in surviving fish using the ratio of the analyte concentration in fish 
muscle to that of the exposure water.  
Following exposure to each treated wastewater effluent, the anti-depressant drugs fluoxetine, 
sertraline and paroxetine were detected in fish dorsal-epaxial muscle, demonstrating both the 
efficacy of the proposed method and the recalcitrant nature of these compounds. The 
concentration of fluoxetine detected in fish muscle ranged from 101 ng/g in 20% CAS (v/v), to 
111.9 ng/g in 50% BNR (v/v) effluent; however, up to 259 ng/g were found in fish exposed to 
20% CAS N (v/v), thereby suggesting all three treatment paradigms allowed passage of 
significant quantities of this drug for uptake by biota. Fish can readily bioconcentrate fluoxetine, 
as has been previously reported 
185
 and to a lesser extent sertraline and paroxetine, despite high 
rates of prescription and parent compound excretion into wastewater systems of the latter two 
drugs 
186
. Notwithstanding the relatively high concentrations of sertraline and paroxetine entering 
Canadian wastewater treatment plants, final effluent concentrations are lower than that of the less 
prescribed fluoxetine, suggesting sertraline and paroxetine are rapidly removed during 
wastewater treatment 
186
. Fluoxetine, despite lower prescription rates and relatively higher rates 
of metabolism in humans, is frequently found in aquatic environments, and is taken up by biota, 
presenting a potential environmental risk 
185-186
.  
All targeted pharmaceuticals were detected in the treated municipal wastewater effluents used in 
this study, as summarized in Table 2. The pharmaceuticals quantified in wastewater were also 




was detected in fish dorsal-epaxial muscle tissue up to 160.8 ng/g in 20% CAS (v/v) effluent, 
along with paroxetine up to 18.8 ng/g in 20% CAS effleunt. The detection of sertraline in tissue 
is consistent with earlier reports in caged fish studies where fathead minnow (Pimphales 
promelas) accumulated 3.83±1.8 µg/kg, although paroxetine was not bioconcentrated in that 
study [31]. This is somewhat surprising due to modeled rates of removal during wastewater 
treatment of 85% and 28% for sertraline and paroxetine, respectively (Table S5). Carbamazepine 
bioconcentration was low (<1.7 ng/g) which is a reflection of its relatively high water solubility 
(log Kow 2.25) 
145
 and persistence (2.9% removal during wastewater treatment). Similarly, the 
highly prescribed antidepressant venlafaxine is predicted to be only sparingly removed during 
wastewater treatment (8.9% removal) 
145
 and is dominantly excreted as the parent compound 
from urine. However, as venlafaxine is fairly water soluble (log Kow of 3.28 
145
 excreted 
unmodified), its rapid excretion in fish also precludes significant bioconcentration, although both 
venlafaxine and sertraline were detected in fish tissues in the 1-3 ng/g range in other studies
186
. 
Gemfibrozil and ibuprofen were not detected in muscle of fish exposed to treated effluent; as 
both pharmaceuticals are acidic drugs, they are easily ionized in the pH range (8-9) of the 
effluent, limiting their bioconcentration relative to that of their neutral form 
145,186
. No target 
pharmaceuticals were detected in the control fish, and for all compounds studied, analyte 
concentrations in tissues after 4 d of exposure may have been subjected to metabolism by 
inducible enzymes systems or eliminated through conjugation with more hydrophilic moieties 
187-189
.  
5.4.9.4 Bioconcentration of pharmaceuticals in field-exposed fathead minnow 
In the case of field exposure of fathead minnow in the Grand River, the antidepressant sertraline 




(sites 3 and 4) with mean bioconcentration factors at the two upstream sites of 186 and 418, 
respectively, while the last downstream sites where sertraline was detected had a 




Table 5:4 Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of pharmaceuticals 
detected in fish muscle of fathead minnow caged in the field near a municipal effluent outfall (n=6). Wastewater samples were 
extracted by solid phase extraction (SPE). Sites 1 and 2 are 1.2 and 0.5 km upstream of the Doon outfall (respectively), while 
sites 3, 4, and 5 are 0.5, 1.7, and 5.6 km downstream, respectively.  
                                
                   Site  1                    Site  2                    Site  3                    Site  4 
 















































CBZ <0.40 0.022 (9) NA <0.40 
0.024 
(10) NA <0.40 
0.117 
(3) NA <0.40 
0.109 
(5) NA <0.40 
0.045 
(5) NA 




(11) 425 < 0.64 
0.005 
(10) NA < 0.64 
0.004 





(10) NA <0.25 
0.007 
(11) NA <0.25 
0.047 
(16) NA <0.25 
0.043 
(14) NA <0.25 
0.018 
(7) <0.25 




(5) 303 < 0.09 
0.264 
(3) NA < 0.09 
0.245 
(5) NA 2.30±1.20 
0.106 
(2) 22 
Norfluoxetine <0.64 0.003(12) NA <0.64 
0.002 
(14) NA <0.64 
0.002 
(11) NA <0.64 
0.0021 
(3) NA <0.64 ND  NA 




(10) 418 < 0.24 
0.013 
(11) NA < 0.24 
0.01 
(9) NA 0.43±1.0 
0.008 
(10) 54 








(3) 28 < 0.25 
0.004 
(6) NA 0.40±0.30 
0.003 
(8) 133 
                 




Similarly, fluoxetine was taken up by fish from the wastewater and bioconcentrated in their 
muscle at sites 1, 2, and 5 with bioconcentration factors of 800, 425, and 753, respectively. 
Conversely, carbamazepine and atorvastatin were not detected in the muscle of caged fish at any 
of the sites, suggesting these drugs have lower bioconcentration potential in fathead minnow. 
Carbamazepine in particular was very frequently detected in wastewater effluents (Table 5.4), 
but with limited bioconcentration in fish tissues due to its relatively high solubility (log Kow = 
2.26) in water. The antidepressant paroxetine was detected in fish muscle in the upstream sites 1 
and 2 (reflecting the discharges of the Waterloo municipal wastewater plant) with BCFs of 83 
and 10, respectively, and was also bioconcentrated at downstream sites 3 and 5 with BCFs of 28 
and 133, respectively. Although target pharmaceuticals were detected in the muscle of field-
exposed Fathead Minnow, concentrations were generally lower than those observed during the 
static laboratory exposure in which Rainbow Trout were used. This may be due to inherent 
species differences, or fluctuations in the bioavailability of the drugs in the river, which is very 
likely to change over time with precipitation events, variation in hydraulic and solids retention 
times in the wastewater treatment plants, differing rates of photolysis in receiving environments, 
and a myriad of other environmental factors that are controlled within a laboratory context.  
 
5.5 Conclusion 
For the first time, non-lethal in vivo thin film SPME was used to quantitate target 
pharmaceuticals in fish muscle under pre-equilibrium conditions. The C18 thin film geometry (as 
a modification of SPME) improves in vivo extraction kinetics and sensitivity, allowing for 
quantification of trace pharmaceuticals in living fish dorsal-epaxial muscle following short term 




fish from wastewater in both laboratory and field based exposures without the requirement of 
sacrificing the fish. In vivo SPME based on thin film geometry is a promising non-lethal 





















Development and evaluation of new in vivo SPME device (sampler) for 
rapid sampling of pharmaceuticals in fish using LC/MS/MS 
 
6.1 Preamble 
This chapter is to be submitted for publication in the Journal of Seperation Science. The 
manuscript has been written as: Oluranti P. Togunde, Heather Lord, Ken D. Oakes, Mark R. 
Servos, and Janusz Pawliszyn “Development and evaluation of new in vivo SPME device 
(sampler) for rapid sampling of pharmaceuticals in fish using LC/MS/MS” 
 
6.2  Introduction 
Increasing concerns about the presence of pharmaceutically active compounds in the 
environment, and in particular aquatic systems, have been documented in the literature due to 




As a result, a number of 
different analytical methodologies have been developed in order to investigate and determine 
trace concentrations of pharmaceuticals in fish tissue. At present, conventional analytical 
methods involve sample preparation, such as solvent extraction (SE), solid phase extraction 
(SPE), accelerated solvent extraction (ASE) and solid phase matrix dispersion (SMD) 
39, 40,177,193
. 
Additionally, passive sampling devices such as the semi-permeable membrane device (SPMD) 
and polar organic chemical integrative sampler (POCIS) stationary sampling device have been 
used to mimic fish in order to determine the time-integrated concentration of bioavailable 
waterborne organic contaminants in fish tissue 
194




determination of pharmaceuticals in fish tissue involves tissue homogenization, followed by 
extraction with an organic or polar solvent. Then, the sample extract is cleaned-up with a method 
such as solid phase extraction before instrumental analysis 
195,196
. One of the major limitations of 
the traditional approach is that the fish sampled have to be sacrificed before tissue samples can 
be collected and analyzed. Invariably, several fish are usually sacrificed before the concentration 
of pharmaceuticals in the fish muscle can be determined. In order to overcome this drawback, 
non-lethal sampling methods (such as tissue biopsy technique, passive sampling device)
197
 are 
increasingly being used to investigate uptake and accumulation of pharmaceuticals in fish tissue. 
This approach can potentially reduce the need to sacrifice large numbers of fish to determine the 
bioaccumulation of pharmaceuticals in fish. One of the techniques recently reported involves 
non-lethal sampling of organic contaminants based on the removal of the adipose fin to 
determine organic contaminants in fish. However, possible adverse effects associated with the 
technique, in particular to the fish having its adipose fin removed, have not presently been well-
studied yet
197
. Recently, solid phase microextraction was used for the determination of trace 
pharmaceuticals in fish muscle
43, 61,178
. The aim of this study is to evaluate the use of the newly 
developed SPME device as a non-lethal sampling technique of organic contaminants in fish 
based on its simplicity for laboratory and field applications. Previous SPME application involved 
a two-step sampling process, as well as anesthetization of the fish before the in vivo sampling 
can be carried; however, the new in vivo sampler has a unique advantage: target compounds can 
be sampled in fish without the anaesthetization process. In addition, the new sampler simplifies 
the process of sampling into a single step. In this study, in vitro and in vivo fish sampling of 
pharmaceuticals were evaluated using this new in vivo device, where the sampler is used to 




pharmaceutical residues in fish muscle. The calibration method for in vivo sampling under pre-
equilibrium sampling has been described elsewhere 
71, 72
.  
                                                                               
6.3 Experimental 
6.3.1 Chemicals and material 
All chemicals used for this study were purchased from Sigma-Aldrich (Oakville, ON, Canada) 
except fluoxetine, diazepam, nordiazepam, lorazepam, and diazepam-d5, which were purchased 
from Cerilliant Corp. (Round Rock TX, USA). Paroxetine and sertraline were purchased from 
Toronto Research Chemical (Toronto, ON, Canada). Agarose (Agarose 15) was purchased from 
BDH Chemicals Ltd., Poole, England. Rainbow Trout (Oncorhynchus mykiss) were purchased 
from Silver Creek Aquaculture (Erin, ON, Canada). Phosphate-buffered saline (PBS) solution, 
pH 7.4 was prepared by dissolving 8.0 g of sodium chloride, 0.2 g of potassium chloride, 0.2 g of 
potassium phosphate, and 1.44 g of sodium phosphate in 1 L of purified water. The experimental 
procedures for the in vivo study were approved by local Animal Care Committee at the 
University of Waterloo (AUP #’s 04-24, 10-17). 
 
6.3.2 New in vivo SPME device (sampler) 
The new device assembly contains four main parts: (a) the plunger with a nut, (b) the probe 
containing the extraction phase, (c) hypodermic needle with a sharp end, and (d) overall body of 
the device (barrel). The plunger is used to move the probe in and out of the device (Figure 6.1). 




























Figure 6:1 Schematic diagram of in vivo tissue sampling device (above). In vivo SPME 
device with PDMS biocompatible coating (Top) Depressing the plunger exposes 1.5 cm 
SPME coating during the extraction. (Bottom) The device is shown retracted for storage. 
(University of Waterloo machine shop made this device for us) 




When the probe is inserted in the device through the hypodermic needle, the nut on the plunger is 
used to hold the probe in position. The hypodermic needle is used to protect the extraction phase 
at the tip of the probe. In addition, the needle is used to pierce the fish muscle so that the 
extraction phase can easily be inserted in the fish muscle. The new device uses PDMS as the 
extraction phase, which is biocompatible with fish tissue for in vivo sampling. The detailed 
preparation and assembly of the custom made poly dimethylsiloxane probe (165 μm coating 
thickness) has been described elsewhere
43
. The new sampler device is designed to make 




in fish muscle, the plunger is moved down in order to expose the extraction phase to fish muscle 
for a specific time (Figure 6.2). 
      
 
Figure 6:2  In vivo SPME device being used for sampling pharmaceuticals in live fish  
 
 The extraction phase can also remain in the fish tissue as long as 1 hdepending on the sensitivity 
of the method. After the sampling process, the extraction phase (fibre) is withdrawn from the fish 
muscle and then gently rinsed with nanopure water, followed by drying the extraction with 
Kimwipe®. Subsequently, the probe (fibre) is desorbed in the optimized desorption solvent for 
injection into LC/MS/MS system.   
  
6.3.3  Evaluation of new in vivo device in spiked gel and fish muscle 
Evaluation of the new device was carried out in spiked gel matrix and fish muscle in order to 
evaluate its simplicity in the laboratory for sampling. Agarose gel was used for the in vitro 
studies because it allows free diffusion of analytes
81




under static mode in order to simulate in vivo sampling conditions. The conditioned PDMS fibre 
was inserted in the device and then directly immersed in the vial containing the gel with 0.1 
μg/mL diazepam, nordiazepam and carbamazepine, for a specified period of time (1 h). After the 
extraction, the fibre was desorbed in desorption solvent (50% acetonitrile: water) for 90 min 
under agitation speed of 1500 rpm. Furthermore, another in vitro experiment was performed 
using homogenized fish muscle (Rainbow Trout) with the same concentration as used in gel. 
Following the extraction, the fibre was desorbed in the solvent as previously described. After 
desorption, 20 µL of the sample extract was injected to the LC/MS/MS for instrumental 
quantification.  
                 
6.3.4 In vivo sampling in Rainbow Trout exposed to municipal effluent in laboratory and 
field monitoring of wild fish 
The juvenile Rainbow Trout used in this study (14.4±0.34 cm; 25.4±1.46 g, mean ±SE, n = 18) 
were acclimated to laboratory conditions in 1400 L holding tanks continuously receiving de-
chlorinated water. Municipal wastewater samples were collected from Burlington, ON, which 
were treated under a variety of pilot-scale conditions from July to September 2011. The 
wastewater samples were treated by either conventional activated sludge (CAS), conventional 
activated sludge with nitrification (CAS-N), or conventional activated sludge with Biological 
Nitrifying Reactor (CAS-BNR). Acclimation of Rainbow Trout began 4 d prior to the onset of 
the experiment. The extraction phase was preloaded with deuterated standard (50 ng/mL in 
spiked phosphate buffer solution) by direct extraction under agitation (500 rpm) for 3 h on a 
shaker platform. At the conclusion of the 8 d exposure period, in vivo sampling with the new 




pre-equilibrium conditions), The fish (Rainbow Trout) was anaesthetized with 0.1% ethyl 3-
aminobenzoate methanesulfonate (M222) until loss of vertical equilibrium, then the in vivo 
sampler with a 20 gauge needle was used to pierce the fish dorsal-epaxial muscle so that the 
extraction phase can be implanted in the fish muscle. After the PDMS fibre is placed in the fish 
muscle, the anaesthetized fish was placed into fresh reference water.After sampling the tissue for 
30 mins, the fish was then reanaesthetized prior to removing the fiber coating,  then the 
extraction phases were removed from fish muscle and rinsed with distilled water prior to 
immersion in desorption solvent (60% methanol-water) for 90 min with agitation speed of 1000 
rpm; an aliquot of desorption solution was injected for LC/MS/MS instrumental analysis. The 
applicability of the new device for sampling of pharmaceuticals was further evaluated in live 
wild fish collected from different rivers located in Paisley, ON. The target species of fish was 
muskellunge (Esox masquinongy), which is only used for catch-and-release sport fishing due to 
its low population numbers. As such, the use of a non-lethal sampling technique is required for 
sampling this protected fish species. For larger wild fish, anesthetizing was not required in order 
to sample the target compounds in fish tissue. The fish were sampled using the device for 30 min 
and then released into the river after sampling. Analysis of the studies in gel, spiked fish and 
field studies samples were carried out using an Accela
TM
 LC-MS/MS instrument from Thermo 
Scientific. 
6.4 Result and discussion 
6.4.1 Evaluation of extraction phase of in vivo SPME device 
The performance of the extraction phases (PDMS and C18 fibre) that are frequently used for 
sampling in living animals has been described elsewhere
181
. PDMS was chosen as the extraction 




complex matrix. Evaluation of the PDMS fibre in spiked phosphate buffered saline shows that 
the selected pharmaceuticals, and in particular diazepam and nordiazepam, have an affinity for 
this extraction phase. As shown in Table 6.1, diazepam has the highest percentage extraction 
recovery, while carbamazepine has the least due to its solubility in water. This observation can 
be related to the different octanol-water partition coefficients of the analytes.  
Table 6:1 Extraction recovery of the target compounds in spiked gel sample at equilibrium 
        
Analytes 
Amount extracted  
(ng) % extracted 
RSD (%) 
(n= 5) 
Carbamazepine 17.5 12 8 
Diazepam 106.5 71 7 
Nordiazepam 52 35 6 
        
     
Although the recovery of carbamazepine is the slightest when compared to the two other 
compounds, overall reproducibility of the extraction phase is very good (RSD < 10%). The limits 
of detection and quantification of the method in fish and gel matrix is summarized in Table 6.2. 
         Table 6:2 Limit of detection in homogenized fish tissue and gel 
   Gel Fish tissue 
Compounds  
LOD  




(ng/g)     
LOQ  
(ng/g)  
               
Carbamazepine  0.01  0.10  0.07  0.48  
Diazepam  0.02  0.19  0.30  0.97  
Nordiazepam  0.07  0.20  0.34  0.40  




6.4.2 In vivo evaluation of new sampler in fish exposed to effluent in the laboratory and 
wild fish 
Results of sampling of target compounds show that the new device can be used to sample 
pharmaceuticals in fish muscle. Table 6.3 summaries the concentration of the target compounds 
determined in fish muscle.  
Table 6:3 The measured concentration and bioconcentrations factors of target pharmaceuticals in 
dorsal-epaxial muscle (ng/g , ±standard deviation)) of rainbow trout (Oncorhynchus mykiss) in 
laboratory 8-day exposure using new SPME device. Water concentration was determined by solid 
phase extraction. 
                
  
                CAS N 20% 
effluent 
 





Conc. in fish 
muscle 




n= 3±S.D BCF 
Conc. in 
fish muscle 







( CBZ) 1.5 ND 8.9±1.2 NA ND 8.5±0.2 NA 
Fluoxetine (FLX) 0.1 0.10-0.14 0.7±0.1 0.2 0.73-0.76 0.6±0.1 1.3 
Sertraline (SER) 0.2 6.4-7.7 0.9±0.1 8.5 7.2-8.0 1.0±0.1 8 
Paroxetine (PAR) 0.2 5.4-6.8 1.4±0.1 5 6.1-7.3 1.4 18 
Atorvastatin 
(ATOR) 0.3 ND 3.6±0.5 NA ND 5.6±0.3 NA 
Diclofenac (DLF) 1.4 <LOQ 1.2±0.2 NA <LOQ 1.3±0.2 NA 
Vanlafaxine 
(VAL) 0.1 <LOQ 1.9±0.2 NA <LOQ 1.8±0.2 NA 
                
        ND- not detected, NA- not applicable 
 
For compounds that are moderately water soluble like carbamazepine, there is low potential for 
this compound to bioconcentrate in muscle, and as a result, carbamazepine was not detected in 
fish muscle at this time. In the case of anti-depressant some of the drugs were dcetected in fish 




ng/g and 7.2 to 8.0 ng/g in the two different effluent exposures. Similarly, the concentration of 
paroxetine in fish muscle ranged from 5.4 to 6.8 ng/g based on CAS-treated effluent exposure 
and 7.2 to 8.0 ng/g based on BNR-treated effluent. As well, the concentration of fluoxetine 
determined in the muscle of fish exposed to CAS treated effluent (0.1 to 0.14 ng/g) was found to 
be lower when compared to the concentration found in the fish (0.73 to 0.76 ng/g) exposed to 
BNR treated effluent. Surprisingly, atorvastatin was not detected in fish muscle, even though its 
Log Kow is greater than 3; this may be due to biotransformation of the compounds in fish to more 
polar metabolites. It is to be noted that while diclofenac and vanlafaxine were detected in the fish 
muscle, their concentrations were below the limit of quantitation. Likewise, in the case of wild 
fish collection, carbamazepine was similarly detected in Muskellunge fish muscle, but its 
concentration was below the limit of quantitation. In sum, the utility of the new SPME device as 
a non-lethal sampling device is a promising alternative in the evaluation of organic contaminants 
in fish muscle. This approach would be particularly useful to those threatened or endangered fish 
species in which lethal sampling may not be feasible.  
 
6.5 Conclusion 
This study evaluates and demonstrates for the first time that the newly developed SPME device 
is a promising device for sampling of organic contaminants in fish. In vivo SPME method is 
demonstrated as a non-lethal sampling technique which can prevent the sacrificing of fish for 
sampling. In the study, a significant step is demonstrated towards the use of a new in vivo SPME 
device for rapid non-lethal monitoring of pharmaceuticals in fish, both in laboratory conditions 
as well as field-based exposure. Some of the selected pharmaceuticals were successfully 




the new device to provide wider applications in terms of coating development, particularly for 






















Laboratory and field study of bioconcentration of pharmaceutical 
residues in fish muscle and bile using solid phase microextraction 
coupled with liquid chromatography-tandem mass spectrometry 
 
7.1 Preamble 
This chapter is to be submitted for publication in the Journal of Chromatography A. The 
manuscript has been written as: Oluranti P. Togunde, Ken D. Oakes, Mark R. Servos, and Janusz 
Pawliszyn “Laboratory and field study of bioconcentration of pharmaceuticals residues in fish 




The presence of biologically active xenobiotic compounds in aquatic environments is an 
emerging concern in many developed and developing countries due to the potential impact on 
both aquatic organisms and human health 
191,192,198-200
. Environmental pharmaceuticals are 
considered emerging contaminants of concern due to their designed biological potency at low 
therapeutic dosages, coupled with the near ubiquitous detection of such in adjacent urban areas 
due to release from human sewage systems 
201-203
. As present conventional municipal sewage 
treatment processes do not completely remove these pharmaceutical contaminants, they 
eventually end up in aquatic receiving environments within municipal wastewater effluents 
(MWWE) where they are available for uptake by resident organisms. Although the 




in the ng/L to μg/L range), organisms are continuously exposed, resulting in relatively water 
soluble, readily metabolized drugs behaving as “pseudopersistent” compounds, due to their 
chemical half-lives being met or exceeded by uptake rates from their MWWE-influenced 
environments 
204
. Generally, the concentration of pharmaceuticals in MWWEs decreases with 
downstream distance from the effluent outfall in riverine environments due to dilution effects, 
bio- and photodegradation processes, and sorption to sediments. However, recalcitrant 
pharmaceuticals may be still detected over longer distances and intervals, and their continuous 




In response to the potential of bioconcentration of environmental pharmaceuticals in tissues of 
fish and other aquatic organisms, different analytical methodologies have been developed to 
quantitatively determine the concentrations of these compounds in specific tissues such as brain, 
muscle, liver, plasma, and bile 
14,44,46
. Most of these analytical methods are based on solvent 
extraction, or solid phase extraction (SPE) as means of sample preparation as well as for 
isolation and pre-concentration of analytes. Recently, solid phase microextraction (SPME) has 
been gaining ground as a valuable analytical technique for non-lethal in vivo determination of 
pharmaceutical residues in fish muscle 
43, 92
. The present study aimed to develop a simplified and 
reliable analytical method suitable for field applications that is based upon SPME, in order to 
investigate uptake and bioconcentration of pharmaceuticals residues in fish bile and muscle.  
Improving our understanding of pharmaceutical bioconcentration within fish tissues is important 
both for our insight into the toxicokinetics of these compounds in exposed biota themselves, but 
also for assessing the risk to humans consuming them. To the best of the authors’ knowledge, 




bioconcentration of pharmaceuticals in fish bile and muscle. A significant advantage of SPME is 
the simplicity of deployment when determining in vivo concentrations of target analytes in fish 
tissues under pre-equilibrium sampling conditions using the kinetic calibration method, as 
represented by equation 1.3. The concentration of target analytes in fish bile samples can be 
determined using the equilibrium SPME approach, as represented by equation 1.1 
                                                                  .  
7.3 Experimental 
7.3.1  Chemicals and materials 
All reagents and pharmaceuticals standards were of highest purity grade available. Gemfibrozil, 
atorvastatin, ibuprofen, atrazine, carbamazepine, diclofenac, naproxen, and bisphenol-A (BPA) 
were obtained from Sigma-Aldrich (Oakville, ON, Canada), while paroxetine and sertraline were 
purchased from Toronto Research Chemical (ON, Canada). Fluoxetine, diazepam, nordiazepam, 
and diazepam-d5 were purchased as certified standards from Cerilliant Corp (Round Rock, TX, 
USA).  Isotopically-labeled atorvastatin-d5, atrazine-d5, BPA-d16, carbamazepine-d10, diazepam-
d5, diclofenac-d4, fluoxetine-d5, gemfibrozil-d6, ibuprofen-d3 and 
13
C-naproxen-d3 were 
purchased from CDN Isotope Inc. (Point-Claire, QC, Canada) while sertraline-d3 and paroxetine-
d4 were purchased from Toronto Research Chemical. Chemical stock solutions were prepared in 
methanol and stored at -20
o
C while working solutions were diluted aliquots of these stocks. 
Dilution water was obtained from a Barnstead Nanopure diamond UV water purification system 
deionized to 18 Ω. Acetonitrile (HPLC grade), methanol (HPLC grade), and glacial acetic acid 
were purchased from Fisher Scientific (Ottawa, ON, Canada). Phosphate-buffered saline (PBS) 




chloride, 0.2 g of potassium phosphate and 1.44 g of sodium phosphate in 1 L of purified water 
and adjusting the pH to 7.4.  The C18 thin film extraction phase (45 µm, 1.5cm coating length) 
and traditional C18 fibres (45µm, 1.5 cm coating length) were obtained from Supelco (Bellefonte, 
PA USA). A 10 mg/L mixed solution containing all the pharmaceuticals studied was obtained by 
diluting the individual stocks with methanol. Rainbow Trout (Oncorhynchus mykiss) were 
purchased from Silvercreek Aquaculture (Erin, ON, Canada). All animal experimental 
procedures were approved by the local Animal Care Committee at the University of Waterloo 
(AUP #’s 04-24, 08-08).  
 
7.3.2  Laboratory exposure of Rainbow Trout to municipal effluent  
The Rainbow Trout used in this study (19.7±1.50 cm; 59.5±12.4 g, (mean ±SE), n = 120) were 
acclimated to laboratory conditions in 1400 L holding tanks continuously receiving de-
chloraminated municipal water, and fed every other day with 2.0 Pt floating commercial trout 
ration (Martin’s Feed Mill, Elmira, ON). Acclimation within the 34 L exposure aquaria 
(containing clean water previously acclimated to in the 1400 L tanks) began 4 d prior to the onset 
of the experiment. The experiment began by exposing fish to wastewater collected from three 
pilot treatment plants receiving raw effluent generated from the City of Burlington (Burlington, 
ON). Wastewater samples were treated by Conventional Activated Sludge (CAS), Conventional 
Activated Sludge with Nitrification (CAS-N), or Conventional Activated Sludge with Biological 
Nitrifying Reactor (CAS-BNR). Exposure of fish involved two controls and six different 
treatment exposure concentrations: CAS-20% v/v, CAS-50% v/v, CAS-N-20% v/v, CAS-N-50% 
v/v, and CAS-BNR-20% v/v, CAS-BNR-50% v/v. Each 34 L aquaria housed 6 fish, for exposure 




obtained wastewater samples. Exposure water quality was checked daily and maintained at 
conditions considered optimal for trout (14.1 ± 0.5
o
C; pH 8.13 ± 0.06; ammonia 23.5 ± 1.5 
μg/L).  
7.3.3  In vivo and in vitro SPME sampling of pharmaceutical residues in fish bile 
and muscle  
In vivo SPME sampling was conducted under pre-equilibrium conditions (30 min) with 
quantitation of pharmaceuticals in fish muscle by kinetic calibration. The C18 blade (45 µm thick, 
1.5cm coating length)  used as the extraction phase was preloaded with deteurated standards of 
the target analytes (50 ng/mL in spiked phosphate buffer solution) by direct extraction under 
agitation (500 rpm) for 3h on a shaker platform. Detailed information on the procedure and 
preparation of C18 blade including its dimensions has been described elsewhere 
206
. At the 
conclusion of the 4 and 8d exposure period, in vivo sampling of target compounds was 
performed in the dorsal-epaxial muscle of anaesthetized (0.1% ethyl 3-amino benzoate 
methanesulfonate) fish for 30 min (pre-equilibrium conditions). After 30 min, the extraction 
phases were removed from fish muscle and rinsed with distilled water prior to immersion in 
desorption solvent (60:40 methanol-water) for 90 min. An aliquot of desorption solution was 
then injected for LC/MS/MS instrumental analysis. Following SPME sampling, fish were re-
anesthetized prior to euthanasia by cervical vertebrae severance. Bile samples were collected 
from the excised gallbladders and immediately frozen in liquid nitrogen and stored at -80
o
C. 
Prior to analysis, the bile was thawed and a portion was de-conjugated with glucuronidase, 
sulfatase and α-glucosidase. Specifically, 100 µL of these enzymes [β-glucuronidase (1000 
units/mL), Sulfatase (2 units/mL), β-glucosidase] were added to a mixture of 100 µL bile: 200 




prior to the introduction of C18 SPME fibres (1.5 cm coating length, 45 µm thickness supplied by 
Supelco Bellefonte, PA, USA) into the vial for extraction under equilibrium conditions at 1200 
rpm continual vortex agitation (model DVX-2500, VWR International, Mississauga ON, 
Canada). Following sample extraction, analytes were desorbed from the SPME fibres for 1.5h at 
1200 rpm into 200 µL methanol: water (1:1) containing 20 ng/ml deuterated analogues of the 
target compounds as internal standards. Subsequently, 20 µL of the sample extract was injected 
to the LC/MS/MS for quantification analysis. Concentrations of waterborne pharmaceuticals in 
the MWWEs fish were exposed to be determined using traditional solid phase extraction (SPE) 
207,208
. Water samples, collected in 500 mL amber glass bottles, were preserved with sodium 
azide (0.2 g/L) and ascorbic acid (0.05 g/L) to prevent analyte degradation by microbial 
activities. Prior to SPE extraction, these samples were spiked with isotopically-labeled surrogates 
before being filtered through Whatman® glass/fibre filter paper (Fisher Scientific, Mississauga, 
ON, Canada). Waters Oasis® HLB cartridges (500 mg) (Milford, MA, United States) were used 
for extraction after pre-conditioning with 5 mL of HLPC grade Methyl Tertiary Butyl Ether 
(MTBE), 5 mL of HLPC grade methanol, 5 mL of HLPC grade water. After water sample 
extraction, SPE cartridges were rinsed with 5 mL of HPLC grade water. Elution of analytes from 
the cartridge was completed with 5 mL of methanol and 5 mL of 10:90 (v/v) methanol/MTBE. 
Eluted solutions were collected and blow dried under a gentle stream of nitrogen. Finally, each 
sample was reconstituted in 500 µL of methanol and stored at -20
o






7.3.4 Wild White Sucker sampling adjacent wastewater outfalls 
White Sucker (Catostomus commersonii) fish were collected from the Grand River in southern 
Ontario from reaches downstream of the Kitchener and Waterloo municipal wastewater 
treatment plant (MWWTP) outfalls in October 2011. White Sucker were selected due to their 
prevalence in the watershed and their inherent ability to withstand adverse conditions below 
these discharges that preclude the presence of more sensitive species. Fish were collected using a 
Smith-Root 12A-POW backpack electroshocking unit (Smith-Root Canada, Merritt, BC) which 
temporarily stuns, but does not harm, captured fish. Although sizes of fish utilized invariably 
differed from site to site, efforts were made to use only similar-sized fish at the sites sampled. 
After collection, fish were transferred to a commercial bait-bucket that received aeration by a 
battery-powered bubbler. In vivo sampling of target analytes in the fish dorsal-epaxial muscle 
was performed using the identical SPME approach previously described for the laboratory-based 
Rainbow Trout exposure. Similarly, pharmaceutical concentrations in bile samples were 
determined using the in vitro SPME approach described in section 7.3.3. 
7.3.5 Instrumental analysis – LC/MS/MS 
Analyses were performed on an AB-Sciex 3200 QTrap Mass Spectrometer equipped with a 
Turbo Ion Spray source (Applied Biosystems Sciex, Foster City, CA, USA). Liquid 
chromatography (LC) was performed on a HP1100 HPLC system (Agilent Technologies) 
equipped with a degasser, binary pump, an autosampler and a column oven. Chromatographic 
separation was performed on a Zorbax Eclipse XDB C18 (150 mm × 21 mm, 3.5µm) column 
which was preceded by a C18 guard column at a flow rate of 0.8 mL/min with mobile phase A 




utilizing a 20 µL injection volume. The gradient elution was programmed as follows: mobile 
phase B was increased from 10% to 50% over 0.5 min and 50% to 100% over 7.5 min, held at 
100% for 2 min and then reduced to 10% over 1 min. Analyst® version 1.4.2 software was used 
for the data analysis. Quality control samples (10 ng/mL of target compounds) were utilized at 
the beginning and end of each run to ensure instrumental stability.  
 
7.4 Results and discussion 
7.4.1 Laboratory verification of pharmaceutical uptake and bioconcentration 
 The uptake of pharmaceuticals and their bioconcentration in Rainbow Trout muscle using an in 
vivo SPME approach has been previously reported 
43, 92
. In the present study, a C18 coated blade 
(45 µm thick, 1.5cm coating length) was used to investigate the uptake of bioactive analytes in 
muscle tissue of fish by utilizing a new SPME geometry, which improves both sensitivity and 
analyte sampling rate in fish muscle. Pharmaceutical residues bioconcentrated in muscle of fish 
exposed to variously-treated MWWEs (Table 7.1) were determined non-lethally, demonstrating 
the potential of the technique to quantify analyte tissue burdens in vivo without sacrificing the 
animal. Anti-depressant drugs such fluoxetine, sertraline, and paroxetine were preferentially 
taken up or retained within fish muscle in this laboratory exposure, relative to other more 





Table 7:1 The measured bioconcentrations factors of target pharmaceuticals in dorsal-epaxial muscle (ng/g , ±standard deviation)) of 
Rainbow Trout (Oncorhynchus mykiss) in laboratory exposure using thin film SPME. 
                    
 
 CAS  20% effluent 
 
 CAS  N 20% effluent 
 















(ng/mL)   








 n= 3  BCF 
Carbamazepine 0.36 - 0.54 9.3±1.0 0 0.61 -1.73 8.63±0.2 0 0.17 - 0.82 11±2 0 
Fluoxetine 3.47 - 9.10 0.6±0.1 15 3.97 - 6.5 0.6±0.1 11 1.9 - 5.28 1.4±0.2 4 
Norfluoxetine 0.16 - 0.6 NA NA 0.82 - 1.98 NA NA <  LOQ NA NA 
Sertraline 0.63 - 7.95 0.9±0.1 9 2.79 - 4.77 0.6±0.1 8 0.44 - 1.26 1.6±0.3 1 
Paroxetine 0.19 - 4.2 <LOQ NA 0.8 - 1.14 < LOQ NA 0.45 - 0.47 < LOQ NA 
Ibuprofen 0.6 - 1.12 1.5±0.1 1 0.30 - 2.39 1.3±0.2 2 0.4 - 1.20 3.2±0.5 0 
Gemfibrozil  0.8 - 1.5  2.3±0.8 1 0.33 - 2.82 0.3±0.1 9 0.52 - 1.71  0.6±0.1 3 
Triclosan 1.3-1.77 <LOQ NA 0.66-0.90 < LOQ NA 1.0-2.85 < LOQ NA 





                    
 
 BNR  20% effluent 
 
 BNR  50% effluent 
 









  n= 3  BCF 
Muscle 
Conc. (ng/g)  












   n= 3  BCF 
Carbamazepine 4.88 8.7±0.3 0 0.17 - 2.40  12±2 0 <  LOQ 23±5 NA 
Fluoxetine 7.85 0.6±0.1 13 4.46 - 6.78 1.5±0.2 5 2.72 - 3.65 1.5±0.4 2 
Norfluoxetine 0.76 NA NA 0.01 - 0.36 NA NA <  LOQ  NA NA 
Sertraline 4.72 0.8±0.2 24 0.69 - 4.09  2±0.5 2 1.72 -2.28 2.3±1.0 1 
Paroxetine 1.25 < LOQ NA 0.11 - 1.56 < LOQ NA 0.53- 0.76 < LOQ NA 
Ibuprofen 2.1 0.6±0.2 4 0.87 - 1.54 1.5±0.4 1 <  LOQ  3.8±0.5 NA 
Gemfibrozil  1.89 2.5±0.4 1 0.53 - 1.57 6.2±1.5 0 0.26 - 0.37 5.8±2.0 0 
 
0.81 < LOQ NA 0.69-1.18 < LOQ NA 0.84-0.94 < LOQ NA 
          





Calculated bioconcentration factors (BCFs; the ratio of the chemical concentration in the fish 
muscle to that in the MWWEs) for fluoxetine (BCFs 2-15) demonstrate that this anti-depressant 
partitioned to, and was retained by fish muscle to a greater degree than more water soluble 
analytes. For example, carbamazepine was not retained in tissues (BCF < 1) despite being 
present at relatively high concentrations in the MWWEs (Table 1), demonstrating that risk to 
exposed organisms is a function of environmental concentrations and the physicochemical 
properties of the compounds. This concept is reinforced by the small but relevant BCFs for 
fluoxetine in muscle of fish exposed to lower, environmentally-relevant 20% wastewater 
concentrations (for CAS-N, CAS-BNR, and CAS) which produced BCFs of 11, 13, and 15, 
respectively).  The main metabolite of fluoxetine, norfluoxetine, was also quantified in fish 
muscle, indicating that the parent compound can be quickly metabolized by fish, and retention 
alone is not the chief factor mediating fluoxetine tissue concentrations 
41
. Rather, the lipophilic 
nature of fluoxetine drives into tissues from the exposure water, while retaining the somewhat 
less lipophilic, but equally bioactive metabolite norfluoxetine in the tissues 
49
. Both sertraline 
(BCFs 1-24) and paroxetine were detected in fish, although a bioconcentration factor for 
paroxetine could not be calculated as its waterborne concentration (determined by solid phase 
extraction) was below the limit of quantitation. Bioconcentration of acidic pharmaceuticals (such 
as gemfibrozil and ibuprofen) were lower, possibly due to ionization within the ambient pH 
environment of the MWWEs evaluated. When in their ionized forms, the relative affinity of 







7.4.2 Bioconcentration of pharmaceuticals in fish bile  
Following the 4 d laboratory exposure of Rainbow Trout to the various MWWEs, most target 
pharmaceutical residues could be detected in the bile of exposed fish with the exception of ibuprofen and 




Table 7:2 Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of pharmaceuticals detected in fish 
bile of Rainbow Trout (Oncorhynchus mykiss) in a 4-day laboratory exposure using SPME method.  
 
                  
 
 CAS  20% effluent 
 
 CAS  N 20% effluent BNR 20% effluent 
 
Analytes 























n= 3  BCF 
Carbamazepine 8.7 ± 2.0 9.3±1.0 1 1.66 8.6±0.2 0 0.4±0.1 8.7±0.3 0 
Fluoxetine 1.7±0.3 0.6±0.1 3 1.4±0.4 0.6±0.1 2 1.8±0.7 0.6±0.1 3 
Sertraline 1.3 0.9±0.1 1 ND 0.6±0.1 NA 1.4 0.8±0.2 2 
Paroxetine ND <LOQ NA ND < LOQ NA ND < LOQ NA 
Ibuprofen ND 1.5±0.1 NA ND 1.3±0.2 NA ND 0.6±0.2 NA 
Gemfibrozil 0.8±0.2 2.3±0.8 0 ND 0.3±0.1 NA 0.7±0.1 2.5±0.4 0 
Triclosan 145.1±14 <LOQ NA 50.1±4 < LOQ NA 56.9±9 < LOQ NA 
                    
          
 
    
 
             
 
BNR 50% effluent 
 
CAS N 50% effluent 
 


















n= 3  BCF 







n= 3  BCF 
Carbamazepine 0.8 ± 0.7 12±2 0 24±0.17 11±2 2 22.2±1.5 23±5 1 
Fluoxetine 2.1±0.2 1.5±0.2 1 2.1±0.2 1.4±0.2 2 2.5±1.5 1.5±0.4 2 
Sertraline 1.4 2±0.5 1 ND 1.6±0.3 NA 1.3 2.3±1.0 1 
Paroxetine 0.4±0.2 < LOQ NA ND < LOQ NA ND < LOQ NA 
Ibuprofen ND 1.5±0.4 NA ND 3.2±0.5 NA ND 3.8±0.5 NA 
Gemfibrizil 1.3±0.3 6.2±1.5 0 ND 0.6±0.1 NA 2.0±0.7 5.8±2.0 0 
Triclosan 97.9±16 < LOQ NA 85.2±19 < LOQ NA 216±15 < LOQ NA 
                    




Two prominent anti-depressives, fluoxetine and sertraline, were detected in the bile of all 
effluent-exposed fish (except the CAS exposure in the 50% v/v treatment, for which sertraline 
was not detected).  Mean fluoxetine concentrations in the bile of fish exposed to CAS 20%, CAS 
N 20% ,and BNR 20% were 1.7±0.3, 1.4±0.4, 1.8±0.7 ng/mL (BCFs 2-3), while those of fish 
exposed to BNR 50%, CAS-N 50%, and CAS 50% were 2.1 ± 0.2, 2.1±0.2 and 2.5 ± 1.5 ng/mL 
(BCFs 1-2) respectively. Similarly, carbamazepine was also detected in all the bile samples of 
effluent-exposed fish, although in low amounts (BCF <1). The anti-depressant sertraline was 
detected in the bile of all fish, with the exception of those exposed to the CAS N 50 % effluent 
treatment. The low bioconcentration of the parent compounds in the fish bile may be attributed to 
the fact that the parent compounds have undergone phase I or phase II metabolic processes, 
thereby reducing the accumulation of the parent compound in the bile.
210-212
  
Similar concentrations of pharmaceuticals were detected in bile of fish exposed for 8 d (4 d 
longer than previous) to variously treated municipal effluents (Table 7.3). Fluoxetine and 
carbamazepine were again detected in most bile samples, although with lower bioconcentration 
factors, suggesting excretion/detoxification pathways were up-regulated over time. However, 
mean concentrations of sertraline (16.1±2.6, 24.9±22.7 mg/mL, BCF 4-19) and paroxetine 
(9.4±6.2, 10.4±3.7 mg/mL, BCF 6-7) were significantly higher after 8 d in bile of fish exposed to 
20 and 50% BNR effluent, suggesting they were not subject to the same removal mechanisms as 
fluoxetine. Surprisingly, BCFs determined for several target analytes differed with the 
percentage effluent (v/v) in the exposure milieu. Similar responses have been reported 






Table 7:3 Summary of the concentration (ng/mL, ±standard deviation) and bioconcentration factor of pharmaceuticals detected in fish 

















                  
 
 CAS  20% effluent 
 


























n= 3±S.D  BCF 
Carbamazepine 10.9±0.9 8.3±0.3 1.2 1.8±0.4 8.9±0.2 0.2 0.9 8.5±0.2 0.1 
Fluoxetine 1.3±0.1 0.6±0.1 2 1.2±0.2 0.7±0.1 2 2.1±0.5 0.6±0.1 3.5 
Sertraline 1.3 0.9±0.1 1.4 ND 0.9±0.1 NA 16.1±2.6 1.0±0.2 16 
Paroxetine 2.8 1.4±0.1 NA 0.9 1.4±0.2 0.6 9.4±6.2 1.4 7 
Ibuprofen ND 1.7±0.5 NA ND 0.5±0.2 NA ND 0.89±0.2 NA 
Gemfibrozil 0.6±0.4 1.9±0.7 0.3 ND 0.4±0.1 NA 1.3±0.2 1.6±0.4 0.8 
Triclosan 91±58 <LOQ NA 46±15 < LOQ NA 16±13 < LOQ NA 
                    








            
 
 
BNR 50% effluent 
 











n= 3±S.D  BCF 







n= 3±S.D  BCF 
 Carbamazepine 1.0±0.7 10.6±2 0.1 3.6±0.5 11.1±0.4 0.3 
 Fluoxetine 3.4±0.4 0.8±0.2 4 2.3±0.8 0.9±0.2 3 
 Sertraline 24.9±22.7 1.3±0.5 19 ND 1.1±0.3 NA 
 Paroxetine 10.4±3.7 1.8 6 0.5 1.8±0.2 0.3 
 Ibuprofen ND 1.1±0.4 NA ND 0.6±0.1 NA 
 Gemfibrozil 1.4±0.3 2.0±0.5 0.7 ND 0.5±0.1 NA 
 Triclosan 52.1±19 < LOQ NA 82±55 < LOQ NA 
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7.4.3 Bioaccumulation of pharmaceuticals in wild White Sucker 
The uptake and bioconcentration of pharmaceutical residues in wild white sucker collected 
from an effluent-dominated river (downstream of the MWWTPs servicing the cities of 
Kitchener and Waterloo) was investigated and determined using the SPME method 
previously developed and validated within the lab environment. In White Sucker muscle 
sampled from fish resident below the Waterloo effluent outfall, BCFs for the anti-depressants 
fluoxetine, venlafaxin, and sertraline were 41-3470, 8-164, and 194-3860 respectively (Table 
7.4). As per the laboratory exposures, water-soluble carbamazepine, while present in the 
environment, did not bioconcentrate in fish muscle. In a similar response, as observed below 
the Waterloo municipal wastewater discharge, White Sucker resident downstream of the 
Kitchener outfall had fluoxetine, venlafaxin and sertraline concentrated in their muscle 
tissues, although with lower BCFs than observed at Waterloo (Table 7.4).  Of the analytes 
examined, the anti-depressants bioconcentrate to the greatest extent in fish muscle, likely due 
to their relatively high octanol-water partition coefficients (log Kow >3), and subsequent 
tendency to partition from water to the relatively hydrophobic environment afforded by fish 
tissues 
31,181, 187, 209
. The higher BCFs observed in the White Sucker utilized in the field study 
relative to that observed with Rainbow Trout in the controlled laboratory exposure may be 
due to analyte uptake in the field from both water and dietary sources. The uptake of 
pharmaceuticals by White Sucker across both the gill (water) and gut epithelium (food) 
would thereby increase the realized body burden in this benthivorous species to levels which 
would be unattainable via water only, as is the case of the lab-exposed Rainbow Trout. 
Although there was no definite evaluation made of pharmaceutical burden obtained through 




rather than bioconcentration factors to reflect the potential routes of contaminant entrance in 
this species. Conversely, acidic drugs such as ibuprofen and gemfibrozil were not detected in 
White Sucker muscle, likely due to ionization, which facilitates rapid excretion/minimal 
uptake under the ambient pH environment of the MWWEs. In contrast, basic anti-depressives 
have a neutral charge at these environmental pH values, facilitating their partitioning to fish 
tissues 
92, 213
.Therefore, the presence and bioconcentration of ionic forms of compounds is a 
function of environmental pH and dissociation constants, whereas bioconcentration of 
neutral, nonpolar forms is attributable to their hydrophobic partitioning tendencies. In all 
instances in this study, in both experimental laboratory treated MWWEs and under real-
world field conditions, ionized acidic drugs or those of low log Kow did not bioconcentrate 
to the same extent as basic, neutral drugs, which were unchanged under local environmental 
conditions.   
Table 7:4 Bioaccumulation factors of pharmaceutical residues in wild White Sucker 
muscle collected near a municipal effluent outfall in downstream Waterloo and Kitchener 
          
  







n = 11 
Water Conc.  
(ng/ml)  Waterloo 
BCF/BAF 
Waterloo 
Carbamazepine 1.0 < LOQ 0.14 NA 
Fluoxetine 0.4 0.41 - 34.7 0.01 41-3470 
Atorvastatin 0.3 ND 0.05 NA 
Venlafaxin 0.1 0.81 - 16.4 0.10 8-164 
Paroxetine 0.5 0.11 - 7.9  ND NA 
Sertraline 0.2 1.94 - 38.6 0.01 194-3860 
Gemfibrozil 0.1 ND 0.01 NA 
Ibuprofen 0.3 ND 0.05 NA 




      
7.4.4 Bioconcentration of pharmaceuticals in wild White Sucker bile 
Fluoxetine, venlafaxin, paroxetine and sertraline bioconcentrated in the bile of wild White 
Sucker collected downstream of local MWWTPs discharging final treated effluent from the 




















Carbamazepine 1.0 ND 0.02 NA 
Fluoxetine 0.4 0.45 - 3.3 0.01 45-330 
Atorvastatin 0.3 ND 0.44 NA 
Venlafaxin 0.1 1.8-3.3 0.04 45-83 
Paroxetine 0.5 0.49 - 4.62 ND NA 
Sertraline 0.2 0.7 - 7.1 0.01 70-710 
Gemfibrozil 0.1 ND 0.01 NA 
Ibuprofen 0.3 ND 0.44 NA 
          




Table 7:5 Measured bioaccumulation factor of pharmaceuticals in wild White Sucker 
bile near a municipal effluent outfall in downstream Waterloo and Kitchener 







 Waterloo   
(ng/mL) 
n = 11 
Water Conc.  
Waterloo   
(ng/mL) 
n = 3 
BCF/BAF  
Waterloo 
Carbamazepine 0.6 ND 0.14 NA 
Fluoxetine 0.4 1.23 ± 0.78 0.01 123 
Atorvastatin 0.3 ND 0.05 NA 
Venlafaxin 0.1 0.59±0.41 0.10 6 
Paroxetine 0.4 1.52±0.77 <LOQ NA 
Sertraline 0.2 8.20±5.05 0.01 820 
Gemfibrozil 0.4 ND 0.01 NA 
Ibuprofen 0.7 ND 0.05 NA 
          
     
 
    






Kitchener    
(ng/mL) 
n = 11 
Water 
Conc.  
Kitchener   
(ng/mL) 
n = 3 
BCF   
Kitchener 
Carbamazepine 0.6 ND 0.02 NA 
Fluoxetine 0.4 4.07±1.24 0.09 45 
Atorvastatin 0.3 ND 0.44 NA 
Venlafaxin 0.1 0.63±0.78 0.04 15 
Paroxetine 0.4 12.23±2.00 < LOQ NA 
Sertraline 0.2 6.69±4.48 0.04 167 
Gemfibrozil 0.4 ND 0.01 NA 
Ibuprofen 0.7 ND 0.44 NA 
          




Water-soluble analytes such as carbamazepine, atorvastatin, ibuprofen and gemfibrozil were 
not detected in bile and, unlike the anti-depressives studied, have no need to undergo Phase I 
and II metabolism to facilitate excretion, and thus, are not transferred to bile 
49, 181, 213
. 
Biological biotransformation involves changing the xenobiotic properties, usually by 
hydroxylation, reduction or oxidation to increase water solubility and facilitate excretion. As 
a result, Phase I metabolites may be excreted directly, or further solubilized when phase II 
complexation conjugates these metabolites (or sometimes parent compounds) with a 
glucuronide, sulfate or glutathione molecule 
214
. Relative to other tissue and depending on the 
lipophilicity of the analyte, a greater portion of metabolites relative to its parent compounds 
may be found in bile as the hepatic processes delivering these analytes to the bile may have 
also subjected them to Phase I biotransformation. Similarly, parent compounds or 
metabolites conjugated to water soluble molecules facilitating excretion of the complex as 
Phase II conjugates were also detected in high concentrations for higher log Kow 
compounds.  
7.5 Conclusion 
This study demonstrates the utility of SPME in investigations into the bioconcentration 
potential of pharmaceuticals in fish, particularly for biological tissues such as bile and dorsal-
epaxial muscle. The present study further reinforces the well-recognized thesis that 
conventional wastewater treatments, both those experimental and in contemporary use by 
municipalities, are inefficient in removal of anti-depressants, which can 




method, solid phase microextraction is a promising analytical sampling technique for the in 























Summary and future directions of SPME technique 
 
8.1 Summary of applications of SPME technique 
8.1.1 Bioconcentration of pharmaceuticals in fish tissues: Analytical perspective 
The presence and bioaccumulation of active pharmaceutical ingredients in aquatic organisms 
such as fish still remains a subject of concern due its possible impact on both human health 
and aquatic biosystems. The primary source of pharmaceuticals in the aquatic environment is 
through treated wastewater (sewage) from municipal wastewater treatment plants, which are 
not presently designed to completely remove them. One of the main analytical challenges 
present involved with studying pharmaceuticals in the environment is the sensitivity of the 
analytical method used. The effect of complex matrices poses yet another challenge, since 
biological and environmental samples have complex matrices which can affect the 
performance of analytical methods. As a result, a vast number of analytical methodologies 
are currently being developed with the aim to identify and quantify contaminant residues in 
aquatic tissue.  
With recent developments, sensitivity of analytical methods has improved, in particular 
through the use of mass spectrometry with higher capability of selectivity and 
sensitivity
40,207,215
. Additionally, as a response to recent studies, the municipal and federal 
authorities have commenced upgrading treatment plants in order to increase the efficiency of 






was observed throughout this thesis in different studies mentioned prior, the fate and 
distribution of these environmental contaminants depend a variety of factors which must be 
taken into consideration such as: physico-chemical properties of the contaminants (water 
solubility, lipophilicity), environmental conditions, as well as diet and aquatic organism 
physiology (age, sex, species, and weight). However, we are able to use the concentration of 
environmental contaminants in fish tissue as an excellent indicator of the quality of water 
entering the aquatic environment. Therefore, it is important to establish the linkage between 
exposure of contaminants and the adverse effect in aquatic organisms such as fish 
212
. In 
order to achieve this, a reliable and robust analytical methodology is required. 
 
8.1.2 In vivo sampling and monitoring of pharmaceuticals in living organism 
Traditional analytical methodologies (Solid phase extraction, Solvent extraction) used for 
determination of pharmaceuticals in fish tissue are laborious, time consuming, and involve 
multiple steps in their workflow. Development and improvements achieved with SPME 
technique have enabled us to address some of the drawbacks associated with the traditional 
analytical methods, in particular their lack of simplicity, as well as the need for reduction of 
multiple steps associated with the analysis. Furthermore, the technique developed and 
discussed in this dissertation (C18 thin film SPME) can be used to investigate the 
concentration of environmental contaminants in living organisms (fish) without major 
consequences.  Hence, the use of SPME as a non-lethal sampling method provides a 




fish tissue without the need to sacrifice the animal being sampled 
61,179
. In view of the 
simplicity of the method, SPME is a promising technique that can be used for monitoring of 
environmental contaminants in fish tissue. Based on the in vivo sampling approach, the real-
time tissue concentration in fish can be determined, since contaminants can undergo 
continuous metabolic transformation in fish. Also, the technique has the potential to study the 
uptake and depuration of organic contaminants in fish, which may provide useful information 
on the bioavailability of contaminants.   
 
8.1.3 High throughput analysis of pharmaceuticals in wastewater  
The development of thin film automated multi-sampler has provided the possibility of 
monitoring environmental contaminants such as pharmaceuticals. Based on thin film 
geometry (blade), enhanced recovery can be achieved due to increased surface area of the 
extraction phase. As a result, method sensitivity and precision is enhanced. The automation 
of SPME procedure (particularly the extraction and desorption steps) coupled with liquid 
chromatography-mass spectrometer is a great advancement for the technique, which can 
provide high throughput analysis of organic contaminants in wastewater. Although manual 
solid phase extraction (SPE) is commonly used for analysis of organic contaminants in 
wastewater, its multi-step approach and the time consuming sample preparation are of 
concern. The development of SPME technique for this purpose acts as more precise and 
sensitive method option, simplifying the sample preparation for extraction of organic 




filtration. In addition, the choice of extraction phase and optimization of fibre coating 
(extraction phase) is crucial to the success of the method in terms of recovery, sensitivity and 
reproducibility of the method. 
 
8.2 Future direction of the SPME technique 
8.2.1 In vivo sampling by SPME for environmental analysis  
In vivo SPME technique has many potential applications, such as the investigation and 
monitoring of organic contaminants in protected or endangered living systems, where the 
organisms being sampled cannot be sacrificed. In addition, as a non-lethal sampling method, 
this technique  also minimizes the number of animals needed in research or monitoring of 
pollutants in aquatic organisms such as fish, minimizing the environmental impact on the 
system. This technique opens new possibilities in the areas of metabolomics study, 
toxicology and tissue analysis in fish.  SPME demonstrated several important advantages 
such as simplicity, sensitivity, and robustness for in vivo application in a dynamic system. 
Also, the automated blade system (based on SPME principle) is a promising method of 
pharmaceutical analysis in wastewater effluents and effluent-influenced surface waters with 
acceptable detection limits, capable of identifying the selected pharmaceuticals for 





8.2.2 Rapid sampling of organic contaminants in fish with new in vivo sampler 
The development of a new in vivo sampler device for sampling pharmaceuticals in fish is a 
great advancement toward implanting extraction phase in living organisms with minimal 
disturbance. Also, the new device can be used to rapidly sample pharmaceuticals in fish 
muscle without the need for anesthetization. Therefore, advancement in SPME device 
technology and methodology has opened up new possibilities for SPME applications, 
especially in combination with powerful mass spectrometers for in vivo monitoring of 
pollutants in living organisms such as fish. However, the development of new coating is 
necessary in order to widen the application of this device for environmental analysis of other 
classes of contaminants. Also, there is on-going development on new biocompatible coatings 
that may widen the applications of SPME for in vivo sampling of polar compounds in 
animals including fish
168
. In summary, SPME is a promising sample preparation technique 
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